<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50260</article-id><article-id pub-id-type="doi">10.7554/eLife.50260</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149974"><name><surname>Evans</surname><given-names>Chantell S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9401-8604</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-14447"><name><surname>Holzbaur</surname><given-names>Erika LF</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5389-4114</contrib-id><email>holzbaur@pennmedicine.upenn.edu</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Physiology, Perelman School of Medicine</institution><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Harper</surname><given-names>Wade</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Senior Editor</role><aff><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>01</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e50260</elocation-id><history><date date-type="received" iso-8601-date="2019-07-16"><day>16</day><month>07</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-19"><day>19</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2020, Evans and Holzbaur</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Evans and Holzbaur</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50260-v1.pdf"/><abstract><p>Mitophagy, the selective removal of damaged mitochondria, is thought to be critical to maintain neuronal homeostasis. Mutations of proteins in the pathway cause neurodegenerative diseases, suggesting defective mitochondrial turnover contributes to neurodegeneration. In primary rat hippocampal neurons, we developed a mitophagy induction paradigm where mild oxidative stress induced low levels of mitochondrial damage. Mitophagy-associated proteins were sequentially recruited to depolarized mitochondria followed by sequestration into autophagosomes. The localization of these mitophagy events had a robust somal bias. In basal and induced conditions, engulfed mitochondria remained in non-acidified organelles for hours to days, illustrating efficient autophagosome sequestration but delayed lysosomal fusion or acidification. Furthermore, expression of an ALS-linked mutation in the pathway disrupted mitochondrial network integrity and this effect was exacerbated by oxidative stress. Thus, age-related decline in neuronal health or expression of disease-associated mutations in the pathway may exacerbate the slow kinetics of neuronal mitophagy, leading to neurodegeneration.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>mitophagy</kwd><kwd>neurodegeneration</kwd><kwd>mitochondrial quality control</kwd><kwd>autophagy</kwd><kwd>parkin</kwd><kwd>lysosome acidification</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R37 NS060698</award-id><principal-award-recipient><name><surname>Holzbaur</surname><given-names>Erika LF</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>Hanna H Gray Fellowship</award-id><principal-award-recipient><name><surname>Evans</surname><given-names>Chantell S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>In neuronal mitophagy, Parkin and OPTN induce efficient sequestration of damaged somal mitochondria into autophagosomes, but slow turnover via lysosomal acidification may be a point of vulnerability for the cell.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The mitochondrial network is a dynamic interconnected system of organelles undergoing continuous renewal and rearrangement to support cellular needs. Given that neurons have high-energy demands at sites far from the soma, the targeted delivery and regulated removal of mitochondria are essential at these distal sites (<xref ref-type="bibr" rid="bib55">Millecamps and Julien, 2013</xref>; <xref ref-type="bibr" rid="bib85">Sheng, 2014</xref>). These organelles utilize mitochondrial membrane potential to perform cellular functions, including energy generation and Ca<sup>2+</sup> buffering. Mitochondrial damage or depolarization decreases function and signals maintenance mechanisms to repair or eliminate damaged organelles.</p><p>Due to the unique characteristics of neurons, multiple quality control mechanisms likely function independently to maintain mitochondrial health (<xref ref-type="bibr" rid="bib17">Evans and Holzbaur, 2019</xref>). In one pathway, mitochondrial fragments are engulfed in autophagosomes via basal, non-selective autophagy that initiates in the distal axon (<xref ref-type="bibr" rid="bib46">Maday and Holzbaur, 2014</xref>; <xref ref-type="bibr" rid="bib105">Wong and Holzbaur, 2014b</xref>). Autophagy, a conserved lysosomal degradation pathway, involves the engulfment of cargo to be degraded by a double-membrane organelle. Autophagosomes mature during trafficking along the axon to the soma by fusion with lysosomes, which leads to efficient cargo degradation (<xref ref-type="bibr" rid="bib11">Cheng et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Hollenbeck, 1993</xref>; <xref ref-type="bibr" rid="bib41">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Maday and Holzbaur, 2014</xref>; <xref ref-type="bibr" rid="bib45">Maday et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Neisch et al., 2017</xref>). In a second maintenance mechanism, dysfunctional mitochondria are removed through selective mitophagy, where damaged organelles are specifically sequestered and eliminated from the cell, also via the autophagic machinery (<xref ref-type="bibr" rid="bib24">Harper et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Misgeld and Schwarz, 2017</xref>; <xref ref-type="bibr" rid="bib65">Nguyen et al., 2016</xref>; <xref ref-type="bibr" rid="bib100">Wang and Klionsky, 2011</xref>; <xref ref-type="bibr" rid="bib108">Youle and Narendra, 2011</xref>). This pathway has been implicated in several neurodegenerative diseases including Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS; <xref ref-type="bibr" rid="bib17">Evans and Holzbaur, 2019</xref>).</p><p>Mitophagy is primarily regulated by two proteins linked to familial PD, PTEN-Induced Putative Kinase 1 (PINK1) and Parkin (<xref ref-type="bibr" rid="bib35">Kitada et al., 1998</xref>; <xref ref-type="bibr" rid="bib60">Narendra et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Narendra et al., 2010b</xref>; <xref ref-type="bibr" rid="bib96">Valente et al., 2004</xref>; <xref ref-type="bibr" rid="bib100">Wang and Klionsky, 2011</xref>; <xref ref-type="bibr" rid="bib108">Youle and Narendra, 2011</xref>). PINK1 recruits Parkin to phospho-ubiquitinate outer mitochondrial membrane proteins, which act as a specific cue for organelle degradation (<xref ref-type="bibr" rid="bib20">Geisler et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Kane et al., 2014</xref>; <xref ref-type="bibr" rid="bib32">Kazlauskaite et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Koyano et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Matsuda et al., 2010</xref>; <xref ref-type="bibr" rid="bib60">Narendra et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Narendra et al., 2010b</xref>; <xref ref-type="bibr" rid="bib67">Ordureau et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Ordureau et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Poole et al., 2010</xref>; <xref ref-type="bibr" rid="bib83">Sarraf et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Vives-Bauza et al., 2010</xref>). Optineurin (OPTN), an autophagy receptor causative for glaucoma and ALS (<xref ref-type="bibr" rid="bib51">Maruyama and Kawakami, 2013</xref>; <xref ref-type="bibr" rid="bib50">Maruyama et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">Rezaie et al., 2002</xref>), is recruited to the mitochondrial surface where it interacts with ubiquitin through its ubiquitin binding in ABIN and NEMO (UBAN) domain (<xref ref-type="bibr" rid="bib22">Gleason et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib79">Rogov et al., 2014</xref>; <xref ref-type="bibr" rid="bib103">Wild et al., 2011</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>; <xref ref-type="bibr" rid="bib111">Zhu et al., 2007</xref>). Other mitophagy receptors, such as Nuclear Dot Protein 52 kDa (NDP52) and TAX1 Binding Protein 1 (TAX1BP1), may be recruited in parallel, downstream from Parkin activity (<xref ref-type="bibr" rid="bib25">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>). OPTN association with the damaged mitochondrial surface is stabilized though phosphorylation by TANK-Binding Kinase 1 (TBK1), a serine/threonine kinase mutated in familial ALS (<xref ref-type="bibr" rid="bib19">Freischmidt et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Richter et al., 2016</xref>; <xref ref-type="bibr" rid="bib103">Wild et al., 2011</xref>). Subsequently, microtubule-associated protein light chain 3 (LC3), is targeted to the ubiquitinated mitochondria via the LC3 interacting region (LIR) of OPTN (<xref ref-type="bibr" rid="bib91">Stolz et al., 2014</xref>; <xref ref-type="bibr" rid="bib103">Wild et al., 2011</xref>), leading to engulfment of the organelle inside an LC3-positive autophagosome. Thus, OPTN is specifically recruited to depolarized organelles to mediate sequestration by an autophagosome and eventual degradation following lysosomal fusion.</p><p>Initial work to characterize mitophagy was performed in non-polarized cell types, such as HeLa cells, with subsequent studies focused on analyzing this mechanism in neurons. These results have been controversial, and the relative contribution of PINK1/Parkin-dependent mitophagy to neuronal health in vivo remains unclear. The mitophagy pathway in primary neuronal cultures appears to utilize the same molecular players described in non-neuronal cell lines, suggesting that PINK1/Parkin-mediated mitophagy is a conserved process across cell types. Surprisingly, however, in vivo studies have not fully supported this idea. PINK1 and Parkin knock-out (KO) mice display mild phenotypes with no dopaminergic neuron loss, a hallmark of PD, implying there are additional compensatory pathways contributing to neuronal mitophagy in vivo (<xref ref-type="bibr" rid="bib1">Akundi et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Goldberg et al., 2003</xref>; <xref ref-type="bibr" rid="bib36">Kitada et al., 2007</xref>; <xref ref-type="bibr" rid="bib70">Perez and Palmiter, 2005</xref>). In sharp contrast, KO rat models of PINK1 exhibited significant dopaminergic neuron loss, and null or mutant flies of PINK1 or Parkin display morphological defects in dopaminergic neurons (<xref ref-type="bibr" rid="bib10">Cha et al., 2005</xref>; <xref ref-type="bibr" rid="bib13">Clark et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Dave et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Park et al., 2006</xref>; <xref ref-type="bibr" rid="bib102">Whitworth et al., 2005</xref>; <xref ref-type="bibr" rid="bib106">Yang et al., 2006</xref>). The use of the acid-sensitive <italic>mito</italic>-QC mitophagy probe also did not reveal deficits in tissues of high metabolic demand in mice (<italic>mito</italic>-QC<sup>+/+</sup> <italic>Pink1</italic><sup>-/-</sup>) or in dopaminergic neurons of PINK1 and Parkin mutant flies (<xref ref-type="bibr" rid="bib42">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">McWilliams et al., 2018</xref>). However, the use of another acid-sensitive mt-Keima probe illustrated insufficiencies in basal mitophagy in dopaminergic neurons of Parkin-deficient flies (<xref ref-type="bibr" rid="bib14">Cornelissen et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Katayama et al., 2011</xref>; <xref ref-type="bibr" rid="bib92">Sun et al., 2015</xref>). Using the same probe in non-neuronal cells, essential roles for PINK1 and Parkin were shown in mitophagy following exhaustive exercise, hypoxic exposure, or rotenone treatment (<xref ref-type="bibr" rid="bib33">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Sliter et al., 2018</xref>). Further, stable isotope labeling of flies showed a slowing in the turnover of mitochondrial proteins isolated from the heads of Parkin null flies (<xref ref-type="bibr" rid="bib97">Vincow et al., 2013</xref>). Interestingly, recent work described an inflammatory phenotype in PINK1 and Parkin KO mice after acute or chronic mitochondrial stress that could be rescued by depletion of a regulator of the type 1 IFN signaling response (<xref ref-type="bibr" rid="bib86">Sliter et al., 2018</xref>). Thus, the respective roles of PINK1 and Parkin in mitophagy versus inflammation remain unclear, making it important to more fully characterize this pathway in neurons.</p><p>Neurons are highly polarized cells with extended axonal and dendritic processes and significant local energy demands (<xref ref-type="bibr" rid="bib57">Misgeld and Schwarz, 2017</xref>). This cellular morphology results in unique challenges for the cell and raises interesting questions as to whether all mitochondria are subject to the same quality control mechanisms and whether neuronal mitophagy is spatially regulated. In primary cortical neurons, the use of cyanide m-chlorophenylhydrazone (CCCP) treatment to induce mitochondrial damage resulted in an accumulation of Parkin-positive mitochondria in somatodendritic compartments, where damaged organelles underwent autophagosome engulfment and lysosomal degradation (<xref ref-type="bibr" rid="bib9">Cai et al., 2012</xref>). Neurons treated with CCCP or Antimycin A (AA; a potent complex III inhibitor) displayed enhanced retrograde mitochondrial motility, suggesting damaged organelles are trafficked back to the soma for degradation (<xref ref-type="bibr" rid="bib9">Cai et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Miller and Sheetz, 2004</xref>). This finding is supported by a recent report in which photo-converted axonal mitochondria underwent mitophagy in the soma after oxygen/glucose deprivation and reperfusion (<xref ref-type="bibr" rid="bib110">Zheng et al., 2019</xref>). In contrast, a study using hippocampal neurons characterized axonal mitophagy induced by treatment with AA or by selective local damage using the construct mito-KillerRed, a genetically encoded photosensitizer that causes light-induced reactive oxygen species (ROS) generation (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>). Clearance of axonal mitochondria was reported to be locally mediated by the autophagic pathway and dependent on PINK1 and Parkin (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>). In addition, several reports have described arrested axonal mitochondrial motility after damage due to the removal of Miro, a mitochondrial motor adaptor protein (<xref ref-type="bibr" rid="bib27">Hsieh et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="bib99">Wang et al., 2011</xref>). These later findings have led to a model in which damaged mitochondria remain stationary to allow for efficient local degradation and to prevent dissemination of damaged components through fusion, but consensus on this point is lacking (<xref ref-type="bibr" rid="bib110">Zheng et al., 2019</xref>). However, in vivo studies of mitophagy in PINK1 or Parkin mutant flies found no enhanced accumulation of axonal mitochondria in motor neurons, but did report dramatic changes in the morphology of somal mitochondria, indicating neuronal mitophagy may be compartmentally restricted (<xref ref-type="bibr" rid="bib16">Devireddy et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">Sung et al., 2016</xref>). Furthermore, analysis of basal mitophagy in Purkinje cells from <italic>mito</italic>-QC mice illustrated mitophagic events in somatodendritic compartments, with no axonal events reported (<xref ref-type="bibr" rid="bib53">McWilliams et al., 2016</xref>).</p><p>One potential reason for the apparent disconnect between in vitro and in vivo studies, as well as the lack of consensus among studies using primary neurons may be the methods used to initiate mitochondrial damage, including treatments with reagents that are highly toxic to neuronal health. Here, we developed a protocol in which mild oxidative stress was used to induce low levels of mitochondrial damage in primary hippocampal neurons without compromising the entire neuronal network, allowing us to readily visualize turnover under conditions in which stressed cells remain viable. Live-cell imaging was used to visualize the spatiotemporal dynamics of mitophagy-associated protein recruitment to damaged mitochondrial fragments. We found a pronounced accumulation of OPTN-positive mitochondria in the somal compartment of stressed neurons. In contrast, OPTN recruitment was rarely visualized in either dendrites or axons. The time course of mitophagy appears to be much slower in neurons than other cell types, with acidification and clearance occurring many hours after initial damage. Expression of an ALS-associated mutation in OPTN is sufficient to disrupt mitochondrial health under basal conditions and this is exacerbated by oxidative stress. Together, these data indicate that OPTN-dependent mitophagy is an important pathway for both the homeostatic regulation of the somal mitochondrial network and the cellular response to stress.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Low-level induction of ROS leads to selective mitochondrial damage without compromising the overall mitochondrial network</title><p>We used multicolor live-cell imaging to examine the spatial and temporal dynamics of mitophagy following mitochondrial damage. To model the subtle increases in ROS experienced by highly metabolically active neurons in vivo, we induced mitochondrial damage in hippocampal neurons by mild oxidative stress via antioxidant (AO) deprivation for 1 or 6 hr, noted as AO-free (<xref ref-type="bibr" rid="bib29">Joselin et al., 2012</xref>). In parallel, a low dose of AA (3 nM) was used as a positive control (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Cell viability limited the time frame of AA treatment, but since AA is a more potent damaging agent, the 2 h AA time point was compared to the 6 h time points from either AO-free or control conditions. None of these conditions caused widespread cell death (&gt;90% of transfected cells remained viable) and treated neurons recovered within 24 h after treatment.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Antioxidant removal induces low levels of mitochondrial damage and sequestration without compromising the entire neuronal network.</title><p>(<bold>A</bold>) Schematic of experimental paradigm to initiate mitophagy. (<bold>B</bold>) Fluorescence intensity quantification of intracellular ROS by the CellROX reagent in control and treated conditions. Mean ± SEM; <italic>n</italic> = 8 wells/condition per replicate, from 4 biological replicates; 7 DIV. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>C–D</bold>) Representative images (<bold>C</bold>) and quantification (<bold>D</bold>) of TMRE fluorescence intensity. Mean ± SEM; <italic>n</italic> = 31-38 neurons from 3-4 biological replicates; 7 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. Scale bar, 5 μm. (<bold>E</bold>) Volume renderings of the somal mitochondrial network; original and enlarged images are shown for each neuron. Scale bar, 0.7 μm; inset, 4 μm. (<bold>F</bold>) Quantification of the somal mitochondrial content. Mean ± SEM; <italic>n</italic> = 16-24 neurons from 3-4 biological replicates; 6-7 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>G–H</bold>) Representative Western blot (<bold>G</bold>) and quantification (<bold>H</bold>) of mitophagy-associated proteins from cultured hippocampal neurons. Data shown as the fold change over control of the protein of interest divided by total protein stain. Normalization factors are shown under representative images. Mean ± SEM; <italic>n</italic> = 5 biological replicates; 7-8 DIV. Not significant (n.s.); *, <italic>p</italic> &lt; 0.05 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>I</bold>) Representative single plane images from a somal z-stack showing OPTN sequestration of damaged spherical mitochondria; examples of these mitophagy events are shown in insets. Scale bar, 3 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>OPTN puncta localize to rounded and fragmented mitochondria.</title><p>(<bold>A</bold>) Relative frequency of the somal mitochondrial aspect ratio. <italic>n</italic> = 21-28 neurons from 3 biological replicates; 7 DIV. (<bold>B–C</bold>) Representative Western blot (<bold>B</bold>) and quantification (<bold>C</bold>) of ATG16L1 and ATG5. Data shown as the fold change over control of the protein of interest divided by total protein stain. Normalization factors are shown under representative images. Mean ± SEM; <italic>n</italic> = 4 biological replicates; 7 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>D</bold>) Quantification of the percent of OPTN puncta on linear and rounded mitochondria. Mean ± SEM; <italic>n</italic> = 21-28 neurons from 3 biological replicates; 7 DIV. Not significant (n.s.); ***, <italic>p</italic> &lt; 0.001 by unpaired t test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To quantitatively assess whether these mild oxidative stresses initiated mitochondrial damage, intracellular ROS was detected by a fluorogenic probe, CellROX. The signal intensity of CellROX was low in control neurons and increased significantly in both the AO-free and AA conditions (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Since rounding and fragmentation are hallmarks of mitochondrial damage (<xref ref-type="bibr" rid="bib95">Twig et al., 2008</xref>; <xref ref-type="bibr" rid="bib101">Westermann, 2010</xref>; <xref ref-type="bibr" rid="bib108">Youle and Narendra, 2011</xref>), we examined morphology following treatments by either staining with tetramethyl rhodamine ethyl ester (TMRE), a vital dye used to measure mitochondrial potential (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>), or by transient transfection with Mito-DsRed (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). Control and treated neurons all displayed dynamic interconnected mitochondrial networks (<xref ref-type="fig" rid="fig1">Figure 1C and E</xref>). As a more sensitive measure, we quantified the mitochondrial aspect ratio from single z-planes and saw a modest increase in mitochondria with an aspect ratio of ≤1.5 in neurons treated with AO-free media compared to control (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Quantification of the TMRE intensity or somal mitochondrial content revealed similar levels across the different treatments (<xref ref-type="fig" rid="fig1">Figure 1D and F</xref>). Thus, large-scale changes in mitochondrial morphology or polarization state were not detected in the somal mitochondrial network following stress.</p><p>In neurons, we examined the endogenous expression levels of mitophagy-associated proteins, including Parkin, TBK1, OPTN, LC3, and LAMP1 (<xref ref-type="bibr" rid="bib25">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib60">Narendra et al., 2008</xref>; <xref ref-type="bibr" rid="bib77">Richter et al., 2016</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>). Protein levels remained consistent across treatments, with the exception of an increase in Parkin expression following 1 h AO-free treatment (<xref ref-type="fig" rid="fig1">Figure 1G–H</xref>), although it should be noted that the magnitude of the increase was comparable to the nonsignificant increases in Parkin levels following other mitophagy treatments. We also observed no significant differences in the expression levels of ATG5 and ATG16L1, proteins required for autophagy initiation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B-C</xref>; <xref ref-type="bibr" rid="bib58">Mizushima et al., 2001</xref>; <xref ref-type="bibr" rid="bib94">Suzuki et al., 2001</xref>). The lack of change in endogenous protein expression suggests that under these conditions, mitophagy is driven by the translocation of existing proteins to damaged mitochondria rather than de novo protein synthesis, which correlates with the time-sensitive nature of this mechanism. However, it is possible that small changes in protein levels due to mitophagic flux cannot be detected via Western blot analysis.</p><p>We next determined whether our mitochondrial damage paradigm was sufficient to not only induce organelle damage, but to initiate neuronal mitophagy. In HeLa cells expressing exogenous Parkin, OPTN was efficiently recruited to fragmented mitochondria within 30 min following CCCP treatment (<xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>). In contrast, Parkin is endogenously expressed in hippocampal neurons (<xref ref-type="fig" rid="fig1">Figure 1G–H</xref>), so Parkin overexpression was not utilized in these experiments unless explicitly stated, to ensure that overexpression did not hyperactivate the pathway leading to non-physiological levels of mitophagy. Cells were transfected with Mito-DsRed and Halo-OPTN and treated for 1 h with control or AO-free media. Monitoring across focal planes using z-stack images, we visualized OPTN rings formed around small spherical mitochondrial fragments distributed throughout the soma (<xref ref-type="fig" rid="fig1">Figure 1I</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). Z-stack images of the entire soma ensured that OPTN-positive mitochondria were indeed spherical and isolated from the network.</p><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-50260-video1.mp4"><label>Video 1.</label><caption><title>OPTN is recruited to spherical, damaged mitochondria in the soma.</title><p>Representative neuron treated for 1 h with AO-free media. Live-cell imaging was used to take a z-stack through the soma. Arrows indicate OPTN rings around damaged spherical mitochondria (see <xref ref-type="fig" rid="fig1">Figure 1I</xref> for single plane images). Scale bar, 5 μm.</p></caption></media><p>To investigate the extent of OPTN association with damaged mitochondria, we quantified the percent of OPTN puncta on linear (i.e. healthy) versus rounded (i.e. damaged) mitochondria. OPTN association with rounded mitochondria significantly increased after mitophagy induction with AO-free treatment compared to control. In contrast, the percentage of OPTN puncta on linear mitochondria was similar in either condition (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). It should be noted that the majority of OPTN puncta (~60–70%) were not associated with mitochondria. These puncta may represent either the self-association of OPTN or the recruitment of OPTN to other autophagy substrates, such as protein aggregates (<xref ref-type="bibr" rid="bib38">Korac et al., 2013</xref>). Of note, OPTN puncta were also observed in cells expressing endogenous levels of OPTN by immunocytochemistry, indicating they are not a consequence of overexpression.</p></sec><sec id="s2-2"><title>OPTN and TBK1 are specifically recruited to damaged mitochondria in hippocampal neurons</title><p>In non-neuronal cells, OPTN, NDP52, and TAX1BP1 are proposed to mediate the autophagic clearance of damaged mitochondria, while p62 clusters organelles without directly facilitating mitophagy (<xref ref-type="bibr" rid="bib25">Heo et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib61">Narendra et al., 2010a</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>). In neurons, the extent to which these autophagy receptors cooperate to mediate neuronal mitophagy is unclear. We compared the endogenous protein levels of OPTN, NDP52, TAX1BP1 and p62. Western blot analysis showed that all autophagy receptors were expressed in total brain, cortex and hippocampus (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). Immunostaining of endogenous OPTN and p62 indicated that both proteins were found in all neuronal compartments (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–H</xref>). The high expression levels of OPTN in human brain samples imply it is the predominate autophagy receptor mediating neuronal mitophagy (<xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>).</p><p>The current model suggests that following damage to a mitochondrion, phospho-ubiquitination of outer mitochondrial membrane proteins mediated by PINK1-recruited Parkin increases the abundance of ubiquitin chains, which recruit OPTN and TBK1 to the organelle (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib24">Harper et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Ordureau et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Richter et al., 2016</xref>). We confirmed that the observed translocation of OPTN to damaged mitochondria in hippocampal neurons was downstream of Parkin by depleting the E3-ubiquitin ligase using siRNA. In a Parkin knock-down (KD) background, overexpression of mCherry-Parkin<sup>WT</sup> significantly increased the percentage of cells with OPTN-positive mitochondria rings following 1 h AO-free treatment compared to KD alone (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Only partial rescue was observed with the Parkinson’s disease-linked mutant mCherry-Parkin<sup>T240R</sup> (<xref ref-type="bibr" rid="bib89">Sriram et al., 2005</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>OPTN colocalizes with upstream mitophagy-associated proteins within an hour of antioxidant removal.</title><p>(<bold>A</bold>) Schematic of the translocation of mitophagy-associated proteins to a damaged organelle. (<bold>B</bold>) Volume rendering of an OPTN-positive mitochondrion. Scale bar, 0.5 μm. (<bold>C</bold>) Representative image of an OPTN-positive mitochondrion that is TMRE-negative, confirming specific recruitment to damaged organelles. Scale bar, 1 μm. (<bold>D–F</bold>) Representative somal images of neurons expressing markers for mitochondria, OPTN, and ubiquitin (Ub; <bold>D</bold>), Parkin (<bold>E</bold>), and TBK1 (<bold>F</bold>). After 1 h in AO-free media, translocated proteins form rings around damaged mitochondria (1; red arrows and inset) and form puncta that colocalize with damaged mitochondria (2; green arrows and inset). Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>OPTN is expressed in various brain regions and localized throughout the neuron.</title><p>(<bold>A–B</bold>) Representative Western blot (<bold>A</bold>) and quantification (<bold>B</bold>) of OPTN, p62, TAX1BP1, and NDP52 in total brain, cortex, and hippocampus. Mean ± SEM; <italic>n</italic> = 3 biological replicates. (<bold>C–E</bold>) Representative image of endogenous OPTN in the soma (<bold>C</bold>), distal axon (<bold>D</bold>), and dendrite (<bold>E</bold>). (<bold>F–H</bold>) Representative image of endogenous p62 in the soma (<bold>F</bold>), distal axon (<bold>G</bold>), and dendrite (<bold>H</bold>). Red arrows in panels C and F depict the axon labeled by anti-Neurofilament H (NF-H) and anti-Tau, respectively; an enlarged image of the soma is shown in the inset. Corresponding line scans for the axon and dendrite are shown to the right of the representative images; red arrows indicate OPTN and p62 puncta. Scale bars: soma, 20 μm; axons and dendrites, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>OPTN fails to engulf damaged mitochondria when Parkin is depleted.</title><p>(<bold>A–B</bold>) Representative Western blot (<bold>A</bold>) and quantification (<bold>B</bold>) of neurons after treatment with mock or Parkin siRNA. Normalization factors are shown under lanes. Data shown as the fold change over control of Parkin divided by total protein stain. Mean ± SEM; <italic>n</italic> = 3 from 3 biological replicates; 8 DIV. ***, <italic>p</italic> &lt; 0.001 by unpaired t test. (<bold>C</bold>) Representative Western blot of non-transfected, Parkin siRNA treated, and Parkin siRNA treated neurons overexpressing mCherry-Parkin<sup>WT</sup> or mCherry-Parkin<sup>T240R</sup>. Normalization factors are shown under lanes. (<bold>D</bold>) Quantification of the percent of neurons with OPTN-positive mitochondria after 1 h AO-free treatment in a Parkin KD and rescue background. The dashed line represents the percent of cells with mitophagic events in treated cells not overexpressing Parkin (see <xref ref-type="fig" rid="fig3">Figure 3D</xref>). Mean ± SEM; <italic>n</italic> = 32-33 neurons from 3 biological replicates; 8 DIV. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01 by one-way ANOVA with Tukey’s multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Since OPTN recruitment to mitochondrial fragments was seen following mitophagy treatment (<xref ref-type="fig" rid="fig1">Figure 1I</xref> and <xref ref-type="fig" rid="fig2">Figure 2B</xref>), we asked whether OPTN translocation is specific to dysfunctional organelles. After mitophagy induction by mild oxidative stress, most mitochondria exhibited normal dynamics and were dual-labeled with Mito-DsRed and TMRE. In contrast, OPTN-positive mitochondria were labeled with Mito-DsRed but displayed little to no TMRE signal, demonstrating specific OPTN recruitment to damaged organelles (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Additionally, we noted that the mitophagy-associated proteins Parkin and TBK1 robustly colocalized along with OPTN to damaged, ubiquitinated organelles (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). These proteins formed rings around damaged mitochondria as observed in confocal slices (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>; red arrows and insets, 1); z-stacks highlight the spherical decoration of mitochondrial fragments with these proteins. We also observed puncta of OPTN and other proteins that colocalized with isolated mitochondrial fragments (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>; green arrows and insets, 2); these puncta may represent the initiating events that nucleate full ring formation. As a result of these findings, we used OPTN translocation and ring formation as a positive identifier of depolarized mitochondria that were undergoing mitophagy for the remaining experiments.</p></sec><sec id="s2-3"><title>OPTN-mediated mitophagy occurs preferentially in the somatodendritic compartment of hippocampal neurons</title><p>Previous observations of mitophagy in neurons have reached differing conclusions on whether mitophagy occurs locally, for example at the site of mitochondrial damage in the axon, or instead is restricted to the somatodendritic compartment (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Cai et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Devireddy et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">Sung et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Zheng et al., 2019</xref>). To address this question, we first characterized the effect of mild oxidative stress in the axon. We measured axonal mitochondria and autophagosome dynamics and observed no differences in motility, density, and area flux between conditions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–H</xref>). Recent work has shown that oxygen/glucose deprivation and reperfusion induce a transient upregulation of retrograde mitochondrial motility (<xref ref-type="bibr" rid="bib110">Zheng et al., 2019</xref>), so it possible that there was a transient response prior to our observation window. While we did note a decrease in the length of axonal mitochondria in both AO-free and AA conditions compared to control conditions, we found no significant difference in TMRE signal per cell (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I–J</xref>). The decrease in length suggests that mitochondrial fragmentation may be induced by oxidative damage, so we measured the average number of fusion and fission events per neuron, but saw no change in mitochondrial fission (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1K</xref>).</p><p>Next, we investigated the spatial dynamics of OPTN-mediated neuronal mitophagy by acquiring z-stacks of neuronal compartments (soma, dendrite, or axon) following mitophagy treatments (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). Cells were transfected with Mito-DsRed, Halo-OPTN, and YFP-Nav<sub>II-III</sub>, which localizes to the proximal region of the axon initial segment (AIS) and was used to discriminate between axons and dendrites. A higher percentage of AO-free treated neurons displayed OPTN-positive mitochondria compared to control cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Strikingly, in AO-free treated neurons ~ 95% of all mitophagic events occurred in the somal compartment, with limited events in either dendrites or axons (<xref ref-type="fig" rid="fig3">Figure 3E</xref>); this trend was also observed in control conditions. Given the much greater mitochondrial volume in the soma relative to the axon (somal mitochondrial content ~0.2 μm<sup>3</sup>/μm<sup>3</sup>; axonal mitochondrial content ~0.02 μm<sup>3</sup>/μm<sup>3</sup>), it is possible that these experiments undersampled axonal events. To address this possibility, we searched specifically for mitophagic events in the axons of control and treated cells. We found a very low frequency of OPTN-positive mitochondrial fragments in axons that was not different between control and treated neurons (3/27 axons in control cells; 1/27 axons in AO-treated cells; 1/28 axons in AA-treated cells).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>OPTN is specifically recruited to damaged mitochondria in the soma after mitophagy induction.</title><p>(<bold>A–C</bold>) Representative image of the soma (<bold>A</bold>), dendrite (<bold>B</bold>), and axon (<bold>C</bold>) of a hippocampal neuron treated for 1 h with AO-free media. Mitophagy events are shown with red arrows. Scale bars: soma, 5 μm; axon and dendrite, 1 μm. (<bold>D</bold>) Quantification of the percent of neurons that contain OPTN-positive mitochondria. Mean ± SEM; <italic>n</italic> = 21-28 neurons from 3 biological replicates; 7 DIV. *, <italic>p</italic> &lt; 0.05 by unpaired t test. (<bold>E</bold>) Quantification of the percent of OPTN-positive mitochondria in each cellular compartment for neurons treated for 1 h with AO-free media. Mean ± SEM; <italic>n</italic> = 21-28 neurons from 3 biological replicates; 7 DIV. ****, <italic>p</italic> &lt; 0.0001 by one-way ANOVA with Dunn’s multiple comparisons test. (<bold>F</bold>) Quantification of the percent of cells with OPTN-positive mitochondria rings for longer and harsher treatment conditions. Mean ± SEM; <italic>n</italic> = 36-48 neurons from 3-4 biological replicates; 7 DIV. **, <italic>p</italic> &lt; 0.01 by one-way ANOVA with Dunn’s multiple comparisons test. (<bold>G–H</bold>) Quantification of CellROX fluorescence intensity in the soma (<bold>G</bold>) and dendrites and axons (<bold>H</bold>). Mean ± SEM; <italic>n</italic> = 38-44 images from 3 biological replicates; 7-9 DIV. ***, <italic>p</italic> &lt; 0.001; ****, <italic>p</italic> &lt; 0.0001 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. Dendrite, Dend.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Antioxidant removal alters axonal mitochondrial length with no effect on the TMRE fluorescence intensity.</title><p>(<bold>A</bold>) Kymographs from live-cell imaging of EGFP-LC3 in hippocampal neurons. Scale bars: horizontal, 10 μm; vertical, 1 min. (<bold>B–D</bold>) Quantification of autophagosome motility (<bold>B</bold>), density (<bold>C</bold>), and area flux (<bold>D</bold>) in the mid-axon. Mean ± SEM; <italic>n</italic> = 16-19 neurons from 3 biological replicates; 6 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>E</bold>) Straightened images and representative kymographs of Mito-DsRed in the mid-axon. Scale bars: horizontal, 10 μm; vertical, 1 min. (<bold>F–H</bold>) Quantification of mitochondrial motility (<bold>F</bold>), density (<bold>G</bold>), and area flux (<bold>H</bold>). Mean ± SEM; <italic>n</italic> = 18-20 neurons from 3 biological replicates; 7-8 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>I</bold>) Quantification of axonal mitochondria length in the mid-axon of control and treated neurons. Mean ± SEM; <italic>n</italic> = 18-20 neurons from 3 biological replicates; 7-8 DIV. **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>J</bold>) Quantification of the TMRE fluorescence intensity of mitochondria in the mid-axon. Mean ± SEM; <italic>n</italic> = 40-46 neurons from 3 biological replicates; 7-8 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>K</bold>) Quantification of the average number of mitochondrial fusion and fission events in the mid-axon. Mean ± SEM; <italic>n</italic> = 18-20 neurons from 3 biological replicates; 7-8 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To follow up on this point, we used longer (6 h AO-free) and harsher (2 h AA) treatments to induce mitophagy and again observed similar levels of OPTN-positive mitochondria in the soma, but rarely in the axon (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). To test whether our mitophagy inducing protocol preferentially targeted somal mitochondria as compared to axonal and dendritic mitochondria, we visualized CellROX in all compartments. We observed similar levels of ROS generation in the soma and processes of treated neurons compared to control (<xref ref-type="fig" rid="fig3">Figure 3G–H</xref>). Consistently, there was change in the TMRE intensity of mitochondria in all compartments, implying that the mitochondrial network health was intact (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J</xref>). We did note that analysis at the level of individual mitochondria revealed a minor decrease in the TMRE fluorescence intensity of axonal mitochondria following 2 h AA treatment compared to 6 h control conditions; this was not observed with 6 h AO-free treatments. We hypothesize that either long-term exposure to low doses (&gt;2 hr) or short periods of high concentration of AA (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>) may disrupt mitochondrial bioenergetics causing axonal mitochondria to undergo mitophagy locally to preserve the health of the neuron. However, under conditions of mild oxidative stress, we find that neuronal mitophagy is generally restricted to the soma.</p></sec><sec id="s2-4"><title>Autophagosome engulfment occurs after OPTN ring formation</title><p>The multiple genetic links between components of the mitophagy pathway and neurodegeneration strongly suggest that failure to remove damaged organelles is detrimental to neuronal health. Therefore, the time course of removal is likely to be critical. In non-neuronal cell lines, the full engulfment of damaged mitochondria by LC3-positive autophagosomes can occur within an hour of an initiating insult, such as CCCP treatment or induction of localized ROS production via mito-KillerRed (<xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>). A similar time course was reported for sequestration and lysosomal removal of damaged axonal mitochondria (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>). However, another study found the pathway was just initiating 24 h post-CCCP treatment, with only a small fraction of neurons displaying detectable Parkin translocation to damaged organelles (<xref ref-type="bibr" rid="bib9">Cai et al., 2012</xref>). We addressed this uncertainty by examining the time course for LC3 recruitment to damaged mitochondria following mitophagy induction (1 or 6 h AO-free or 2 h AA). Cells were transfected with Mito-DsRed, Halo-OPTN, and EGFP-LC3 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>); in some experiments YFP-Nav<sub>II-III</sub> was used to discriminate between compartments, so neurons were instead transfected with Mito-SNAP, Halo-OPTN, and mScarlet-LC3 (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>). We visualized fragmented mitochondrial puncta that were OPTN- and LC3-positive in the soma, with limited events observed in the dendrites and axons, 6 h after antioxidant deprivation (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; red arrows and inset).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>LC3 translocates to damaged mitochondria after OPTN ring formation.</title><p>(<bold>A–C</bold>) Representative image of the soma (<bold>A</bold>), dendrite (<bold>B</bold>), and axon (<bold>C</bold>) of a hippocampal neuron treated for 6 h with AO-free media. A mitophagosome is specified by red arrows and inset. Scale bars: soma, 5 μm; axon and dendrite, 2 μm. (<bold>D</bold>) Gallery of representative images demonstrating fully formed OPTN rings around damaged mitochondria with various stages of LC3 ring development, including EGFP-LC3 positive, negative, or incomplete (containing a punctum or partial ring). Red arrows highlight LC3 puncta. Scale bar, 1 μm. (<bold>E</bold>) Quantification of the number OPTN rings that are LC3-positive, LC3-negative, or partial-LC3. The total number of events are listed for each condition. <italic>n</italic> = 36–48 neurons from 3 to 4 biological replicates; 7 DIV.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig4-v1.tif"/></fig><p>LC3 ring formation was captured at multiple stages, as shown by the gallery of images (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Initially, fully formed OPTN rings around damaged mitochondria were LC3-negative. LC3 targeted to ubiquitinated OPTN-positive mitochondria appeared as a punctum on the OPTN ring, that expanded with time to form full LC3 rings surrounding mitochondrial fragments or mitophagosomes (<xref ref-type="fig" rid="fig4">Figure 4D</xref>); note that rings were observed in a single confocal plane, but these correspond to spheres in 3D reconstructions from z-stacks. We quantified the relative percentage of OPTN-positive rings that were LC3-negative, partially positive (a punctum or partial ring), or completely engulfed to determine whether there was a difference in the distribution among the experimental conditions. For all treatments, approximately a quarter of events were OPTN-positive but LC3-negative, a quarter displayed LC3 puncta or partially formed rings, and half of fragmented mitochondria were both OPTN- and LC3-positive (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). These observations indicate that effective mitophagosome formation occurs within an hour after initial damage. This efficient sequestration of damaged organelles may be critical to prevent dissemination of damaged components throughout the mitochondrial network.</p></sec><sec id="s2-5"><title>Acidification of OPTN-positive mitochondria is a rate-limiting step in neuronal mitophagy</title><p>We next investigated the time course for lysosomal engulfment of damaged mitochondria by monitoring the recruitment of LAMP1, a late endosomal/lysosomal marker. Neurons were transfected with Mito-DsRed, Halo-OPTN, and LAMP1-EGFP and mitophagy was induced. We identified OPTN-positive mitochondria and quantified the ratio of LAMP1-positive or LAMP1-negative events (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). In control conditions, the vast majority of events were LAMP1-positive. Induction of mitophagy significantly increased the number of LAMP1-negative mitophagic events compared to control (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Thus, under basal conditions, neurons can efficiently sequester dysfunctional mitochondria, but perturbations to the system that increase organelle damage may overwhelm the pathway and stall lysosomal fusion.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mitochondria are sequestered in LAMP1-positive organelles that are non-acidified.</title><p>(<bold>A</bold>) Representative image of a hippocampal neuron 6 h after AO-free treatment; an OPTN-LAMP1-positive event is indicated by the red arrows and the inset. Scale bar, 5 μm. (<bold>B</bold>) Quantification of the ratio of OPTN-positive mitochondria that are LAMP1-positive or LAMP1-negative compared to the total number of events. Mean ± SEM; <italic>n</italic> = 32-35 neurons from 3 biological replicates; 6-8 DIV. *, <italic>p</italic> &lt; 0.05 by unpaired t test. (<bold>C</bold>) Representative image of a hippocampal neuron; an OPTN-positive mitochondrion is negative for Lysotracker Green (LysoT) 6 h after mitophagy induction (red arrows and inset). Scale bar, 5 μm. (<bold>D</bold>) Quantification of the ratio of OPTN-positive events that are LysoT-positive or LysoT-negative compared to the total number of events. Mean ± SEM; <italic>n</italic> = 33-40 neurons from 3-4 biological replicates; 6-8 DIV. Not significant (n.s.) by one-way ANOVA with Tukey’s multiple comparisons test. (<bold>E–G</bold>) Representative Western blot (<bold>E</bold>) and quantification of TFEB (<bold>F</bold>) and pTFEB<sup>S211</sup> (<bold>G</bold>) from cultured hippocampal neurons. Data shown as the fold change over control of TFEB divided by total protein stain (<bold>F</bold>) or as pTFEB<sup>S211</sup> over total TFEB (<bold>G</bold>). Normalization factors are shown under representative images. Mean ± SEM; <italic>n</italic> = 3 biological replicates; 7-8 DIV. Not significant (n.s.) by one-way ANOVA with Dunn’s multiple comparisons test. (<bold>H–J</bold>) Representative Western blot (<bold>H</bold>) and quantification of ProCathepsin D (ProCatD; <bold>I</bold>) and mature Cathepsin D (CatD; <bold>J</bold>) from primary hippocampal neurons. Data shown as the fold change over control of the protein of interest divided by total protein stain. Mean ± SEM; <italic>n</italic> = 3 biological replicates; 7-8 DIV. Not significant (n.s.); *, <italic>p</italic> &lt; 0.05 by one-way ANOVA with Dunn’s multiple comparisons test. (<bold>K</bold>) Schematic of lysosomal fusion (marked by LAMP1) and acidification (marked by LysoT) of damaged mitochondria in basal and induced conditions. The majority of mitophagosomes are LAMP1-positive in control conditions, but only half of mitophagosomes are LAMP1-positive in treated neurons. However, most fragmented mitochondria are LysoT-negative in either basal or induced neurons. (<bold>L</bold>) Table depicting the various vesicular compartments that sequester damaged mitochondria.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Mitophagy induction does not alter the acidification of cellular autophagosomes or lysosomes.</title><p>(<bold>A–B</bold>) Quantification of the percent of autophagosomes per neuron that are non-acidified and acidified 1 h (<bold>A</bold>) or 6 h (<bold>B</bold>) after treatment. Mean ± SEM; <italic>n</italic> = 23-29 neurons from 3 biological replicates; 6 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>C</bold>) Quantification of the percent of lysosomes per neuron that are non-acidified and acidified 1 h after treatment. Mean ± SEM; <italic>n</italic> = 37-38 neurons from 3 biological replicates; 6-7 DIV. Not significant (n.s.) by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>D–E</bold>) Representative images of hippocampal neurons expressing LAMP1-EGFP (<bold>D</bold>) or LAMP2-EGFP (<bold>E</bold>) and labeled with LysoT. The majority of LAMP organelles are LysoT-positive (red arrows and inset), denoting acidified organelles. A minor population are non-acidified (LAMP-positive LysoT-negative; white arrows). Scale bar, 5 μm. (<bold>F–G</bold>) Representative images of hippocampal neurons treated for 1 h with control (<bold>F</bold>) or AO-free (<bold>G</bold>) media. OPTN-LC3-positive mitochondria are negative for WIPI2B, indicating fully formed autophagosomes (red arrows and inset); immature autophagosomes, WIPI2B-LC3-positive, are also found in the soma (green arrows). Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Mitophagosomes are quickly acidified to clear damaged mitochondria in HeLa cells.</title><p>(<bold>A–B</bold>) Representative images of HeLa cells expressing untagged Parkin that were treated for 90 min with AA/Oligomycin A (OA) and allowed to recover in control media. Cells were imaged at various time points after the completion of treatments to monitor LAMP1 (<bold>A</bold>) and LysoT (<bold>B</bold>) recruitment to OPTN-positive mitochondria; events are highlighted in insets. Quantification of the percent of mitophagosomes per cell that are LAMP1- and LysoT-positive are shown below the representative images. Mean ± SEM; <italic>n</italic> = 47-55 cells from 3 biological replicates. ****, <italic>p</italic> &lt; 0.0001 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig5-figsupp2-v1.tif"/></fig></fig-group><p>A similar analysis was performed for neurons treated with LysoTracker Green (LysoT), a fluorescent dye that marks acidic vesicular compartments, to monitor the organelle acidification that is required for mitochondrial degradation (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). In sharp contrast to our observations of LAMP1 co-localization, nearly all mitophagy events observed were LysoT-negative, no matter the treatment condition (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). A small number of OPTN-positive mitochondria became LysoT-positive at longer timepoints. These observations illustrate that following induction of neuronal mitophagy, acidification and turnover of damaged mitochondria is quite slow.</p><p>However, it may be that our mitophagy induction paradigm unexpectedly disrupts the acidification state of cellular autophagosomes and lysosomes. We examined the acidification of both organelles and determined that neither autophagosome nor lysosome acidification was disrupted by antioxidant deprivation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>). These data are consistent with previous reports that autophagosomes effectively fuse with lysosomes to degrade cargo (<xref ref-type="bibr" rid="bib8">Boland et al., 2008</xref>; <xref ref-type="bibr" rid="bib34">Kimura et al., 2008</xref>; <xref ref-type="bibr" rid="bib41">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib45">Maday et al., 2012</xref>). In addition, we monitored expression level of Transcription Factor EB (TFEB), a master transcriptional regulator of genes that are involved in lysosomal biogenesis and function (<xref ref-type="bibr" rid="bib5">Bajaj et al., 2019</xref>; <xref ref-type="bibr" rid="bib82">Sardiello, 2016</xref>). TFEB phosphorylation (pTFEB) at S211 sequesters the protein in the cytosol (<xref ref-type="bibr" rid="bib49">Martina et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Roczniak-Ferguson et al., 2012</xref>). We saw no changes in the levels of TFEB or pTFEB<sup>S211</sup> across all treatments compared to control (<xref ref-type="fig" rid="fig5">Figure 5E–G</xref>). We also examined Cathepsin D (CatD), a protease localized to lysosomes that nonspecifically degrades autophagosomal contents following autophagosome-lysosome fusion (<xref ref-type="bibr" rid="bib7">Benes et al., 2008</xref>). ProCatD is targeted to intracellular vesicles where it undergoes processing to form an active enzyme, CatD (<xref ref-type="bibr" rid="bib7">Benes et al., 2008</xref>). The levels of ProCatD remained consistent across treatments, with the exception of a minor decrease in expression following 6 h AO-free treatment (<xref ref-type="fig" rid="fig5">Figure 5H–I</xref>). No changes in expression levels of active CatD were seen in either the AO-free or AA conditions compared to control (<xref ref-type="fig" rid="fig5">Figure 5H and J</xref>). Thus, the delay in the degradation of damaged mitochondria reported here is specific to mitophagic events.</p><p>We compared these observations to the time course of mitophagy in HeLa cells treated with AA/Oligomycin A (10 μm) to initiate complete turnover of the mitochondrial network. We found a similar time course of mitochondrial fragmentation and engulfment by LC3, complete within ~1–2 hr. However, the time course of mitophagosome acidification was markedly faster in HeLa cells as compared to primary neurons, with &gt;80% of OPTN-positive mitochondrial fragments also positive for LysoT within 1 h after mitophagy induction (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Thus, we find that in neurons damaged mitochondria are efficiently sequestered, but the acidification of these mitophagosomes, which is required to fully degrade the engulfed mitochondrial fragments, takes more than 6 h and is much slower than the corresponding time course in HeLa cells expressing exogenous Parkin.</p><p>While LAMP1 is routinely used as a marker of lysosomes, recent work has demonstrated that a portion of LAMP1-positive organelles did not colocalize with lysosomal hydrolases, implying not all LAMP1 is on degradation-competent vesicles but also on late endosomes (<xref ref-type="bibr" rid="bib12">Cheng et al., 2018</xref>; <xref ref-type="bibr" rid="bib107">Yap et al., 2018</xref>). Under our conditions, we determined ~86% of LAMP1 or LAMP2 structures were LysoT-positive (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–E</xref>). Since earlier steps in the formation of autophagosomes are not rate-limiting (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F–G</xref>), most damaged organelles are efficiently sequestered in autophagosomes within an hour of damage, forming mitophagosomes (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). In control conditions, the majority of mitophagosomes were LAMP1-positive, but ≤50% were LAMP1-positive in treated conditions. Moreover, most mitophagosomes were LysoT-negative across all conditions, consistent with the slow acidification of engulfed mitochondria under both control and oxidative stress conditions (<xref ref-type="fig" rid="fig5">Figures 5B, D and K</xref>). These findings suggest that most damaged mitochondria are efficiently engulfed in mitophagosomes (LC3-positive) or ‘late’ mitophagosomes (both LC3- and LAMP1-positive), but have yet to fuse with protease-containing lysosomes to become degradation-competent mitophagolysosomes (LC3-LAMP1-LysoT-positive; <xref ref-type="fig" rid="fig5">Figure 5L</xref>).</p><p>To test this idea, we examined mitochondrial flux using a tandem Cox8-EGFP-mCherry reporter. The fluorescence signal of EGFP, but not mCherry, quenches in acidic environments and thus the shift in fluorescence from yellow to red is commonly used to measure the efficiency of mitophagy (<xref ref-type="bibr" rid="bib2">Allen et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">McWilliams et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Rojansky et al., 2016</xref>). Under all conditions, we routinely identified OPTN-positive mitochondria that were dual labeled with EGFP and mCherry, illustrating these mitophagic events persist in non-acidified compartments representing mitophagosomes or ‘late’ mitophagosomes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Distinct from the dual labeled mitochondrial population, we identified some mCherry-only puncta (red arrows; <xref ref-type="fig" rid="fig6">Figure 6B</xref>). A subpopulation of these puncta colocalized with OPTN (blue arrows), suggesting mitochondrial turnover via mitophagy.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Lysosomal acidification is a rate-limiting step in the turnover of damaged mitochondria in neurons.</title><p>(<bold>A</bold>) Representative images of OPTN-positive mitochondria that are labeled with a tandem Mito-EGFP-mCherry marker. Line scans of the mitophagy events are shown under representative images for all conditions. Scale bar, 1 μm. (<bold>B</bold>) Representative image of the dual labeled somal mitochondria network labeled with Mito-EGFP-mCherry. A population have undergone lysosomal fusion and acidification (shown as magenta only puncta; red arrows). A subset of this population is also OPTN-positive demonstrating turnover (blue arrows). Scale bar, 5 μm. (<bold>C</bold>) Schematic of the tandem SEP-LAMP1-RFP marker. In acidified environments, SEP is quenched and lysosomes are labeled only by RFP. (<bold>D</bold>) Representative images of OPTN-positive mitochondria showing conditions where they were LAMP1-negative, dual labeled in ‘late’ mitophagosomes, or RFP-only labeled in mitophagolysosomes. Scale bar, 1 μm. (<bold>E</bold>) Quantification of the number OPTN-positive mitochondria that are LAMP1-negative, LAMP1 dual labeled, or only labeled by RFP. The total number of events are listed for each condition. <italic>n</italic> = 30–32 neurons from 3 biological replicates; 6–7 DIV.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>OPTN-positive mitochondria rings and puncta undergo lysosomal engulfment.</title><p>(<bold>A</bold>) Representative images of OPTN rings and puncta that colocalize with damaged mitochondria. Line scans of mitophagy events are shown under representative images. Scale bar, 1 μm. (<bold>B</bold>) Quantification of the total number of OPTN rings (data presented in <xref ref-type="fig" rid="fig6">Figure 6E</xref>) and puncta that are LAMP1-negative, LAMP1 dual labeled, or only labeled by RFP. The total number of events are listed for each condition. <italic>n</italic> = 30–32 neurons from three biological replicates; 6–7 DIV.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Since we observed differences in the localization of LAMP1 and LysoT with mitophagosomes, we performed similar experiments using a tandem SEP-LAMP1-RFP reporter, where superecliptic pHluorin (SEP) is fused to the lumen of LAMP1-RFP (<xref ref-type="fig" rid="fig6">Figure 6C</xref>; <xref ref-type="bibr" rid="bib18">Farías et al., 2017</xref>). Thus, we could visualize both LAMP1 localization and acidification, as the fluorescence signal of the SEP will quench in acidic environments while the RFP signal will persist (pH &lt;6; <xref ref-type="bibr" rid="bib81">Sankaranarayanan et al., 2000</xref>). The temporal dynamics of lysosomal fusion and acidification were determined by comparing LAMP1 recruitment to damaged mitochondria following mitophagy induction (1 or 6 h control/AO-free or 2 h AA). We quantified the relative percentage of OPTN-positive mitochondria rings that were LAMP1-negative, dual LAMP1 labeled, or LAMP1 RFP-only labeled (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>). Consistent with previous data, mitophagic events in control cells were predominantly LAMP1-positive. Interestingly, there was a shift in a sub-population of events that were LAMP1-negative after 1 h to LAMP1 RFP-only following 6 h in control media, exhibiting mitochondrial turnover on a longer time scale. Induction of mitophagy by antioxidant deprivation substantially increased both the fraction of LAMP-1 negative and the total number of mitophagy events compared to control (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). However, as with the tandem reporter for mitochondria, most mitophagic events in all conditions were dual labeled with SEP and RFP, confirming that these damaged organelles are sequestered in a non-acidified ‘late’ mitophagosome.</p><p>As previously mentioned, two types of OPTN localization were observed with damaged mitochondria, OPTN rings and puncta (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). OPTN puncta may represent an early stage of nucleation, but it also conceivable that an OPTN ring collapses into punctum following rounds of lysosome fusion at the end stages of mitophagy (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>), causing the pre-ring and post-ring formation states of OPTN to be morphologically indistinguishable. To address this possibility, we repeated our quantification, this time including OPTN-positive mitochondrial puncta and rings. Using this criterion, we observed a larger percentage of LAMP1-negative and LAMP1 RFP-only mitophagic events, as well as an overall increase in the total number of events for all treatments (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). This analysis suggests that OPTN-positive puncta are most likely to be in non-acidified organelles formed prior to the expansion of OPTN to form a full ring, and further support a model were sequestration of damaged organelles occurs quickly, but acidification is delayed in neuronal mitophagy.</p></sec><sec id="s2-6"><title>‘Aged’ mitochondria are sequestered in the soma during basal mitophagy</title><p>To investigate long-term autolysosome sequestration hours after initial damage, we performed SNAP-tag pulse-chase experiments. Neurons were transfected with Mito-SNAP, Halo-OPTN, and in some experiments LAMP1-EGFP. The following day, mitophagy was initiated and mitochondria were labeled with the first SNAP ligand for 30 min. Subsequently, treated neurons were placed in control maintenance media, 2 h SNAP block was used to saturate the remaining SNAP-binding sites, and neurons were incubated overnight. Prior to imaging, cells were labeled with a second SNAP ligand (a spectrally distinct fluorophore) for 30 min and in some experiments labeled with LysoT (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). As a result, ‘age’-related mitochondrial sequestration and elimination can be examined since ‘Old’ (labeling of Mito-SNAP expressed from the time of transfection until SNAP Block labeling;~24 hr) and ‘Young’ (labeling of Mito-SNAP expressed after SNAP Block until imaging;~22 hr) mitochondrial populations are distinct (<xref ref-type="fig" rid="fig7">Figure 7B–C</xref>). Using multiple lysosomal markers [<xref ref-type="fig" rid="fig7">Figure 7B</xref>; LAMP1 (1) and LysoT (2)], we determined whether OPTN-positive mitochondria were sequestered in mitophagosomes (red; LAMP1- and LysoT-negative) or in mitophagolysosomes (blue; LAMP1- and LysoT-positive).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>‘Aged’ mitochondria are sequestered in non-acidified compartments twenty-four hours after treatment.</title><p>(<bold>A–B</bold>) Time line (<bold>A</bold>) and schematic (<bold>B</bold>) of mitochondrial pulse-chase experiments. Following transient transfection, mitophagy was induced (6 h control or AO-free) and mitochondria were labeled with the first SNAP ligand (‘Old’ Mito; shown as magenta). SNAP block was added for 2 h to saturate the remaining binding sites and neurons were left overnight. Prior to imaging, mitochondria were labeled with a second spectrally distinct SNAP ligand (‘Young’ Mito; shown in green). Both ‘Old’ and ‘Young’ ligands were labeled for 30 min, followed by two quick washes, and a 30 min washout. (<bold>C</bold>) Representative image of ‘Old’ and ‘Young’ mitochondrial populations in the soma. Scale bar, 5 μm. (<bold>D–E</bold>) Representative images of neurons that are 24 h post-treatment illustrating OPTN sequestered ‘Old’ mitochondria that are negative for LAMP1 and the ‘Young’ mitochondria marker (red arrows and insets). Scale bar, 5 μm. Line scans of mitophagy events are shown on the right. (<bold>F–G</bold>) Representative somal images of neurons that are 24 h post-treatment. Red arrows highlight OPTN-positive ‘Old’ mitochondria that are negative for ‘Young’ mitochondria and LysoT. Scale bar, 5 μm. Line scans of mitophagic events are shown to the right of the image.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig7-v1.tif"/></fig><p>Twenty-four hours post-treatment, we visualized spherical, single labeled ‘Old’ Mito-SNAP puncta that were engulfed by Halo-OPTN rings. Strikingly, these OPTN-positive mitochondria were negative for ‘Young’ Mito-SNAP and LAMP1-EGFP or LysoT (<xref ref-type="fig" rid="fig7">Figure 7D–G</xref>), indicating these isolated ‘Old’ mitochondrial fragments were engulfed by OPTN within hours of initial damage, as they were not labeled by the ‘Young’ SNAP ligand, but still had not undergone autolysosome sequestration and degradation 24 h later. Not only were these delayed mitophagic events observed in the soma of AO-free treated neurons (LAMP1, 10.3%; LysoT, 4%; <xref ref-type="fig" rid="fig7">Figure 7E and G</xref>), they were also seen in control treated neurons (LAMP1, 6.3%; LysoT, 13.3%; <xref ref-type="fig" rid="fig7">Figure 7D and F</xref>), revealing this slow mitochondrial turnover is detected under both basal and induced conditions. Thus, while neurons can efficiently undergo mitophagosome and ‘late’ mitophagosome formation and sequestration, it appears there is inefficient turnover where the degradation of damaged mitochondria can occur &gt;24 h after initial damage. Even under basal conditions, slow mitochondrial removal could cause a buildup of depolarized organelles, exposing the neuron to damage and disease-associated mitophagy mutants may exacerbate this pathology.</p></sec><sec id="s2-7"><title>Expression of an ALS-associated OPTN mutant increases the neurons susceptibility to stress and damage</title><p>Genetic studies have identified mutations in OPTN as causative for ALS and frontotemporal dementia (FTD; <xref ref-type="bibr" rid="bib28">Ito et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Maruyama and Kawakami, 2013</xref>; <xref ref-type="bibr" rid="bib72">Pottier et al., 2015</xref>). OPTN<sup>E478G</sup> is a heterozygous missense mutation identified in both sporadic and familial cases of ALS (<xref ref-type="fig" rid="fig8">Figure 8A</xref>; <xref ref-type="bibr" rid="bib51">Maruyama and Kawakami, 2013</xref>; <xref ref-type="bibr" rid="bib50">Maruyama et al., 2010</xref>). In HeLa cells, OPTN<sup>E478G</sup> inhibits mitophagy by failing to translocate to damaged, ubiquitinated mitochondria (<xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>). OPTN<sup>E478G</sup> has also been linked to the activation of inflammation, a hallmark of ALS (<xref ref-type="bibr" rid="bib21">Gkikas et al., 2018</xref>). We sought to test the functional significance of ALS-associated OPTN<sup>E478G</sup> expression on the mitophagy pathway by examining mitochondrial health in primary neurons expressing this mutation.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>A disease-associated OPTN mutant increases mitochondrial vulnerability to oxidative stress.</title><p>(<bold>A</bold>) Schematic of OPTN and its various domains. LIR, LC3 interacting region. UBAN, ubiquitin binding in ABIN and NEMO. The ALS-associated OPTN mutant E478G fails to bind ubiquitin. (<bold>B</bold>) Representative image of AO-free treated neurons expressing WT OPTN (OPTN<sup>WT</sup>; upper panel) or a disease-linked OPTN mutant (OPTN<sup>E478G</sup>; lower panel). White arrows denote swollen mitochondria. Scale bar, 5 μm. (<bold>C</bold>) Volume renderings of the somal mitochondrial network; OPTN<sup>E478G</sup> expression induces the appearance of enlarged organelles compared to the expression of OPTN<sup>WT</sup> (white arrows). Scale bar, 1 μm. (<bold>D</bold>) Quantification of the somal mitochondrial content. Mean ± SEM; <italic>n</italic> = 24-40 neurons from 5 biological replicates; 8 DIV. Not significant (n.s.) by unpaired t test. (<bold>E</bold>) Quantification of the number of OPTN puncta per cell. Mean ± SEM; <italic>n</italic> = 24-40 neurons from 5 biological replicates; 8 DIV. ****, <italic>p</italic> &lt; 0.0001 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test. (<bold>F</bold>) Quantification of the TMRE fluorescence intensity. Mean ± SEM; <italic>n</italic> = 24-40 neurons from 5 biological replicates; 8 DIV. **, <italic>p</italic> &lt; 0.01; ****, <italic>p</italic> &lt; 0.0001 by Kruskal-Wallis ANOVA with Dunn’s multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>OPTN is efficiently knocked-down in neurons with siRNA.</title><p>(<bold>A–B</bold>) Representative Western blot (<bold>A</bold>) and quantification (<bold>B</bold>) of neurons after treatment with mock or OPTN siRNA. Data shown as the fold change over control of OPTN divided by total protein stain. Normalization factors are shown under lanes. Mean ± SEM; <italic>n</italic> = 4 from 3 biological replicates; 8 DIV. ****, <italic>p</italic> &lt; 0.0001 by unpaired t test. (<bold>C</bold>) Representative Western blot of non-transfected, OPTN siRNA treated, and OPTN siRNA treated neurons overexpressing Halo-OPTN<sup>WT</sup> or Halo-OPTN<sup>E478G</sup> mutant. Normalization factors are shown under lanes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig8-figsupp1-v1.tif"/></fig></fig-group><p>Endogenous OPTN was depleted using siRNA, leading to a ~ 60% reduction in OPTN protein levels (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). Expression of OPTN<sup>E478G</sup> did not grossly alter somal mitochondrial content, but did affect the morphology of the mitochondrial network, resulting in the appearance of swollen organelles, as compared to expression of OPTN<sup>WT</sup> (<xref ref-type="fig" rid="fig8">Figure 8B–D</xref>). These large mitochondria were observed in both basal and treated conditions, suggesting OPTN<sup>E478G</sup> expression is sufficient to alter mitochondrial morphology. In addition, there was a decrease in the number of OPTN<sup>E478G</sup> puncta compared to OPTN<sup>WT</sup> (<xref ref-type="fig" rid="fig8">Figure 8E</xref>) and mutant puncta did not colocalize with mitochondria as often. It is likely that OPTN<sup>E478G</sup> remains more cytosolic due to its inability to bind ubiquitin and associate with damaged mitochondria. As a result, OPTN<sup>E478G</sup> fails to initiate mitophagy and the turnover of depolarized mitochondria, leading to accumulation of swollen organelles.</p><p>Finally, we asked whether OPTN<sup>E478G</sup> expression altered mitochondrial network polarization. We saw a significant decrease in TMRE fluorescence intensity of mitochondria in neurons expressing OPTN<sup>E478G</sup> compared to OPTN<sup>WT</sup> in AO-free treated neurons, illustrating mitochondrial membrane potential was altered with mutant OPTN expression (<xref ref-type="fig" rid="fig8">Figure 8F</xref>). Surprisingly, this was also observed in control conditions, so OPTN<sup>E478G</sup> expression alone was sufficient to disrupt mitochondrial health. Furthermore, in an OPTN<sup>E478G</sup> background AO-free treatments exacerbated the effect compared to control. Together these findings suggest a model where in a heterozygous background, OPTN<sup>E478G</sup> expression alters mitochondrial health but functional OPTN<sup>WT</sup> expression maintains sufficient levels of mitophagy. However, in stressed conditions which further disrupts mitochondrial health, levels of mitophagy are no longer adequate to maintain the health of the neuron. Thus, expression of the ALS-linked OPTN<sup>E478G</sup> mutant becomes sufficient to disrupt mitophagy and cause neurodegeneration.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The mitophagy pathway has been studied in detail in non-neuronal cells lines, leading to the identification of OPTN as an autophagy receptor that facilitates the engulfment of mitochondrial fragments in a PINK1/Parkin-dependent manner (<xref ref-type="bibr" rid="bib40">Lazarou et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>; <xref ref-type="bibr" rid="bib104">Wong and Holzbaur, 2014a</xref>). However, a rigorous analysis of OPTN-mediated mitophagy in neurons has yet to be carried out, limiting our understanding of how this mechanism functions in neurons expressing endogenous levels of Parkin, and further, how defects in the pathway might lead to neurodegeneration. In this study, we used multicolor live-cell imaging to examine the spatiotemporal dynamics of OPTN-mediated mitophagy in primary hippocampal neurons. We find that mild oxidative stress, induced through antioxidant deprivation or by low doses of AA, results in minor somal and axonal mitochondrial fragmentation, without compromising the overall network (<xref ref-type="fig" rid="fig1">Figure 1C–F</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We noted that OPTN was dynamically recruited to damaged TMRE-negative organelles following these treatments, indicating initiation of the selective mitophagic pathway (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Using this experimental paradigm, we saw frequent mitophagic events in the soma, with only limited events in either dendrites or axons (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This finding demonstrates that OPTN-dependent mitophagy occurs in a spatially-restricted manner in primary neurons (<xref ref-type="fig" rid="fig9">Figure 9A</xref>).</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Model depicting the spatial and temporal regulation of OPTN-mediated neuronal mitophagy.</title><p>(<bold>A</bold>) Upon mitophagy induction, Parkin translocates to spherical mitochondria and increases the abundance of ubiquitin chains. OPTN and its kinase TBK1 are recruited followed by sequestration and elimination via autophagosome engulfment and lysosomal fusion, as monitored by LC3 and LAMP1/LysoT, respectively. This quality control mechanism is compartmentally restricted to the soma and rarely occurs in the axon. As a result, other quality control pathways may regulate axonal mitochondria. (<bold>B</bold>) Parkin, Ub, TBK1 and OPTN localize with damaged organelles within an hour of inducing mitophagy. LC3 translocation occurs after OPTN and ~75% of OPTN-positive mitochondria are LC3-positive, forming mitophagosomes an hour after initial damage. Under basal conditions, ‘late’ mitophagosomes (OPTN-LAMP-positive mitochondria) routinely form within an hour. However, mitophagy induction perturbs this pathway, increasing the number of LAMP1-negative OPTN-positive mitochondria. Interestingly, only a small fraction of OPTN-positive mitochondria are acidified in either basal or induced conditions, suggesting lysosomal acidification to eliminate damaged organelles is rate-limiting.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-fig9-v1.tif"/></fig><p>Additionally, we determined that ‘late’ mitophagosome formation is efficient under basal conditions, but oxidative stress can overwhelm the system. Surprisingly, lysosomal acidification and turnover were rarely observed in either basal or stressed conditions at all time points tested (<xref ref-type="fig" rid="fig5">Figure 5</xref>). These findings were confirmed using tandem markers for mitochondria and lysosomes, where we could simultaneously monitor localization and acidification (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Moreover, mitophagosomes that were LAMP1- and LysoT-negative were still visualized a full day after treatment (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Taken together, these results illustrate that sequestered mitochondria are persistently sequestered in non-acidified organelles, where removal of damaged mitochondria is slow and inefficient (<xref ref-type="fig" rid="fig9">Figure 9B</xref>). Interestingly, this delay was shown to be specific to these mitophagic events, as most neuronal lysosomes were efficiently acidified (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). We speculate that this slow acidification is attributed to the multiple autophagosome-lysosome fusion events that may be required to fully acidify a mitophagolysosome. Alternatively, ion transporters or other proteins associated with this vesicular compartment could be differentially regulated (<xref ref-type="bibr" rid="bib48">Majumdar et al., 2011</xref>), but further work will be required to determine the underlying cause. Of note, the slow time course of mitophagosome acidification in primary neurons following very limited mitochondrial damage differs markedly from the more rapid process in HeLa cells engaged in the wholesale turnover of their mitochondrial networks (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>).</p><p>Importantly, the slow removal of sequestered mitochondrial fragments occurs under both basal and stressed conditions, suggesting that this is a potential point of vulnerability in the pathway supporting neuronal homeostasis. This susceptibility can be exacerbated by multiple factors related to aging and neurodegeneration, including increased levels of oxidative damage to cellular organelles, changes in lysosomal acidification with aging (<xref ref-type="bibr" rid="bib41">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Lie and Nixon, 2019</xref>), or the expression of mutations in pathway components. These alterations to the system might further impede the rate of turnover, increasing neuronal sensitivity to damage and degeneration. We tested this idea by expressing an ALS-linked OPTN mutation, and observed an overall decrease in the membrane potential of the mitochondrial network (<xref ref-type="fig" rid="fig8">Figure 8F</xref>). It is likely that damaged mitochondria were not efficiently sequestered but instead free to fuse with the cellular network disrupting overall cellular health. We propose that expression of mutant OPTN is detrimental to the neuron through a feedforward mechanism. First, OPTN<sup>E478G</sup> fails to translocate to damaged organelles, which may perturb the mitophagy pathway in a dominant-negative manner (<xref ref-type="bibr" rid="bib59">Moore and Holzbaur, 2016</xref>). Second, decreased mitochondrial network health due to mutant expression could increase the number of damaged organelles that need to be recycled via mitophagy. However, OPTN<sup>E478G</sup> is not recruited to these depolarized mitochondria, further compounding the problem, leading to cellular stress and potential neurodegeneration.</p><p>Since the OPTN<sup>E478G</sup> mutation is autosomal dominant, one copy is sufficient to cause neurodegeneration and ALS (<xref ref-type="bibr" rid="bib50">Maruyama et al., 2010</xref>). In an OPTN<sup>WT</sup> background, our data indicates that the mitophagic pathway can cope with hours of oxidative stress to effectively sequester damaged mitochondria and maintain neuronal health. However, the expression of OPTN<sup>E478G</sup> is sufficient to disrupt the mitochondrial network even under control conditions. In this mutant background, a second hit to the system induced by long-term oxidative stress resulted in additional mitochondrial network damage (<xref ref-type="fig" rid="fig8">Figure 8F</xref>). It appears that mutant expression and stressed conditions further enhance the susceptibility of the neuron to cellular stress. Thus, we propose that mitochondrial quality control is tightly regulated in neurons, where sequestration of damaged organelles is critical to prevent dissemination of damaged components and disruption of the pathway is sufficient to cause neurodegeneration.</p><p>A constitutive pathway for axonal autophagy has been reported in neurons both in vitro (<xref ref-type="bibr" rid="bib46">Maday and Holzbaur, 2014</xref>; <xref ref-type="bibr" rid="bib105">Wong and Holzbaur, 2014b</xref>) and in vivo (<xref ref-type="bibr" rid="bib64">Neisch et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Soukup et al., 2016</xref>; <xref ref-type="bibr" rid="bib90">Stavoe et al., 2016</xref>). In this pathway, autophagosomes non-selectively engulf and degrade mitochondrial fragments at the axon tip. But this is distinct from the selective receptor-mediated clearance of damaged mitochondria described here, which is almost entirely a somal quality control mechanism. The spatial specificity of mitophagy was previously postulated based on observations in vivo in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib16">Devireddy et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">Sung et al., 2016</xref>), qualitative findings of acidified mitochondria only within the soma in <italic>mito</italic>-QC mice (<xref ref-type="bibr" rid="bib53">McWilliams et al., 2016</xref>), and visualization of the somal clearance of ischemically damaged axonal mitochondria (<xref ref-type="bibr" rid="bib110">Zheng et al., 2019</xref>). Countering this literature is a report of axonal mitochondria turnover downstream from PINK1 and Parkin (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>) and studies indicating that axonal mitochondria motility is arrested following mitochondrial damage (<xref ref-type="bibr" rid="bib27">Hsieh et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="bib99">Wang et al., 2011</xref>), necessitating a local clearance mechanism. It may be that under wholesale disruption of the mitochondrial network, initiated by CCCP or higher levels of Antimycin/Oligomycin, there is more widespread induction of mitophagy downstream from Parkin, leading to the local mitophagy of axonal mitochondria previously described (<xref ref-type="bibr" rid="bib4">Ashrafi et al., 2014</xref>). However, we argue that the limited damage examined here may more accurately reflect the levels of mitochondrial turnover seen in vivo and during aging, stress, or expression of dominant mutations in pathway components, such as the OPTN<sup>E478G</sup> mutant. Under these conditions, as we demonstrate in vitro and was previously shown in vivo (<xref ref-type="bibr" rid="bib16">Devireddy et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">McWilliams et al., 2016</xref>; <xref ref-type="bibr" rid="bib93">Sung et al., 2016</xref>), the PINK1/Parkin mitophagy pathway is compartmentally restricted to the soma. Thus, neuronal mitophagy is both molecularly and spatially distinct from the previously characterized constitutive axonal autophagy pathway (<xref ref-type="bibr" rid="bib17">Evans and Holzbaur, 2019</xref>).</p><p>While we focus here on the PINK1/Parkin pathway, given its genetic links to neurodegenerative diseases like PD and ALS, it is likely that additional and potentially compensatory pathways are actively contributing to mitochondrial quality control in neurons. Previous studies have proposed that mitochondrial ubiquitin ligase 1 (MUL1) plays a role in mitochondrial quality control in neurons, where it functions as an additional E3 ubiquitin ligase in a parallel pathway to Parkin (<xref ref-type="bibr" rid="bib3">Ambivero et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Puri et al., 2019</xref>; <xref ref-type="bibr" rid="bib109">Yun et al., 2014</xref>). Other studies have suggested that alternative pathways such as NIPSNAP/Parkin-mediated mitophagy (<xref ref-type="bibr" rid="bib63">Nautiyal et al., 2010</xref>; <xref ref-type="bibr" rid="bib73">Princely Abudu et al., 2019</xref>) and NIX/BNIP3L-dependent mitophagy (<xref ref-type="bibr" rid="bib6">Bellot et al., 2009</xref>; <xref ref-type="bibr" rid="bib37">Koentjoro et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Real et al., 2005</xref>; <xref ref-type="bibr" rid="bib88">Sowter et al., 2001</xref>) support mitochondrial clearance. Further studies will be required to quantitatively assess the interplay of these various pathways in mitochondrial quality control in neurons and the extent of their overlap. In addition, further work will be required to determine the relative contributions of defects in mitophagy and systemic changes in inflammation that can also be induced by mutations in PINK1 and/or Parkin, although it is likely that both aspects contribute to the onset of neurodegeneration in PD and perhaps ALS. The continued development of more physiologically relevant model systems coupled to rigorous quantitative analysis will be required to address these important questions and advance therapeutic strategies for neurodegeneration.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Reagents</title><p>Constructs used include the following: Mito-DsRed (kindly provided by. T. Schwartz, Harvard Medical School, Boston), Mito-SNAP (recloned from Mito-DsRed into a pSNAPf [New England Biolabs]), Cox8-EGFP-mCherry was subcloned from Addgene 78520, pEGFP-LC3B (a gift from T. Yoshimori, Osaka University, Osaka), mScarlet-LC3B (EGFP was replaced with mScarlet from Addgene 85054), mCherry-EGFP-LC3 (kindly provided by T. Johansen, University of Tromso, Tromso, Norway), pEGFP-OPTN (kindly provided from I. Dikic, Goethe University, Frankfurt), Halo-OPTN (subcloned from EGFP-OPTN to a pHaloTag vector [Promega]), Halo-OPTN<sup>E478G</sup> was subcloned from HA-OPTN<sup>E479G</sup> (kindly provided from I. Dikic, Goethe University, Frankfurt) to a pHaloTag vector (Promega), YFP-Parkin and mCherry-Parkin (a gift from R. Youle, NIH, Bethesda), mutant mCherry-Parkin T240R was generated from site-directed mutagenesis, untagged-Parkin (mCherry-Parkin was removed), YFP-Nav<sub>II-III</sub> (Addgene 26056), GFP-Ub (Addgene 11928), TBK1 (Addgene 23851) was recloned into a pSNAPf vector (New England Biolabs), LAMP1-EGFP was subcloned from Addgene 1817 where RFP was replaced with EGFP, LAMP2-EGFP (provided by E. Chapman, University of Wisconsin-Madison was subcloned into pEGFP_N1), SEP-LAMP1-RFP (kindly provided by J. Bonifacino, NIH, Bethesda) and SNAP-WIPI2B (subcloned from GFP-WIPI2B). All constructs were verified by DNA sequencing. ON-TARGET<italic>Plus</italic> Rat OPTN (246294) siRNA <italic>SMARTpoo</italic>l (L-097177-02-0005) and ON-TARGET<italic>Plus</italic> Rat Prkn (56816) siRNA <italic>SMARTpoo</italic>l (L-090709-02-0005) were purchased from Dharmacon. Reagents used include the following: TMRE (tetramethylrhodamine ethyl ester, Ethyl Ester, Perchlorate; Life Technologies, T-669), Antimycin A (Sigma-Aldrich, A8674), Oligomycin A (Sigma Aldrich, 75351), LysoTracker Green DND-26 (ThermoFisher, L7526) and Deep Red (ThermoFisher, L12492), MitoTracker Green FM (ThermoFisher M7514), CellMask Orange Plasma membrane Stain (ThermoFisher 10045), B-27 Supplement minus antioxidants (ThermoFisher, 10889038), and CellROX Deep Red Reagent (Invitrogen, C10422). HaloTag constructs were labeled with Janelia Fluor 646 HaloTag (Promega, GA1120) and SNAP-Tag constructs were labeled with JF646-SNAP (provided by Luke Lavis, Janelia Farms), SNAP-Cell TMR-Star (New England Biolabs, S9015S), SNAP-Cell 430 (New England Biolabs, S9109S), and SNAP-Cell Block (New England Biolabs, S9106S). For a list of key reagents, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>Primary hippocampal culture</title><p>Sprague Dawley rat hippocampal neurons at embryonic day 18 were obtained from the Neurons R Us Culture Service Center at the University of Pennsylvania. Cells (fixed imaging, 175,000 cells; live imaging, 250,000 cells) were plated on 25 mm acid-washed glass coverslips (World Precision) or in a 35 mm glass-bottom dishes (MatTek) that were precoated with 0.5 mg/ml poly-L-lysine (Sigma Aldrich). Cells were initially plated in Attachment Media (AM; MEM supplemented with 10% horse serum, 33 mM D-glucose, and 1 mM sodium pyruvate) which was replaced with Maintenance Media (MM; Neurobasal [Gibco] supplemented with 33 mM D-glucose, 2 mM GlutaMAX (Invitrogen), 100 units/ml penicillin, 100 μg/ml streptomycin, and 2% B-27 [ThermoFisher]) after 5 hr. Neurons were maintained at 37 C in a 5% CO<sub>2</sub> incubator; AraC (5 μM) was added the day after plating to prevent glia cell proliferation. For transfections, neurons (5–8 DIV) were transfected with 0.8–1.2 μg of total plasmid DNA using Lipofectamine 2000 Transfection Reagent (ThermoFisher) and incubated for 18–24 hr; DNA and siRNAs (45 pmol) mixtures were incubated 36–48 hr.</p></sec><sec id="s4-3"><title>HeLa culture</title><p>HeLa-M (A. Peden, Cambridge Institute for Medical Research) cells were maintained in DMEM (Corning) that was supplemented with 1% GlutaMAX and 10% FBS. Cells were maintained at 37 C in a 5% CO<sub>2</sub> incubator. For transfection, cells were plated on uncoated 35 mm glass-bottom dishes (MatTek), transfected with 2 μg of DNA using FuGene 6 (Promega), and incubated for 18 hr. HeLa cells were routinely tested for mycoplasma using a MycoAlert detection kit (Lonza, LT07). Cells were authenticated by STR profiling using GenePrint10 (Promega, B9510) at the DNA Sequencing Facility at The University of Pennsylvania.</p></sec><sec id="s4-4"><title>Neuronal mitophagy induction treatments</title><p>Mitochondrial damaged was induced via oxidative stress through antioxidant removal or by inhibiting complex III of the electron transport chain using Antimycin A (AA; Sigma Aldrich). For treatments, neuronal media was fully replaced with control MM, AO-free MM (MM where the B-27 supplement has been replaced B-27 supplement, minus antioxidants [ThermoFisher]), or AA MM (MM plus 3 nM AA) for a time course of 1, 2 or 6 hr. For SNAP pulse-chase experiments, neurons were maintained in control media following treatment.</p></sec><sec id="s4-5"><title>HeLa mitophagy induction treatments</title><p>In HeLa cells, mitochondrial damage was induced by oxidative stress using a bath application of 10 μM AA and 10 μM Oligomycin A. Cells were treated for 90 min then maintained in control media. Recruitment was assessed 0,1, 2, 4, and 6 h after treatment.</p></sec><sec id="s4-6"><title>Live-cell imaging</title><p> One hour prior to imaging, SNAP (100 nM TMR or JF646; 2 μM Blue 430) and Halo-tag ligands (100 nM) were applied for 30 min, followed by two quick washes and a 30 min washout totaling 1 hr; 2.5 μM Halo-tag ligand was used for HeLa cells. For SNAP pulse-chase experiments, SNAP Block was applied at 1 μM for 2 hr, followed by two quick washes and a 30 min washout. To asses mitochondrial membrane potential, neurons were loaded with 2.5 nM TMRE for 30 min, which occurred during the SNAP or Halo-tag ligand washout. Lysosome acidification was determined using Lysotracker (25–50 nM) that was incubated for 30 min during SNAP or Halo-tag ligand washout. For live-cell imaging, neurons were imaged in Imaging Media (HibernateE [Brain Bits] supplemented with 2% B27 and 33 mM D-glucose). Again, 2% B27, minus antioxidants replaced the standard B27 for AO-free conditions and 3 nM AA was added to the imaging media for AA conditions. HeLa cells were imaged in Leibovitz’s (1X) L-15 Medium (Gibco) supplemented with 10% FBS. For TMRE experiments, 2.5 nM TMRE was added to all Imaging Media. Mitochondrial and autophagosome motility was monitored in the mid-axon of 7–8 DIV neurons that were imaged at a rate of 4 timepoints/sec for 5 min. Neurons were imaged in an environmental chamber at 37 C on a Perkin Elmer UltraView Vox spinning disk confocal on a Nikon Eclipse Ti Microscope with a Plan Apochromat Lambda 60 × 1.40 NA and an Apochromat 100 × 1.49 NA oil-immersion objectives and a Hamamatsu EMCCD C9100-50 camera driven by Volocity (Volocity Software, Perkin Elmer). Z-stacks were acquired at 150 nm step-size.</p></sec><sec id="s4-7"><title>Intracellular ROS measurements</title><p>Hippocampal neurons (20,000–50,000 per well) were plated in 96 well black plate with clear bottom (Corning) that was precoated with 0.5 mg/ml poly-L-lysine, grown for 7 DIV, and treated to induce mitochondrial damage. CellROX (5 μM) was added to each well 30 min prior to the end of treatment (6 h control or AO-free; 2 h AA). Cells were washed three times with PBS and fluorescence was immediately analyzed using a plate reader. For fluorescent imaging of intracellular ROS, CellROX (5 μM) and MitoTracker (20 nM) were added 30 min prior to the end of treatment (6 h control or AO-free; 2 h AA), cells were incubated with CellMask (5 μg/ml) for 5 min, and washed with media three times; neurons were immediately imaged.</p></sec><sec id="s4-8"><title>Immunostaining</title><p>Neurons were fixed for 10 min using warm 4% PFA (HeLa cells) or 4%/4 %Sucrose (hippocampal neurons). Cells were washed two times with PBS (50 mM NaPO<sub>4</sub>, 150 mM NaCl, pH 7.4), permeabilized with ice cold methanol for 8 min at −20 C, and blocked for 1 h in blocking solution (5% goat serum and 1% BSA in PBS). Samples were incubated in primary antibodies diluted in blocking solution for 1 h and were washed three times with PBS; these steps was repeated with secondary antibodies. Following the three PBS washes after secondary antibodies, 0.1 mg/ml of Hoechst 33342 reagent (ThermoFisher, H21492) was added to samples and incubated for 10 min; one last PBS wash occurred after this step. Coverslips were mounted in ProLong Gold (Life Technologies) and images were acquired on a Leica DMI6000B inverted epifluorescence microscope with a 63 × 1.4 NA oil-immersion objective and a Hamamatsu ORCA-R2 charge-coupled device camera driven by LAS-AF (Leica Microsystems) or the previously mentioned Perkin Elmer spinning disk confocal.</p></sec><sec id="s4-9"><title>Immunoblotting</title><p>For fluorescent Western blotting, neurons were washed twice with ice cold PBS and lysed with RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 1 mM DTT, 1 mM PMSF, and 1x complete protease inhibitor mixture) for 30 min at 4 C. Samples were centrifuged at 4 C for 10 min at 15,800 x g, supernatant was collected, and a BCA assay was performed to determine total protein concentration. Supernatants (20–40 μg) were analyzed by SDS-PAGE and transferred onto PDVF Immobilon FL (Millipore). Membranes were dried for 1 hr, rehydrated in methanol, and stained for total protein (LI-COR REVERT Total Protein Stain). Following imaging of the total protein, membranes were destained, blocked for 1 h in Odyssey Blocking Buffer TBS (LI-COR), and incubated overnight at 4 C primary with antibodies diluted in Blocking Buffer with 0.2% Tween-20. Membranes were washed four times for 5 min in 1xTBS Washing Solution (50 mM Tris-HCl pH 7.4, 274 mM NaCl, 9 mM KCl, 0.1% Tween-20), incubated in secondary antibodies diluted in Odyssey Blocking Buffer TBS (LI-COR) with 0.2% Tween-20% and 0.01% SDS for 1 hr, and again washed four times for 5 min in the washing solution. Membranes were immediately imaged using an Odyssey CLx Infrared Imaging System (LI-COR).</p></sec><sec id="s4-10"><title>Analysis</title><sec id="s4-10-1"><title>Image processing</title><p>After live-cell confocal imaging of neurons, z-stack images were processed using Huygens Professional Deconvolution Software (Scientific Volume Imaging, The Netherlands, <ext-link ext-link-type="uri" xlink:href="http://svi.nl">http://svi.nl</ext-link>) to remove background noise and increase resolution and signal-to noise. It should be noted that fluorescence intensity measurement for TMRE and CellRox experiments were quantified from unprocessed z-stacks. For deconvolution, up to 50 iterations of the Classic Maximum Likelihood Estimation (CMLE) algorithm with theoretical PSF was performed. Background was automatically corrected, the signal to noise ratio was 20–30, and all other settings were default. The number of iterations and signal to noise ratio varied based on the construct. Volume renderings of somal mitochondria and a representative OPTN-positive mitochondrion were generated using the normal shading mode in the volume function of Imaris Software (Bitplane); images were rotated to highlight the mitochondrial network.</p></sec><sec id="s4-10-2"><title>Image analysis</title><p>After image processing, mitochondrial fragments and protein ring or puncta formation in z-stack images were manually identified and counted using Fiji (<xref ref-type="bibr" rid="bib84">Schindelin et al., 2012</xref>); only clearly defined mitochondrial localized structures were quantified. Axonal mitochondrial length was quantified using the first frame of each 5 min movie and the Particle Analyzer function in Fiji. The somal mitochondrial aspect ratio was calculated by thresholding single plane images with watershed segmentation and using the Particle Analyzer function. The circularity and area parameters were used to determine the mitochondrial aspect ratio and length, respectively. Cellular acidification of autophagosomes and lysosomes was determined using tandem reporters, where the fluorescence of GFP or SEP quenched in acidic environments. Using single plane images, the total number of single or dual labeled puncta was compared to the total number of puncta for each cell and averaged across trials. The number of OPTN<sup>WT</sup> and OPTN<sup>E478G</sup> puncta were manually counted using Volocity. Prism (GraphPad) was used to plot all graphs and determine statistical significance. Adobe Illustrator was used to prepare all figures and images.</p></sec><sec id="s4-10-3"><title>CellROX quantification</title><p>For measurements of CellROX using a plate reader, the average CellROX fluorescence intensity from eight wells for each experimental treatment was quantified and normalized to the control. Values for each treatment were averaged across biological replicates. For fluorescence imaging measurements of CellROX, fluorescence intensities were quantified from unprocessed z-stack images. The mean gray value for each soma was determined by averaging the values of five individual areas (2.2 × 2.2 μm square) in the soma. For axons and dendrites, the mean gray value of a minimum of 40 mitochondria were manually measured per image and averaged across biological replicates.</p></sec><sec id="s4-10-4"><title>TMRE quantification</title><p> Fluorescence intensities were quantified from max projections of unprocessed z-stack images. In Fiji, the mean gray value for each cell was determined by averaging the values of five individual areas (2.2 × 2.2 μm square) in the soma. In the axon, the mean gray value of mitochondria was manually traced and measured for each cell.</p></sec><sec id="s4-10-5"><title>Mitochondrial content quantification</title><p>The somal and mitochondrial volume for each neuron was determined using the volume measurement function in Volocity Quantitation. Mitochondrial content was determined by dividing the mitochondrial volume by the somal volume.</p></sec><sec id="s4-10-6"><title>Immunoblotting quantification</title><p>Bands were quantified using Image Studio Software (LI-COR). For each experimental trial, a total protein normalization factor was calculated based on the total protein from each lane. Band intensities for proteins of interest were quantified and divided by the total protein normalization factor corresponding to the same lane. Treatments were normalized relative to the control sample and presented as fold change over control.</p></sec><sec id="s4-10-7"><title>Axonal transport of autophagosomes and mitochondria</title><p>In Fiji, kymographs were generated for each axon using a three-pixel line width and the MultipleKymograph plugin. Kymographs were analyzed using MATLAB software (MathWorks). Axonal transport was quantified as described previously (<xref ref-type="bibr" rid="bib47">Maday and Holzbaur, 2016</xref>). The area &lt;100 μm from the axon tip was defined as the distal axon. The mid-axon was the area &gt;100 μm from the axon terminal and from the soma. Directionality of moving organelle was determined by the following: net anterograde, displacement of ≥5 μm within the 5 min imaging window; net retrograde, displacement of ≥5 μm within 5 min; and bidirectional/stationary, displacement of &lt;5 μm within 5 min. The percentage of motility was determined for each treatment and averaged across experimental trials. Organelle density was quantified as the number of organelles (from the first frame of the movie) divided by the axonal distance and averaged across biological replicates. The area flux was quantified as the total number of organelles, within the 5 min movie, divided by the length of the axon and time (number of organelles/100 μm/min) and averaged across experimental trials.</p></sec><sec id="s4-10-8"><title>Line scans</title><p>In Fiji, line scans were generated using a pixel line width to trace OPTN-positive mitochondria and a three-pixel line width to trace axons and dendrites. Intensity values were normalized by dividing the dataset by its maximum.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank the members of the Holzbaur laboratory for thoughtful discussion and comments related to this manuscript and Mariko Tokito and Andrea Stavoe for assistance in the design and cloning of constructs. This study was supported by a grant from NIH NINDS (R37 NS060698) to ELFH. CSE was supported by the Howard Hughes Medical Institute Hanna H Gray Fellowship.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Visualization, Methodology</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Supervision, Funding acquisition</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Pennsylvania (protocol number: 803657). All animals were euthanized prior to harvesting tissue.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Key Resources Table.</title><p>A list of key reagents in this study, including reagent type, designation, source, and identifier (when available or applicable).</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-50260-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-50260-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed for this study are included in the manuscript and supporting files. Newly generated reagents are available upon request to the authors.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akundi</surname> <given-names>RS</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Eason</surname> <given-names>J</given-names></name><name><surname>Pandya</surname> <given-names>JD</given-names></name><name><surname>Zhi</surname> <given-names>L</given-names></name><name><surname>Cass</surname> <given-names>WA</given-names></name><name><surname>Sullivan</surname> <given-names>PG</given-names></name><name><surname>Büeler</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e16038</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016038</pub-id><pub-id pub-id-type="pmid">21249202</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>GF</given-names></name><name><surname>Toth</surname> <given-names>R</given-names></name><name><surname>James</surname> <given-names>J</given-names></name><name><surname>Ganley</surname> <given-names>IG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of iron triggers PINK1/Parkin-independent mitophagy</article-title><source>EMBO Reports</source><volume>14</volume><fpage>1127</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.168</pub-id><pub-id pub-id-type="pmid">24176932</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambivero</surname> <given-names>CT</given-names></name><name><surname>Cilenti</surname> <given-names>L</given-names></name><name><surname>Main</surname> <given-names>S</given-names></name><name><surname>Zervos</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP</article-title><source>Cellular Signalling</source><volume>26</volume><fpage>2921</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2014.09.004</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname> <given-names>G</given-names></name><name><surname>Schlehe</surname> <given-names>JS</given-names></name><name><surname>LaVoie</surname> <given-names>MJ</given-names></name><name><surname>Schwarz</surname> <given-names>TL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin</article-title><source>The Journal of Cell Biology</source><volume>206</volume><fpage>655</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1083/jcb.201401070</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajaj</surname> <given-names>L</given-names></name><name><surname>Lotfi</surname> <given-names>P</given-names></name><name><surname>Pal</surname> <given-names>R</given-names></name><name><surname>Ronza</surname> <given-names>AD</given-names></name><name><surname>Sharma</surname> <given-names>J</given-names></name><name><surname>Sardiello</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lysosome biogenesis in health and disease</article-title><source>Journal of Neurochemistry</source><volume>148</volume><fpage>573</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1111/jnc.14564</pub-id><pub-id pub-id-type="pmid">30092616</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellot</surname> <given-names>G</given-names></name><name><surname>Garcia-Medina</surname> <given-names>R</given-names></name><name><surname>Gounon</surname> <given-names>P</given-names></name><name><surname>Chiche</surname> <given-names>J</given-names></name><name><surname>Roux</surname> <given-names>D</given-names></name><name><surname>Pouyssegur</surname> <given-names>J</given-names></name><name><surname>Mazure</surname> <given-names>NM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypoxia-Induced autophagy is mediated through Hypoxia-Inducible factor induction of BNIP3 and BNIP3L via their BH3 domains</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.1128/MCB.00166-09</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benes</surname> <given-names>P</given-names></name><name><surname>Vetvicka</surname> <given-names>V</given-names></name><name><surname>Fusek</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cathepsin D--many functions of one aspartic protease</article-title><source>Critical Reviews in Oncology/Hematology</source><volume>68</volume><fpage>12</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2008.02.008</pub-id><pub-id pub-id-type="pmid">18396408</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname> <given-names>B</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Platt</surname> <given-names>FM</given-names></name><name><surname>Wegiel</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>WH</given-names></name><name><surname>Nixon</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>6926</fpage><lpage>6937</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0800-08.2008</pub-id><pub-id pub-id-type="pmid">18596167</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Q</given-names></name><name><surname>Zakaria</surname> <given-names>HM</given-names></name><name><surname>Simone</surname> <given-names>A</given-names></name><name><surname>Sheng</surname> <given-names>ZH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons</article-title><source>Current Biology</source><volume>22</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2012.02.005</pub-id><pub-id pub-id-type="pmid">22342752</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname> <given-names>GH</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>SB</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name><name><surname>Chung</surname> <given-names>J</given-names></name><name><surname>Cho</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Parkin negatively regulates JNK pathway in the dopaminergic neurons of <italic>Drosophila</italic></article-title><source>PNAS</source><volume>102</volume><fpage>10345</fpage><lpage>10350</lpage><pub-id pub-id-type="doi">10.1073/pnas.0500346102</pub-id><pub-id pub-id-type="pmid">16002472</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>XT</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Lin</surname> <given-names>MY</given-names></name><name><surname>Cai</surname> <given-names>Q</given-names></name><name><surname>Sheng</surname> <given-names>ZH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes</article-title><source>The Journal of Cell Biology</source><volume>209</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1083/jcb.201412046</pub-id><pub-id pub-id-type="pmid">25940348</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>XT</given-names></name><name><surname>Xie</surname> <given-names>YX</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Huang</surname> <given-names>N</given-names></name><name><surname>Farfel-Becker</surname> <given-names>T</given-names></name><name><surname>Sheng</surname> <given-names>ZH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>3127</fpage><lpage>3139</lpage><pub-id pub-id-type="doi">10.1083/jcb.201711083</pub-id><pub-id pub-id-type="pmid">29695488</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>IE</given-names></name><name><surname>Dodson</surname> <given-names>MW</given-names></name><name><surname>Jiang</surname> <given-names>C</given-names></name><name><surname>Cao</surname> <given-names>JH</given-names></name><name><surname>Huh</surname> <given-names>JR</given-names></name><name><surname>Seol</surname> <given-names>JH</given-names></name><name><surname>Yoo</surname> <given-names>SJ</given-names></name><name><surname>Hay</surname> <given-names>BA</given-names></name><name><surname>Guo</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title><italic>Drosophila</italic> pink1 is required for mitochondrial function and interacts genetically with parkin</article-title><source>Nature</source><volume>441</volume><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1038/nature04779</pub-id><pub-id pub-id-type="pmid">16672981</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelissen</surname> <given-names>T</given-names></name><name><surname>Vilain</surname> <given-names>S</given-names></name><name><surname>Vints</surname> <given-names>K</given-names></name><name><surname>Gounko</surname> <given-names>N</given-names></name><name><surname>Verstreken</surname> <given-names>P</given-names></name><name><surname>Vandenberghe</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deficiency of Parkin and PINK1 impairs age-dependent mitophagy in <italic>Drosophila</italic></article-title><source>eLife</source><volume>7</volume><elocation-id>e35878</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35878</pub-id><pub-id pub-id-type="pmid">29809156</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dave</surname> <given-names>KD</given-names></name><name><surname>De Silva</surname> <given-names>S</given-names></name><name><surname>Sheth</surname> <given-names>NP</given-names></name><name><surname>Ramboz</surname> <given-names>S</given-names></name><name><surname>Beck</surname> <given-names>MJ</given-names></name><name><surname>Quang</surname> <given-names>C</given-names></name><name><surname>Switzer</surname> <given-names>RC</given-names></name><name><surname>Ahmad</surname> <given-names>SO</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Walker</surname> <given-names>D</given-names></name><name><surname>Cui</surname> <given-names>X</given-names></name><name><surname>Fisher</surname> <given-names>DA</given-names></name><name><surname>McCoy</surname> <given-names>AM</given-names></name><name><surname>Gamber</surname> <given-names>K</given-names></name><name><surname>Ding</surname> <given-names>X</given-names></name><name><surname>Goldberg</surname> <given-names>MS</given-names></name><name><surname>Benkovic</surname> <given-names>SA</given-names></name><name><surname>Haupt</surname> <given-names>M</given-names></name><name><surname>Baptista</surname> <given-names>MA</given-names></name><name><surname>Fiske</surname> <given-names>BK</given-names></name><name><surname>Sherer</surname> <given-names>TB</given-names></name><name><surname>Frasier</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease</article-title><source>Neurobiology of Disease</source><volume>70</volume><fpage>190</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2014.06.009</pub-id><pub-id pub-id-type="pmid">24969022</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devireddy</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>A</given-names></name><name><surname>Lampe</surname> <given-names>T</given-names></name><name><surname>Hollenbeck</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The organization of mitochondrial quality control and life cycle in the nervous system in vivo in the absence of PINK1</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>9391</fpage><lpage>9401</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1198-15.2015</pub-id><pub-id pub-id-type="pmid">26109662</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>CS</given-names></name><name><surname>Holzbaur</surname> <given-names>ELF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Autophagy and mitophagy in ALS</article-title><source>Neurobiology of Disease</source><volume>122</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2018.07.005</pub-id><pub-id pub-id-type="pmid">29981842</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farías</surname> <given-names>GG</given-names></name><name><surname>Guardia</surname> <given-names>CM</given-names></name><name><surname>De Pace</surname> <given-names>R</given-names></name><name><surname>Britt</surname> <given-names>DJ</given-names></name><name><surname>Bonifacino</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>BORC/kinesin-1 ensemble drives polarized transport of lysosomes into the axon</article-title><source>PNAS</source><volume>114</volume><fpage>E2955</fpage><lpage>E2964</lpage><pub-id pub-id-type="doi">10.1073/pnas.1616363114</pub-id><pub-id pub-id-type="pmid">28320970</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freischmidt</surname> <given-names>A</given-names></name><name><surname>Wieland</surname> <given-names>T</given-names></name><name><surname>Richter</surname> <given-names>B</given-names></name><name><surname>Ruf</surname> <given-names>W</given-names></name><name><surname>Schaeffer</surname> <given-names>V</given-names></name><name><surname>Müller</surname> <given-names>K</given-names></name><name><surname>Marroquin</surname> <given-names>N</given-names></name><name><surname>Nordin</surname> <given-names>F</given-names></name><name><surname>Hübers</surname> <given-names>A</given-names></name><name><surname>Weydt</surname> <given-names>P</given-names></name><name><surname>Pinto</surname> <given-names>S</given-names></name><name><surname>Press</surname> <given-names>R</given-names></name><name><surname>Millecamps</surname> <given-names>S</given-names></name><name><surname>Molko</surname> <given-names>N</given-names></name><name><surname>Bernard</surname> <given-names>E</given-names></name><name><surname>Desnuelle</surname> <given-names>C</given-names></name><name><surname>Soriani</surname> <given-names>MH</given-names></name><name><surname>Dorst</surname> <given-names>J</given-names></name><name><surname>Graf</surname> <given-names>E</given-names></name><name><surname>Nordström</surname> <given-names>U</given-names></name><name><surname>Feiler</surname> <given-names>MS</given-names></name><name><surname>Putz</surname> <given-names>S</given-names></name><name><surname>Boeckers</surname> <given-names>TM</given-names></name><name><surname>Meyer</surname> <given-names>T</given-names></name><name><surname>Winkler</surname> <given-names>AS</given-names></name><name><surname>Winkelman</surname> <given-names>J</given-names></name><name><surname>de Carvalho</surname> <given-names>M</given-names></name><name><surname>Thal</surname> <given-names>DR</given-names></name><name><surname>Otto</surname> <given-names>M</given-names></name><name><surname>Brännström</surname> <given-names>T</given-names></name><name><surname>Volk</surname> <given-names>AE</given-names></name><name><surname>Kursula</surname> <given-names>P</given-names></name><name><surname>Danzer</surname> <given-names>KM</given-names></name><name><surname>Lichtner</surname> <given-names>P</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Ludolph</surname> <given-names>AC</given-names></name><name><surname>Strom</surname> <given-names>TM</given-names></name><name><surname>Andersen</surname> <given-names>PM</given-names></name><name><surname>Weishaupt</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nn.4000</pub-id><pub-id pub-id-type="pmid">25803835</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geisler</surname> <given-names>S</given-names></name><name><surname>Holmström</surname> <given-names>KM</given-names></name><name><surname>Treis</surname> <given-names>A</given-names></name><name><surname>Skujat</surname> <given-names>D</given-names></name><name><surname>Weber</surname> <given-names>SS</given-names></name><name><surname>Fiesel</surname> <given-names>FC</given-names></name><name><surname>Kahle</surname> <given-names>PJ</given-names></name><name><surname>Springer</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations</article-title><source>Autophagy</source><volume>6</volume><fpage>871</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.4161/auto.6.7.13286</pub-id><pub-id pub-id-type="pmid">20798600</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gkikas</surname> <given-names>I</given-names></name><name><surname>Palikaras</surname> <given-names>K</given-names></name><name><surname>Tavernarakis</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The role of mitophagy in innate immunity</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1283</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01283</pub-id><pub-id pub-id-type="pmid">29951054</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleason</surname> <given-names>CE</given-names></name><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Gourlay</surname> <given-names>R</given-names></name><name><surname>Arthur</surname> <given-names>JS</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>35663</fpage><lpage>35674</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.267567</pub-id><pub-id pub-id-type="pmid">21862579</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname> <given-names>MS</given-names></name><name><surname>Fleming</surname> <given-names>SM</given-names></name><name><surname>Palacino</surname> <given-names>JJ</given-names></name><name><surname>Cepeda</surname> <given-names>C</given-names></name><name><surname>Lam</surname> <given-names>HA</given-names></name><name><surname>Bhatnagar</surname> <given-names>A</given-names></name><name><surname>Meloni</surname> <given-names>EG</given-names></name><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Ackerson</surname> <given-names>LC</given-names></name><name><surname>Klapstein</surname> <given-names>GJ</given-names></name><name><surname>Gajendiran</surname> <given-names>M</given-names></name><name><surname>Roth</surname> <given-names>BL</given-names></name><name><surname>Chesselet</surname> <given-names>MF</given-names></name><name><surname>Maidment</surname> <given-names>NT</given-names></name><name><surname>Levine</surname> <given-names>MS</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>43628</fpage><lpage>43635</lpage><pub-id pub-id-type="doi">10.1074/jbc.M308947200</pub-id><pub-id pub-id-type="pmid">12930822</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname> <given-names>JW</given-names></name><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Heo</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Building and decoding ubiquitin chains for mitophagy</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>19</volume><fpage>93</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.129</pub-id><pub-id pub-id-type="pmid">29358684</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname> <given-names>JM</given-names></name><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Paulo</surname> <given-names>JA</given-names></name><name><surname>Rinehart</surname> <given-names>J</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy</article-title><source>Molecular Cell</source><volume>60</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.08.016</pub-id><pub-id pub-id-type="pmid">26365381</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenbeck</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport</article-title><source>The Journal of Cell Biology</source><volume>121</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1083/jcb.121.2.305</pub-id><pub-id pub-id-type="pmid">7682217</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>CH</given-names></name><name><surname>Shaltouki</surname> <given-names>A</given-names></name><name><surname>Gonzalez</surname> <given-names>AE</given-names></name><name><surname>Bettencourt da Cruz</surname> <given-names>A</given-names></name><name><surname>Burbulla</surname> <given-names>LF</given-names></name><name><surname>St Lawrence</surname> <given-names>E</given-names></name><name><surname>Schüle</surname> <given-names>B</given-names></name><name><surname>Krainc</surname> <given-names>D</given-names></name><name><surname>Palmer</surname> <given-names>TD</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic parkinson's Disease</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.08.002</pub-id><pub-id pub-id-type="pmid">27618216</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>H</given-names></name><name><surname>Nakamura</surname> <given-names>M</given-names></name><name><surname>Komure</surname> <given-names>O</given-names></name><name><surname>Ayaki</surname> <given-names>T</given-names></name><name><surname>Wate</surname> <given-names>R</given-names></name><name><surname>Maruyama</surname> <given-names>H</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Fujita</surname> <given-names>K</given-names></name><name><surname>Kaneko</surname> <given-names>S</given-names></name><name><surname>Okamoto</surname> <given-names>Y</given-names></name><name><surname>Ihara</surname> <given-names>M</given-names></name><name><surname>Konishi</surname> <given-names>T</given-names></name><name><surname>Ogasawara</surname> <given-names>K</given-names></name><name><surname>Hirano</surname> <given-names>A</given-names></name><name><surname>Kusaka</surname> <given-names>H</given-names></name><name><surname>Kaji</surname> <given-names>R</given-names></name><name><surname>Takahashi</surname> <given-names>R</given-names></name><name><surname>Kawakami</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation</article-title><source>Acta Neuropathologica</source><volume>122</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1007/s00401-011-0842-y</pub-id><pub-id pub-id-type="pmid">21644038</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joselin</surname> <given-names>AP</given-names></name><name><surname>Hewitt</surname> <given-names>SJ</given-names></name><name><surname>Callaghan</surname> <given-names>SM</given-names></name><name><surname>Kim</surname> <given-names>RH</given-names></name><name><surname>Chung</surname> <given-names>YH</given-names></name><name><surname>Mak</surname> <given-names>TW</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Slack</surname> <given-names>RS</given-names></name><name><surname>Park</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>4888</fpage><lpage>4903</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds325</pub-id><pub-id pub-id-type="pmid">22872702</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname> <given-names>LA</given-names></name><name><surname>Lazarou</surname> <given-names>M</given-names></name><name><surname>Fogel</surname> <given-names>AI</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Yamano</surname> <given-names>K</given-names></name><name><surname>Sarraf</surname> <given-names>SA</given-names></name><name><surname>Banerjee</surname> <given-names>S</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity</article-title><source>The Journal of Cell Biology</source><volume>205</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1083/jcb.201402104</pub-id><pub-id pub-id-type="pmid">24751536</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname> <given-names>H</given-names></name><name><surname>Kogure</surname> <given-names>T</given-names></name><name><surname>Mizushima</surname> <given-names>N</given-names></name><name><surname>Yoshimori</surname> <given-names>T</given-names></name><name><surname>Miyawaki</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery</article-title><source>Chemistry &amp; Biology</source><volume>18</volume><fpage>1042</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2011.05.013</pub-id><pub-id pub-id-type="pmid">21867919</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazlauskaite</surname> <given-names>A</given-names></name><name><surname>Kondapalli</surname> <given-names>C</given-names></name><name><surname>Gourlay</surname> <given-names>R</given-names></name><name><surname>Campbell</surname> <given-names>DG</given-names></name><name><surname>Ritorto</surname> <given-names>MS</given-names></name><name><surname>Hofmann</surname> <given-names>K</given-names></name><name><surname>Alessi</surname> <given-names>DR</given-names></name><name><surname>Knebel</surname> <given-names>A</given-names></name><name><surname>Trost</surname> <given-names>M</given-names></name><name><surname>Muqit</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65</article-title><source>Biochemical Journal</source><volume>460</volume><fpage>127</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1042/BJ20140334</pub-id><pub-id pub-id-type="pmid">24660806</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>YY</given-names></name><name><surname>Um</surname> <given-names>J-H</given-names></name><name><surname>Yoon</surname> <given-names>J-H</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>D-Y</given-names></name><name><surname>Lee</surname> <given-names>YJ</given-names></name><name><surname>Jee</surname> <given-names>HJ</given-names></name><name><surname>Kim</surname> <given-names>YM</given-names></name><name><surname>Jang</surname> <given-names>JS</given-names></name><name><surname>Jang</surname> <given-names>Y-G</given-names></name><name><surname>Chung</surname> <given-names>J</given-names></name><name><surname>Park</surname> <given-names>HT</given-names></name><name><surname>Finkel</surname> <given-names>T</given-names></name><name><surname>Koh</surname> <given-names>H</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Assessment of mitophagy in mt-Keima <italic>Drosophila</italic> revealed an essential role of the PINK1-Parkin pathway in mitophagy induction <italic>in vivo</italic></article-title><source>The FASEB Journal</source><volume>33</volume><fpage>9742</fpage><lpage>9751</lpage><pub-id pub-id-type="doi">10.1096/fj.201900073R</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname> <given-names>S</given-names></name><name><surname>Noda</surname> <given-names>T</given-names></name><name><surname>Yoshimori</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes</article-title><source>Cell Structure and Function</source><volume>33</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1247/csf.08005</pub-id><pub-id pub-id-type="pmid">18388399</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname> <given-names>T</given-names></name><name><surname>Asakawa</surname> <given-names>S</given-names></name><name><surname>Hattori</surname> <given-names>N</given-names></name><name><surname>Matsumine</surname> <given-names>H</given-names></name><name><surname>Yamamura</surname> <given-names>Y</given-names></name><name><surname>Minoshima</surname> <given-names>S</given-names></name><name><surname>Yokochi</surname> <given-names>M</given-names></name><name><surname>Mizuno</surname> <given-names>Y</given-names></name><name><surname>Shimizu</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism</article-title><source>Nature</source><volume>392</volume><fpage>605</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1038/33416</pub-id><pub-id pub-id-type="pmid">9560156</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname> <given-names>T</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name><name><surname>Porter</surname> <given-names>DR</given-names></name><name><surname>Yamaguchi</surname> <given-names>H</given-names></name><name><surname>Tscherter</surname> <given-names>A</given-names></name><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Pothos</surname> <given-names>EN</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice</article-title><source>PNAS</source><volume>104</volume><fpage>11441</fpage><lpage>11446</lpage><pub-id pub-id-type="doi">10.1073/pnas.0702717104</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koentjoro</surname> <given-names>B</given-names></name><name><surname>Park</surname> <given-names>JS</given-names></name><name><surname>Sue</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related parkinson's disease</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>44373</elocation-id><pub-id pub-id-type="doi">10.1038/srep44373</pub-id><pub-id pub-id-type="pmid">28281653</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korac</surname> <given-names>J</given-names></name><name><surname>Schaeffer</surname> <given-names>V</given-names></name><name><surname>Kovacevic</surname> <given-names>I</given-names></name><name><surname>Clement</surname> <given-names>AM</given-names></name><name><surname>Jungblut</surname> <given-names>B</given-names></name><name><surname>Behl</surname> <given-names>C</given-names></name><name><surname>Terzic</surname> <given-names>J</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ubiquitin-independent function of optineurin in Autophagic clearance of protein aggregates</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>580</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1242/jcs.114926</pub-id><pub-id pub-id-type="pmid">23178947</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyano</surname> <given-names>F</given-names></name><name><surname>Okatsu</surname> <given-names>K</given-names></name><name><surname>Kosako</surname> <given-names>H</given-names></name><name><surname>Tamura</surname> <given-names>Y</given-names></name><name><surname>Go</surname> <given-names>E</given-names></name><name><surname>Kimura</surname> <given-names>M</given-names></name><name><surname>Kimura</surname> <given-names>Y</given-names></name><name><surname>Tsuchiya</surname> <given-names>H</given-names></name><name><surname>Yoshihara</surname> <given-names>H</given-names></name><name><surname>Hirokawa</surname> <given-names>T</given-names></name><name><surname>Endo</surname> <given-names>T</given-names></name><name><surname>Fon</surname> <given-names>EA</given-names></name><name><surname>Trempe</surname> <given-names>JF</given-names></name><name><surname>Saeki</surname> <given-names>Y</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Matsuda</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ubiquitin is phosphorylated by PINK1 to activate parkin</article-title><source>Nature</source><volume>510</volume><fpage>162</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/nature13392</pub-id><pub-id pub-id-type="pmid">24784582</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarou</surname> <given-names>M</given-names></name><name><surname>Sliter</surname> <given-names>DA</given-names></name><name><surname>Kane</surname> <given-names>LA</given-names></name><name><surname>Sarraf</surname> <given-names>SA</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Burman</surname> <given-names>JL</given-names></name><name><surname>Sideris</surname> <given-names>DP</given-names></name><name><surname>Fogel</surname> <given-names>AI</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</article-title><source>Nature</source><volume>524</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/nature14893</pub-id><pub-id pub-id-type="pmid">26266977</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Nixon</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an alzheimer's-Like Axonal Dystrophy</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>7817</fpage><lpage>7830</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6412-10.2011</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JJ</given-names></name><name><surname>Sanchez-Martinez</surname> <given-names>A</given-names></name><name><surname>Zarate</surname> <given-names>AM</given-names></name><name><surname>Benincá</surname> <given-names>C</given-names></name><name><surname>Mayor</surname> <given-names>U</given-names></name><name><surname>Clague</surname> <given-names>MJ</given-names></name><name><surname>Whitworth</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Basal mitophagy is widespread in <italic>Drosophila</italic> but minimally affected by loss of Pink1 or parkin</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>1613</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1083/jcb.201801044</pub-id><pub-id pub-id-type="pmid">29500189</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lie</surname> <given-names>PPY</given-names></name><name><surname>Nixon</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lysosome trafficking and signaling in health and neurodegenerative diseases</article-title><source>Neurobiology of Disease</source><volume>122</volume><fpage>94</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2018.05.015</pub-id><pub-id pub-id-type="pmid">29859318</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Sawada</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>W</given-names></name><name><surname>Silverio</surname> <given-names>G</given-names></name><name><surname>Alapatt</surname> <given-names>P</given-names></name><name><surname>Millan</surname> <given-names>I</given-names></name><name><surname>Shen</surname> <given-names>A</given-names></name><name><surname>Saxton</surname> <given-names>W</given-names></name><name><surname>Kanao</surname> <given-names>T</given-names></name><name><surname>Takahashi</surname> <given-names>R</given-names></name><name><surname>Hattori</surname> <given-names>N</given-names></name><name><surname>Imai</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002537</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002537</pub-id><pub-id pub-id-type="pmid">22396657</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname> <given-names>S</given-names></name><name><surname>Wallace</surname> <given-names>KE</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons</article-title><source>The Journal of Cell Biology</source><volume>196</volume><fpage>407</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1083/jcb.201106120</pub-id><pub-id pub-id-type="pmid">22331844</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname> <given-names>S</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway</article-title><source>Developmental Cell</source><volume>30</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.06.001</pub-id><pub-id pub-id-type="pmid">25026034</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname> <given-names>S</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Compartment-Specific regulation of autophagy in primary neurons</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>5933</fpage><lpage>5945</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4401-15.2016</pub-id><pub-id pub-id-type="pmid">27251616</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majumdar</surname> <given-names>A</given-names></name><name><surname>Capetillo-Zarate</surname> <given-names>E</given-names></name><name><surname>Cruz</surname> <given-names>D</given-names></name><name><surname>Gouras</surname> <given-names>GK</given-names></name><name><surname>Maxfield</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes</article-title><source>Molecular Biology of the Cell</source><volume>22</volume><fpage>1664</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1091/mbc.e10-09-0745</pub-id><pub-id pub-id-type="pmid">21441306</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname> <given-names>JA</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Gucek</surname> <given-names>M</given-names></name><name><surname>Puertollano</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB</article-title><source>Autophagy</source><volume>8</volume><fpage>903</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.4161/auto.19653</pub-id><pub-id pub-id-type="pmid">22576015</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname> <given-names>H</given-names></name><name><surname>Morino</surname> <given-names>H</given-names></name><name><surname>Ito</surname> <given-names>H</given-names></name><name><surname>Izumi</surname> <given-names>Y</given-names></name><name><surname>Kato</surname> <given-names>H</given-names></name><name><surname>Watanabe</surname> <given-names>Y</given-names></name><name><surname>Kinoshita</surname> <given-names>Y</given-names></name><name><surname>Kamada</surname> <given-names>M</given-names></name><name><surname>Nodera</surname> <given-names>H</given-names></name><name><surname>Suzuki</surname> <given-names>H</given-names></name><name><surname>Komure</surname> <given-names>O</given-names></name><name><surname>Matsuura</surname> <given-names>S</given-names></name><name><surname>Kobatake</surname> <given-names>K</given-names></name><name><surname>Morimoto</surname> <given-names>N</given-names></name><name><surname>Abe</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Aoki</surname> <given-names>M</given-names></name><name><surname>Kawata</surname> <given-names>A</given-names></name><name><surname>Hirai</surname> <given-names>T</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Ogasawara</surname> <given-names>K</given-names></name><name><surname>Hirano</surname> <given-names>A</given-names></name><name><surname>Takumi</surname> <given-names>T</given-names></name><name><surname>Kusaka</surname> <given-names>H</given-names></name><name><surname>Hagiwara</surname> <given-names>K</given-names></name><name><surname>Kaji</surname> <given-names>R</given-names></name><name><surname>Kawakami</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutations of optineurin in amyotrophic lateral sclerosis</article-title><source>Nature</source><volume>465</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nature08971</pub-id><pub-id pub-id-type="pmid">20428114</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname> <given-names>H</given-names></name><name><surname>Kawakami</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Optineurin and amyotrophic lateral sclerosis</article-title><source>Geriatrics &amp; Gerontology International</source><volume>13</volume><fpage>528</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1111/ggi.12022</pub-id><pub-id pub-id-type="pmid">23279185</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>N</given-names></name><name><surname>Sato</surname> <given-names>S</given-names></name><name><surname>Shiba</surname> <given-names>K</given-names></name><name><surname>Okatsu</surname> <given-names>K</given-names></name><name><surname>Saisho</surname> <given-names>K</given-names></name><name><surname>Gautier</surname> <given-names>CA</given-names></name><name><surname>Sou</surname> <given-names>YS</given-names></name><name><surname>Saiki</surname> <given-names>S</given-names></name><name><surname>Kawajiri</surname> <given-names>S</given-names></name><name><surname>Sato</surname> <given-names>F</given-names></name><name><surname>Kimura</surname> <given-names>M</given-names></name><name><surname>Komatsu</surname> <given-names>M</given-names></name><name><surname>Hattori</surname> <given-names>N</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PINK1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent parkin for mitophagy</article-title><source>The Journal of Cell Biology</source><volume>189</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1083/jcb.200910140</pub-id><pub-id pub-id-type="pmid">20404107</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWilliams</surname> <given-names>TG</given-names></name><name><surname>Prescott</surname> <given-names>AR</given-names></name><name><surname>Allen</surname> <given-names>GF</given-names></name><name><surname>Tamjar</surname> <given-names>J</given-names></name><name><surname>Munson</surname> <given-names>MJ</given-names></name><name><surname>Thomson</surname> <given-names>C</given-names></name><name><surname>Muqit</surname> <given-names>MM</given-names></name><name><surname>Ganley</surname> <given-names>IG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>mito-QC illuminates mitophagy and mitochondrial architecture in vivo</article-title><source>The Journal of Cell Biology</source><volume>214</volume><fpage>333</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1083/jcb.201603039</pub-id><pub-id pub-id-type="pmid">27458135</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWilliams</surname> <given-names>TG</given-names></name><name><surname>Prescott</surname> <given-names>AR</given-names></name><name><surname>Montava-Garriga</surname> <given-names>L</given-names></name><name><surname>Ball</surname> <given-names>G</given-names></name><name><surname>Singh</surname> <given-names>F</given-names></name><name><surname>Barini</surname> <given-names>E</given-names></name><name><surname>Muqit</surname> <given-names>MMK</given-names></name><name><surname>Brooks</surname> <given-names>SP</given-names></name><name><surname>Ganley</surname> <given-names>IG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.008</pub-id><pub-id pub-id-type="pmid">29337137</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millecamps</surname> <given-names>S</given-names></name><name><surname>Julien</surname> <given-names>J-P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Axonal transport deficits and neurodegenerative diseases</article-title><source>Nature Reviews Neuroscience</source><volume>14</volume><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nrn3380</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>KE</given-names></name><name><surname>Sheetz</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Axonal mitochondrial transport and potential are correlated</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>2791</fpage><lpage>2804</lpage><pub-id pub-id-type="doi">10.1242/jcs.01130</pub-id><pub-id pub-id-type="pmid">15150321</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misgeld</surname> <given-names>T</given-names></name><name><surname>Schwarz</surname> <given-names>TL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture</article-title><source>Neuron</source><volume>96</volume><fpage>651</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.055</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname> <given-names>N</given-names></name><name><surname>Yamamoto</surname> <given-names>A</given-names></name><name><surname>Hatano</surname> <given-names>M</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Kabeya</surname> <given-names>Y</given-names></name><name><surname>Suzuki</surname> <given-names>K</given-names></name><name><surname>Tokuhisa</surname> <given-names>T</given-names></name><name><surname>Ohsumi</surname> <given-names>Y</given-names></name><name><surname>Yoshimori</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells</article-title><source>The Journal of Cell Biology</source><volume>152</volume><fpage>657</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1083/jcb.152.4.657</pub-id><pub-id pub-id-type="pmid">11266458</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>AS</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy</article-title><source>PNAS</source><volume>113</volume><fpage>E3349</fpage><lpage>E3358</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523810113</pub-id><pub-id pub-id-type="pmid">27247382</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narendra</surname> <given-names>D</given-names></name><name><surname>Tanaka</surname> <given-names>A</given-names></name><name><surname>Suen</surname> <given-names>DF</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title><source>The Journal of Cell Biology</source><volume>183</volume><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1083/jcb.200809125</pub-id><pub-id pub-id-type="pmid">19029340</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narendra</surname> <given-names>D</given-names></name><name><surname>Kane</surname> <given-names>LA</given-names></name><name><surname>Hauser</surname> <given-names>DN</given-names></name><name><surname>Fearnley</surname> <given-names>IM</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both</article-title><source>Autophagy</source><volume>6</volume><fpage>1090</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.4161/auto.6.8.13426</pub-id><pub-id pub-id-type="pmid">20890124</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narendra</surname> <given-names>DP</given-names></name><name><surname>Jin</surname> <given-names>SM</given-names></name><name><surname>Tanaka</surname> <given-names>A</given-names></name><name><surname>Suen</surname> <given-names>DF</given-names></name><name><surname>Gautier</surname> <given-names>CA</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Cookson</surname> <given-names>MR</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>PINK1 is selectively stabilized on impaired mitochondria to activate parkin</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000298</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000298</pub-id><pub-id pub-id-type="pmid">20126261</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nautiyal</surname> <given-names>M</given-names></name><name><surname>Sweatt</surname> <given-names>AJ</given-names></name><name><surname>MacKenzie</surname> <given-names>JA</given-names></name><name><surname>Mark Payne</surname> <given-names>R</given-names></name><name><surname>Szucs</surname> <given-names>S</given-names></name><name><surname>Matalon</surname> <given-names>R</given-names></name><name><surname>Wallin</surname> <given-names>R</given-names></name><name><surname>Hutson</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neuronal localization of the mitochondrial protein NIPSNAP1 in rat nervous system</article-title><source>European Journal of Neuroscience</source><volume>32</volume><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07326.x</pub-id><pub-id pub-id-type="pmid">20646061</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neisch</surname> <given-names>AL</given-names></name><name><surname>Neufeld</surname> <given-names>TP</given-names></name><name><surname>Hays</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A STRIPAK complex mediates axonal transport of autophagosomes and dense core vesicles through PP2A regulation</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>441</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1083/jcb.201606082</pub-id><pub-id pub-id-type="pmid">28100687</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>TN</given-names></name><name><surname>Padman</surname> <given-names>BS</given-names></name><name><surname>Lazarou</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deciphering the molecular signals of PINK1/Parkin mitophagy</article-title><source>Trends in Cell Biology</source><volume>26</volume><fpage>733</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2016.05.008</pub-id><pub-id pub-id-type="pmid">27291334</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Sarraf</surname> <given-names>SA</given-names></name><name><surname>Duda</surname> <given-names>DM</given-names></name><name><surname>Heo</surname> <given-names>JM</given-names></name><name><surname>Jedrychowski</surname> <given-names>MP</given-names></name><name><surname>Sviderskiy</surname> <given-names>VO</given-names></name><name><surname>Olszewski</surname> <given-names>JL</given-names></name><name><surname>Koerber</surname> <given-names>JT</given-names></name><name><surname>Xie</surname> <given-names>T</given-names></name><name><surname>Beausoleil</surname> <given-names>SA</given-names></name><name><surname>Wells</surname> <given-names>JA</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Schulman</surname> <given-names>BA</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis</article-title><source>Molecular Cell</source><volume>56</volume><fpage>360</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.09.007</pub-id><pub-id pub-id-type="pmid">25284222</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Heo</surname> <given-names>JM</given-names></name><name><surname>Duda</surname> <given-names>DM</given-names></name><name><surname>Paulo</surname> <given-names>JA</given-names></name><name><surname>Olszewski</surname> <given-names>JL</given-names></name><name><surname>Yanishevski</surname> <given-names>D</given-names></name><name><surname>Rinehart</surname> <given-names>J</given-names></name><name><surname>Schulman</surname> <given-names>BA</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy</article-title><source>PNAS</source><volume>112</volume><fpage>6637</fpage><lpage>6642</lpage><pub-id pub-id-type="doi">10.1073/pnas.1506593112</pub-id><pub-id pub-id-type="pmid">25969509</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordureau</surname> <given-names>A</given-names></name><name><surname>Paulo</surname> <given-names>JA</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Ahfeldt</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Cohn</surname> <given-names>EF</given-names></name><name><surname>Hou</surname> <given-names>Z</given-names></name><name><surname>Heo</surname> <given-names>JM</given-names></name><name><surname>Rubin</surname> <given-names>LL</given-names></name><name><surname>Sidhu</surname> <given-names>SS</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dynamics of PARKIN-Dependent mitochondrial ubiquitylation in induced neurons and model systems revealed by digital snapshot proteomics</article-title><source>Molecular Cell</source><volume>70</volume><fpage>211</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.012</pub-id><pub-id pub-id-type="pmid">29656925</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>SB</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Song</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Bae</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Shong</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name><name><surname>Chung</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial dysfunction in <italic>Drosophila</italic> PINK1 mutants is complemented by parkin</article-title><source>Nature</source><volume>441</volume><fpage>1157</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1038/nature04788</pub-id><pub-id pub-id-type="pmid">16672980</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname> <given-names>FA</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Parkin-deficient mice are not a robust model of parkinsonism</article-title><source>PNAS</source><volume>102</volume><fpage>2174</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1073/pnas.0409598102</pub-id><pub-id pub-id-type="pmid">15684050</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname> <given-names>AC</given-names></name><name><surname>Thomas</surname> <given-names>RE</given-names></name><name><surname>Yu</surname> <given-names>S</given-names></name><name><surname>Vincow</surname> <given-names>ES</given-names></name><name><surname>Pallanck</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e10054</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0010054</pub-id><pub-id pub-id-type="pmid">20383334</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pottier</surname> <given-names>C</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Finch</surname> <given-names>N</given-names></name><name><surname>van de Vorst</surname> <given-names>M</given-names></name><name><surname>Baker</surname> <given-names>M</given-names></name><name><surname>Perkersen</surname> <given-names>R</given-names></name><name><surname>Brown</surname> <given-names>P</given-names></name><name><surname>Ravenscroft</surname> <given-names>T</given-names></name><name><surname>van Blitterswijk</surname> <given-names>M</given-names></name><name><surname>Nicholson</surname> <given-names>AM</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Josephs</surname> <given-names>KA</given-names></name><name><surname>Parisi</surname> <given-names>JE</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Veltman</surname> <given-names>JA</given-names></name><name><surname>Gilissen</surname> <given-names>C</given-names></name><name><surname>Murray</surname> <given-names>ME</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease</article-title><source>Acta Neuropathologica</source><volume>130</volume><fpage>77</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1436-x</pub-id><pub-id pub-id-type="pmid">25943890</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Princely Abudu</surname> <given-names>Y</given-names></name><name><surname>Pankiv</surname> <given-names>S</given-names></name><name><surname>Mathai</surname> <given-names>BJ</given-names></name><name><surname>Håkon Lystad</surname> <given-names>A</given-names></name><name><surname>Bindesbøll</surname> <given-names>C</given-names></name><name><surname>Brenne</surname> <given-names>HB</given-names></name><name><surname>Yoke Wui Ng</surname> <given-names>M</given-names></name><name><surname>Thiede</surname> <given-names>B</given-names></name><name><surname>Yamamoto</surname> <given-names>A</given-names></name><name><surname>Mutugi Nthiga</surname> <given-names>T</given-names></name><name><surname>Lamark</surname> <given-names>T</given-names></name><name><surname>Esguerra</surname> <given-names>CV</given-names></name><name><surname>Johansen</surname> <given-names>T</given-names></name><name><surname>Simonsen</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>NIPSNAP1 and NIPSNAP2 act as 'Eat Me' Signals for Mitophagy</article-title><source>Developmental Cell</source><volume>49</volume><fpage>509</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.03.013</pub-id><pub-id pub-id-type="pmid">30982665</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname> <given-names>R</given-names></name><name><surname>Cheng</surname> <given-names>XT</given-names></name><name><surname>Lin</surname> <given-names>MY</given-names></name><name><surname>Huang</surname> <given-names>N</given-names></name><name><surname>Sheng</surname> <given-names>ZH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3645</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11636-5</pub-id><pub-id pub-id-type="pmid">31409786</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Real</surname> <given-names>PJ</given-names></name><name><surname>Benito</surname> <given-names>A</given-names></name><name><surname>Cuevas</surname> <given-names>J</given-names></name><name><surname>Berciano</surname> <given-names>MT</given-names></name><name><surname>de Juan</surname> <given-names>A</given-names></name><name><surname>Coffer</surname> <given-names>P</given-names></name><name><surname>Gomez-Roman</surname> <given-names>J</given-names></name><name><surname>Lafarga</surname> <given-names>M</given-names></name><name><surname>Lopez-Vega</surname> <given-names>JM</given-names></name><name><surname>Fernandez-Luna</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Blockade of epidermal growth factor receptors chemosensitizes breast Cancer cells through up-regulation of Bnip3L</article-title><source>Cancer Research</source><volume>65</volume><fpage>8151</fpage><lpage>8157</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1134</pub-id><pub-id pub-id-type="pmid">16166289</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaie</surname> <given-names>T</given-names></name><name><surname>Child</surname> <given-names>A</given-names></name><name><surname>Hitchings</surname> <given-names>R</given-names></name><name><surname>Brice</surname> <given-names>G</given-names></name><name><surname>Miller</surname> <given-names>L</given-names></name><name><surname>Coca-Prados</surname> <given-names>M</given-names></name><name><surname>Héon</surname> <given-names>E</given-names></name><name><surname>Krupin</surname> <given-names>T</given-names></name><name><surname>Ritch</surname> <given-names>R</given-names></name><name><surname>Kreutzer</surname> <given-names>D</given-names></name><name><surname>Crick</surname> <given-names>RP</given-names></name><name><surname>Sarfarazi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Adult-onset primary open-angle Glaucoma caused by mutations in optineurin</article-title><source>Science</source><volume>295</volume><fpage>1077</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1126/science.1066901</pub-id><pub-id pub-id-type="pmid">11834836</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname> <given-names>B</given-names></name><name><surname>Sliter</surname> <given-names>DA</given-names></name><name><surname>Herhaus</surname> <given-names>L</given-names></name><name><surname>Stolz</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Beli</surname> <given-names>P</given-names></name><name><surname>Zaffagnini</surname> <given-names>G</given-names></name><name><surname>Wild</surname> <given-names>P</given-names></name><name><surname>Martens</surname> <given-names>S</given-names></name><name><surname>Wagner</surname> <given-names>SA</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phosphorylation of OPTN by TBK1 enhances its binding to ub chains and promotes selective autophagy of damaged mitochondria</article-title><source>PNAS</source><volume>113</volume><fpage>4039</fpage><lpage>4044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523926113</pub-id><pub-id pub-id-type="pmid">27035970</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roczniak-Ferguson</surname> <given-names>A</given-names></name><name><surname>Petit</surname> <given-names>CS</given-names></name><name><surname>Froehlich</surname> <given-names>F</given-names></name><name><surname>Qian</surname> <given-names>S</given-names></name><name><surname>Ky</surname> <given-names>J</given-names></name><name><surname>Angarola</surname> <given-names>B</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name><name><surname>Ferguson</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis</article-title><source>Science Signaling</source><volume>5</volume><elocation-id>ra42</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2002790</pub-id><pub-id pub-id-type="pmid">22692423</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogov</surname> <given-names>V</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Johansen</surname> <given-names>T</given-names></name><name><surname>Kirkin</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy</article-title><source>Molecular Cell</source><volume>53</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.12.014</pub-id><pub-id pub-id-type="pmid">24462201</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojansky</surname> <given-names>R</given-names></name><name><surname>Cha</surname> <given-names>MY</given-names></name><name><surname>Chan</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1</article-title><source>eLife</source><volume>5</volume><elocation-id>e17896</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17896</pub-id><pub-id pub-id-type="pmid">27852436</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sankaranarayanan</surname> <given-names>S</given-names></name><name><surname>De Angelis</surname> <given-names>D</given-names></name><name><surname>Rothman</surname> <given-names>JE</given-names></name><name><surname>Ryan</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The use of pHluorins for optical measurements of presynaptic activity</article-title><source>Biophysical Journal</source><volume>79</volume><fpage>2199</fpage><lpage>2208</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(00)76468-X</pub-id><pub-id pub-id-type="pmid">11023924</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases</article-title><source>Annals of the New York Academy of Sciences</source><volume>1371</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1111/nyas.13131</pub-id><pub-id pub-id-type="pmid">27299292</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarraf</surname> <given-names>SA</given-names></name><name><surname>Raman</surname> <given-names>M</given-names></name><name><surname>Guarani-Pereira</surname> <given-names>V</given-names></name><name><surname>Sowa</surname> <given-names>ME</given-names></name><name><surname>Huttlin</surname> <given-names>EL</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization</article-title><source>Nature</source><volume>496</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/nature12043</pub-id><pub-id pub-id-type="pmid">23503661</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>Z-H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial trafficking and anchoring in neurons: new insight and implications</article-title><source>The Journal of Cell Biology</source><volume>204</volume><fpage>1087</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1083/jcb.201312123</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliter</surname> <given-names>DA</given-names></name><name><surname>Martinez</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Sun</surname> <given-names>N</given-names></name><name><surname>Fischer</surname> <given-names>TD</given-names></name><name><surname>Burman</surname> <given-names>JL</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Narendra</surname> <given-names>DP</given-names></name><name><surname>Cai</surname> <given-names>H</given-names></name><name><surname>Borsche</surname> <given-names>M</given-names></name><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Youle</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Parkin and PINK1 mitigate STING-induced inflammation</article-title><source>Nature</source><volume>561</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0448-9</pub-id><pub-id pub-id-type="pmid">30135585</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soukup</surname> <given-names>SF</given-names></name><name><surname>Kuenen</surname> <given-names>S</given-names></name><name><surname>Vanhauwaert</surname> <given-names>R</given-names></name><name><surname>Manetsberger</surname> <given-names>J</given-names></name><name><surname>Hernández-Díaz</surname> <given-names>S</given-names></name><name><surname>Swerts</surname> <given-names>J</given-names></name><name><surname>Schoovaerts</surname> <given-names>N</given-names></name><name><surname>Vilain</surname> <given-names>S</given-names></name><name><surname>Gounko</surname> <given-names>NV</given-names></name><name><surname>Vints</surname> <given-names>K</given-names></name><name><surname>Geens</surname> <given-names>A</given-names></name><name><surname>De Strooper</surname> <given-names>B</given-names></name><name><surname>Verstreken</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A LRRK2-Dependent EndophilinA phosphoswitch is critical for macroautophagy at Presynaptic terminals</article-title><source>Neuron</source><volume>92</volume><fpage>829</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.037</pub-id><pub-id pub-id-type="pmid">27720484</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sowter</surname> <given-names>HM</given-names></name><name><surname>Ratcliffe</surname> <given-names>PJ</given-names></name><name><surname>Watson</surname> <given-names>P</given-names></name><name><surname>Greenberg</surname> <given-names>AH</given-names></name><name><surname>Harris</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors</article-title><source>Cancer Research</source><volume>61</volume><fpage>6669</fpage><lpage>6673</lpage><pub-id pub-id-type="pmid">11559532</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sriram</surname> <given-names>SR</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Ko</surname> <given-names>HS</given-names></name><name><surname>Chung</surname> <given-names>KK</given-names></name><name><surname>Wong</surname> <given-names>E</given-names></name><name><surname>Lim</surname> <given-names>KL</given-names></name><name><surname>Dawson</surname> <given-names>VL</given-names></name><name><surname>Dawson</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin</article-title><source>Human Molecular Genetics</source><volume>14</volume><fpage>2571</fpage><lpage>2586</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi292</pub-id><pub-id pub-id-type="pmid">16049031</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavoe</surname> <given-names>AK</given-names></name><name><surname>Hill</surname> <given-names>SE</given-names></name><name><surname>Hall</surname> <given-names>DH</given-names></name><name><surname>Colón-Ramos</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>KIF1A/UNC-104 transports ATG-9 to regulate neurodevelopment and autophagy at synapses</article-title><source>Developmental Cell</source><volume>38</volume><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.06.012</pub-id><pub-id pub-id-type="pmid">27396362</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolz</surname> <given-names>A</given-names></name><name><surname>Ernst</surname> <given-names>A</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cargo recognition and trafficking in selective autophagy</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/ncb2979</pub-id><pub-id pub-id-type="pmid">24875736</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>N</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Malide</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Rovira</surname> <given-names>II</given-names></name><name><surname>Holmström</surname> <given-names>KM</given-names></name><name><surname>Fergusson</surname> <given-names>MM</given-names></name><name><surname>Yoo</surname> <given-names>YH</given-names></name><name><surname>Combs</surname> <given-names>CA</given-names></name><name><surname>Finkel</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Measuring in vivo mitophagy</article-title><source>Molecular Cell</source><volume>60</volume><fpage>685</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.009</pub-id><pub-id pub-id-type="pmid">26549682</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname> <given-names>H</given-names></name><name><surname>Tandarich</surname> <given-names>LC</given-names></name><name><surname>Nguyen</surname> <given-names>K</given-names></name><name><surname>Hollenbeck</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Compartmentalized regulation of Parkin-Mediated mitochondrial quality control in the <italic>Drosophila</italic> nervous system in vivo</article-title><source>Journal of Neuroscience</source><volume>36</volume><fpage>7375</fpage><lpage>7391</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0633-16.2016</pub-id><pub-id pub-id-type="pmid">27413149</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname> <given-names>K</given-names></name><name><surname>Kirisako</surname> <given-names>T</given-names></name><name><surname>Kamada</surname> <given-names>Y</given-names></name><name><surname>Mizushima</surname> <given-names>N</given-names></name><name><surname>Noda</surname> <given-names>T</given-names></name><name><surname>Ohsumi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>5971</fpage><lpage>5981</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.21.5971</pub-id><pub-id pub-id-type="pmid">11689437</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twig</surname> <given-names>G</given-names></name><name><surname>Elorza</surname> <given-names>A</given-names></name><name><surname>Molina</surname> <given-names>AJ</given-names></name><name><surname>Mohamed</surname> <given-names>H</given-names></name><name><surname>Wikstrom</surname> <given-names>JD</given-names></name><name><surname>Walzer</surname> <given-names>G</given-names></name><name><surname>Stiles</surname> <given-names>L</given-names></name><name><surname>Haigh</surname> <given-names>SE</given-names></name><name><surname>Katz</surname> <given-names>S</given-names></name><name><surname>Las</surname> <given-names>G</given-names></name><name><surname>Alroy</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Py</surname> <given-names>BF</given-names></name><name><surname>Yuan</surname> <given-names>J</given-names></name><name><surname>Deeney</surname> <given-names>JT</given-names></name><name><surname>Corkey</surname> <given-names>BE</given-names></name><name><surname>Shirihai</surname> <given-names>OS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fission and selective fusion govern mitochondrial segregation and elimination by autophagy</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601963</pub-id><pub-id pub-id-type="pmid">18200046</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname> <given-names>EM</given-names></name><name><surname>Abou-Sleiman</surname> <given-names>PM</given-names></name><name><surname>Caputo</surname> <given-names>V</given-names></name><name><surname>Muqit</surname> <given-names>MM</given-names></name><name><surname>Harvey</surname> <given-names>K</given-names></name><name><surname>Gispert</surname> <given-names>S</given-names></name><name><surname>Ali</surname> <given-names>Z</given-names></name><name><surname>Del Turco</surname> <given-names>D</given-names></name><name><surname>Bentivoglio</surname> <given-names>AR</given-names></name><name><surname>Healy</surname> <given-names>DG</given-names></name><name><surname>Albanese</surname> <given-names>A</given-names></name><name><surname>Nussbaum</surname> <given-names>R</given-names></name><name><surname>González-Maldonado</surname> <given-names>R</given-names></name><name><surname>Deller</surname> <given-names>T</given-names></name><name><surname>Salvi</surname> <given-names>S</given-names></name><name><surname>Cortelli</surname> <given-names>P</given-names></name><name><surname>Gilks</surname> <given-names>WP</given-names></name><name><surname>Latchman</surname> <given-names>DS</given-names></name><name><surname>Harvey</surname> <given-names>RJ</given-names></name><name><surname>Dallapiccola</surname> <given-names>B</given-names></name><name><surname>Auburger</surname> <given-names>G</given-names></name><name><surname>Wood</surname> <given-names>NW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Hereditary early-onset parkinson's disease caused by mutations in PINK1</article-title><source>Science</source><volume>304</volume><fpage>1158</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1126/science.1096284</pub-id><pub-id pub-id-type="pmid">15087508</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincow</surname> <given-names>ES</given-names></name><name><surname>Merrihew</surname> <given-names>G</given-names></name><name><surname>Thomas</surname> <given-names>RE</given-names></name><name><surname>Shulman</surname> <given-names>NJ</given-names></name><name><surname>Beyer</surname> <given-names>RP</given-names></name><name><surname>MacCoss</surname> <given-names>MJ</given-names></name><name><surname>Pallanck</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo</article-title><source>PNAS</source><volume>110</volume><fpage>6400</fpage><lpage>6405</lpage><pub-id pub-id-type="doi">10.1073/pnas.1221132110</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vives-Bauza</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>C</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Cui</surname> <given-names>M</given-names></name><name><surname>de Vries</surname> <given-names>RL</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>May</surname> <given-names>J</given-names></name><name><surname>Tocilescu</surname> <given-names>MA</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Ko</surname> <given-names>HS</given-names></name><name><surname>Magrané</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>DJ</given-names></name><name><surname>Dawson</surname> <given-names>VL</given-names></name><name><surname>Grailhe</surname> <given-names>R</given-names></name><name><surname>Dawson</surname> <given-names>TM</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Tieu</surname> <given-names>K</given-names></name><name><surname>Przedborski</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PINK1-dependent recruitment of parkin to mitochondria in mitophagy</article-title><source>PNAS</source><volume>107</volume><fpage>378</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1073/pnas.0911187107</pub-id><pub-id pub-id-type="pmid">19966284</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Winter</surname> <given-names>D</given-names></name><name><surname>Ashrafi</surname> <given-names>G</given-names></name><name><surname>Schlehe</surname> <given-names>J</given-names></name><name><surname>Wong</surname> <given-names>YL</given-names></name><name><surname>Selkoe</surname> <given-names>D</given-names></name><name><surname>Rice</surname> <given-names>S</given-names></name><name><surname>Steen</surname> <given-names>J</given-names></name><name><surname>LaVoie</surname> <given-names>MJ</given-names></name><name><surname>Schwarz</surname> <given-names>TL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PINK1 and parkin target miro for phosphorylation and degradation to arrest mitochondrial motility</article-title><source>Cell</source><volume>147</volume><fpage>893</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.018</pub-id><pub-id pub-id-type="pmid">22078885</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>K</given-names></name><name><surname>Klionsky</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondria removal by autophagy</article-title><source>Autophagy</source><volume>7</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.4161/auto.7.3.14502</pub-id><pub-id pub-id-type="pmid">21252623</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermann</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mitochondrial fusion and fission in cell life and death</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>11</volume><fpage>872</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1038/nrm3013</pub-id><pub-id pub-id-type="pmid">21102612</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitworth</surname> <given-names>AJ</given-names></name><name><surname>Theodore</surname> <given-names>DA</given-names></name><name><surname>Greene</surname> <given-names>JC</given-names></name><name><surname>Benes</surname> <given-names>H</given-names></name><name><surname>Wes</surname> <given-names>PD</given-names></name><name><surname>Pallanck</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a <italic>Drosophila</italic> model of Parkinson's disease</article-title><source>PNAS</source><volume>102</volume><fpage>8024</fpage><lpage>8029</lpage><pub-id pub-id-type="doi">10.1073/pnas.0501078102</pub-id><pub-id pub-id-type="pmid">15911761</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname> <given-names>P</given-names></name><name><surname>Farhan</surname> <given-names>H</given-names></name><name><surname>McEwan</surname> <given-names>DG</given-names></name><name><surname>Wagner</surname> <given-names>S</given-names></name><name><surname>Rogov</surname> <given-names>VV</given-names></name><name><surname>Brady</surname> <given-names>NR</given-names></name><name><surname>Richter</surname> <given-names>B</given-names></name><name><surname>Korac</surname> <given-names>J</given-names></name><name><surname>Waidmann</surname> <given-names>O</given-names></name><name><surname>Choudhary</surname> <given-names>C</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Bumann</surname> <given-names>D</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth</article-title><source>Science</source><volume>333</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1126/science.1205405</pub-id><pub-id pub-id-type="pmid">21617041</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>YC</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation</article-title><source>PNAS</source><volume>111</volume><fpage>E4439</fpage><lpage>E4448</lpage><pub-id pub-id-type="doi">10.1073/pnas.1405752111</pub-id><pub-id pub-id-type="pmid">25294927</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>YC</given-names></name><name><surname>Holzbaur</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>1293</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1870-13.2014</pub-id><pub-id pub-id-type="pmid">24453320</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Gehrke</surname> <given-names>S</given-names></name><name><surname>Imai</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Ouyang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J-W</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Beal</surname> <given-names>MF</given-names></name><name><surname>Vogel</surname> <given-names>H</given-names></name><name><surname>Lu</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of <italic>Drosophila</italic> Pink1 is rescued by parkin</article-title><source>PNAS</source><volume>103</volume><fpage>10793</fpage><lpage>10798</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602493103</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>CC</given-names></name><name><surname>Digilio</surname> <given-names>L</given-names></name><name><surname>McMahon</surname> <given-names>LP</given-names></name><name><surname>Garcia</surname> <given-names>ADR</given-names></name><name><surname>Winckler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Degradation of dendritic cargos requires Rab7-dependent transport to somatic lysosomes</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>3141</fpage><lpage>3159</lpage><pub-id pub-id-type="doi">10.1083/jcb.201711039</pub-id><pub-id pub-id-type="pmid">29907658</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youle</surname> <given-names>RJ</given-names></name><name><surname>Narendra</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms of mitophagy</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>12</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/nrm3028</pub-id><pub-id pub-id-type="pmid">21179058</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname> <given-names>J</given-names></name><name><surname>Puri</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Lizzio</surname> <given-names>MA</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Sheng</surname> <given-names>ZH</given-names></name><name><surname>Guo</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin</article-title><source>eLife</source><volume>3</volume><elocation-id>e01958</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01958</pub-id><pub-id pub-id-type="pmid">24898855</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Ahsan</surname> <given-names>A</given-names></name><name><surname>Ma</surname> <given-names>S</given-names></name><name><surname>Xiao</surname> <given-names>Z</given-names></name><name><surname>Han</surname> <given-names>F</given-names></name><name><surname>Qin</surname> <given-names>ZH</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Somatic autophagy of axonal mitochondria in ischemic neurons</article-title><source>The Journal of Cell Biology</source><volume>218</volume><fpage>1891</fpage><lpage>1907</lpage><pub-id pub-id-type="doi">10.1083/jcb.201804101</pub-id><pub-id pub-id-type="pmid">30979799</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Ashwell</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP</article-title><source>Current Biology</source><volume>17</volume><fpage>1438</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.07.041</pub-id><pub-id pub-id-type="pmid">17702576</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50260.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Harper</surname><given-names>Wade</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper describes a systematic analysis of recruitment of the autophagy cargo adaptor to damaged mitochondria in hippocampal neurons. Under mild oxidative stress, OPTN is recruited to damaged mitochondria and promotes recruitment of additional autophagy proteins and formation of an autophagosome, occurring robustly in the cell soma. OPTN- and LAMP1-positive structures remained in a non-acidic state for extended time periods, suggesting that acidification of lysosomes containing mitochondria is rate-limiting for degradation. This work is relevant to Parkinson's disease and ALS.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Mitophagosome acidification is rate-limiting in the maintenance of the somal mitochondrial network in neurons&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Suzanne Pfeffer as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>This paper addresses the interesting question of how the autophagy cargo adaptor OPTN is employed in post-mitotic neurons to remove damaged mitochondria downstream of the Parkin ubiquitin ligase. Parkin is recruited to damaged mitochondria in response to PINK1 activation and catalyzes ubiquitylation of a number of proteins on the outer membrane of mitochondria. OPTN then binds to ubiquitin chains to promote recruitment of the autophagy machinery. The authors characterize this process in neurons in the presence of &quot;endogenous&quot; mitochondrial damage. Through a series of studies, they provide evidence that mitoautophagosomes acidify slowly, suggesting that acidification is a rate-limiting step in mitophagy.</p><p>While the reviewers all feel that the paper is timely and interesting, there are several concerns that need to be addressed before the paper can be considered further. These concerns generally fall into 4 areas:</p><p>1) OPTN overexpression. The paper extensively employs ectopic expression of tagged OPTN. Although this is very useful for detection of OPTN-coated mitochondria, it raises issues in the context of the model wherein mitolysosome acidification is rate-limiting in neurons. Depending upon the levels of overexpression, it is possible that autophagosome formation is accelerated in some way that makes acidification seem slow (rate-limiting). The paper also tries to make comparisons with HeLa cells in this context. Because the abundance of endogenous OPTN relative to the tagged OPTN isn't shown in either the case of neurons or HeLa cells, it is difficult to know the extent to which this may be an issue in the experiments that are shown. It is important to show the levels of overexpression either in the population, or preferably in individual cells using endogenous OPTN antibodies. This issue is also important in light of the fact that there are a substantial number of OPTN puncta that are not co-localized with mitochondria. Are these aggregates resulting from overexpression or are they something else? DO such OPTN puncta appear in neurons using endogenous antibodies? In terms of overexpression of OPTN accelerating early steps, it may be possible to visualize mitoautophagosomes using GFP-LC3, and since this is functioning at a step downstream of OPTN recruitment, it may allow an independent assessment of whether acidification is rate-limiting.</p><p>2) Lysosome acidification as the rate-limiting step. All three reviewers had concerns about this strong conclusion, which is also featured in the Title of the paper. This reflects, in part, the OPTN overexpression as discussed above, as well as the approaches being used to examine acidification. The reviewer' feel that a more direct method, including measurement of mitophagic flux using Keima or mito-QC would strengthen the results. Is there evidence of mitochondria inside lysosomes that have not yet either activated the Keima red-shift or converted the yellow GFP-mCherry signal to mCherry only, which would indicate non-instantaneous acidification, and if so, what is the time constant for conversion to the acidic state? There is also some concern that the LAMP1 marker used for marking lysosomes may also, when overexpressed, mark autophagosomes, making the designation of mitolysosomes complicated. It may be possible to follow local diffusion (i.e. signal expansion) of lysotracker from a lysosome into an OPTN-positive autophagosome in order to measure the length of time from full OPTN recruitment to acidification. Previous studies have used this approach to examine the kinetics by live-cell imaging.</p><p>3) A third issue brought up by the reviewers concerns the question of whether the pathway being examined is the Parkin-PINK1 pathway or not. This is the expectation given the fact that OPTN is recruited to the damaged mitochondria, but isn't formally demonstrated. Might it be possible to deplete PINK1 or Parkin by shRNA and examine the number of OPTN-positive mitochondria that appear over time in individual cells relative to cells transfected with control shRNA?</p><p>4) The current work implies that the delay in acidification is specific to mitophagosomes. However, the acidification rate of autophagosomes in general, under the authors experimental conditions, was not tested. The authors could monitor the formation of OPTN -ve LC3 puncta using their mild depolarising media and determine if these equally take as long to become acidified.</p><p><italic>Reviewer #1:</italic></p><p>This paper describes an analysis of mitophagy in neuronal cells. Mitophagy is perhaps best understood in the context of PINK1 and PARK2-dependent mitochondrial ubiquitylation and targeting to the autophagosome via an OPTN-TBK1-dependent pathway (although NDP52 and TAX1BP1 can also function in this pathway redundantly with OPTN). The majority of studies examining PARK2-dependent mitophagy have been done in cancer cell lines overexpressing PARK2 and there has been conflicting data for PARK2-dependent mitophagy in neuronal cell lineages. This paper tries to address some of these conflicting data and also presents a new model related to lysosomal acidification as being rate-limiting for mitophagy in neurons.</p><p>In mito-QC or mito-Keima mice that lack PINK1 or PARK2, there is no discernable defect in mitophagic flux across all/most tissues, indicating that the majority of mitophagic flux is through a PARK2-independent pathway. However, this doesn't necessarily mean that there isn't a small amount of flux (not detectable by the methods used) that is still PARK2-dependent in specific classes of neurons. Additionally, previous studies have used various types of mitochondrial depolarizing agents to examine mitophagy in neurons in culture. In some experiments, mitophagy is initiated in the axon while in others, it occurs in the soma. While there are discrepancies in some of the conclusions, it's also probably fair to say that some of the conclusions are not really based on strong experiments. As such, there is still much that is unclear concerning when, where, and how mitochondria are degraded by autophagy in neurons.</p><p>This study uses removal of anti-oxidants (AOF) from the media as a way to induce endogenous mitochondrial damage, with the idea that it will be possible to examine mitophagy mechanisms in a more physiological setting. The paper is primarily based on imaging.</p><p>Major comments:</p><p>Throughout the paper, the authors employ overexpression of Halo-OPTN. There is the distinct possibility that overexpression of OPTN can artificially accelerate steps in mitophagy that are downstream of PARK2-action on mitochondria. This complicates the interpretation of the data in terms of the rates of mitochondrial turnover and the conclusions related to lysosomal acidification being limiting. The recent finding that autophagy receptors (NDP52 in particular) can recruit ULK1-FIP200 raises the question as to whether having additional receptor in the cell could accelerate autophagosome formation around ubiquitylated mitochondira. Additionally, in Figure 1I, there appear to be many Halo-OPTN puncta that are not co-localizing with mitochondria. It is unclear what these puncta are. Do they reflect Halo-OPTN aggregates, for example, resulting from overexpression? Or are they OPTN localized on other autophagic cargo?</p><p>In Figure 2 the authors examine localization of PARK2, TBK1 and OPTN with mitochondria and correlate it with TMRE signal. In some sense, it's a bit hard to judge because they are only showing AOF treated samples and so there isn't a systematic quantification of the number of OPTN-coated mitochondria in the absence of oxidative stress. There are a lot of OPTN-positive, TBK1-positive puncta whose identity are unknown. I also am unsure what the authors mean concerning Figure 2G, where the authors say that the number of OPTN on linear mitochondria are &quot;low and similar in either conditions&quot;. The value is ~29%, which is much higher that the OPTN on fragmented mitochondria, so this doesn't seem to make sense. I am also not sure about the argument made concerning the aspect ratio with and without AOF in Figure 2H. The highest signal in the control sample is also the &lt;1.5 ratio, and this only marginally increased with AOF. So, it would seem to be hard to conclude that this small mitochondria directly represents the ones that are subsequently tagged with OPTN.</p><p>Figure 3 looks at the frequency of OPTN encircled mitochondria in axons, dendrites and soma, indicating that virtually no OPTN-positive mitochondria are seen in the axon. The frequency of OPTN-positive mitochondria relative to the total mitochondrial volume in the soma indicates that with AOF, there is a very small amount of damaged mitochondria relative to the total mitochondrial volume. Given this very low value, it would appear to take many axons in order to achieve a similar mitochondrial volume in order to directly compare the frequency of damage and capture by OPTN. So based on a stochastic damage argument, it may be very difficult to detect damaged mito in the axon but that doesn't necessarily mean it doesn't happen there. So, the conclusion in subsection “OPTN-mediated mitophagy occurs preferentially in the somatodendritic compartment of hippocampal neurons” might be too strong.</p><p>The experiment in Figure 5 is a bit hard to interpret. Since LAMP1 is overexpressed, it is possible that it is marking organelles such as endosomes, in addition to lysosomes. In any event, the apparent number of LysoT positive puncta is far lower than the number of LAMP1 positive puncta, albeit not in the same cells. The major conclusion is that lysosomes are acidified more slowly in neurons, and results in HeLa cells overexpressing OPTN and LAMP1 are used to compare the rates of lysosome acidification. Interpretation of this experiment is difficult because there is no indication of the levels of expression of OPTN/cell. If OPTN overexpression can accelerate the assembly of a fully coated autophagosome around the damaged mitochondria, and therefore the rate of fusion with a lysosome since full closure is required, then the difference in the apparent rate of acidification could simply represent the levels of OPTN in each cell being examined. Since there are no measurements of OPTN levels/per cell and specifically in the cells that are being imaged, it makes it challenging to make the conclusion that rates of acidification are intrinsically slower in neurons. If much less overexpressed OPTN is present in neurons than HeLa, this could explain the difference seen. The authors examined cathepsin cleavage, and find only minor differences as measured in a western blot assay. Since cathepsin processing also requires low lysosomal pH, this a priori would suggest no issue with lysosomal acidification at a global level in the neurons, raising the question of precisely how acidification is regulated.</p><p>With regards to the conclusions in Figure 5, an ultrastructure analysis in the cited Cheng et al., 2018 paper suggests that LAMP1 can be present on immature double membrane autophagosome-like structures. Is it possible that some of the LAMP1-positive signals lacking LysoT positivity are actually autophagosomes that are LAMP1 positive but not yet fused with a lysosome? Could LAMP1 overexpression affect the interpretation of the experiments?</p><p>Subsection “Low-level induction of ROS leads to selective mitochondrial damage without compromising the overall mitochondrial network”. In the two color old/new mitochondrial experiment, it's hard to imagine how the age can be precisely controlled using the described protocol. The SNAP tag for mito localization contains a COXVIII MTS sequence. As such, it would seem like any mitochondria with a functional translocon could import the SNAP-tag protein, regardless of whether it is old or new, however the authors state that the two populations are &quot;distinct&quot;. The interpretation that old mitochondria can import the newly synthesized snap tag is consistent with most of the mitochondria being double labeled (Figure 6C). Because the mass of old mitochondria is much larger than the mass of new mitochondria that has been made since the new dye was added (dye added for 1 hour) and the number of those mitochondria not undergoing intermixing by fusion is small, the frequency with which such a &quot;new&quot; mitochondria would be identified as damaged and associated with OPTN would be particularly low, relative to the much more abundant old mito. So it seems possible, that this experiment doesn't really have the statistical power to rule out similar rates of old and new mitochondrial engulfment. The authors argue that the absence in green signal means that they are exclusively old, but it also may be that the signal to noise isn't equivalent. The labeling period for old was 24 hours while the labeling for new was only 1 hour. Therefore, all things being equal in terms of mitochondrial assembly/fission/fusion, there should be far less signal for new snap relative to old snap/per individual mito.</p><p>In Figure 7, the authors examine an OPTN mutant found in ALS, and see general but small effects on mitochondrial size. This experiment is somewhat limited by the fact that OPTN deletion by siRNA is only ~60%, and it is possible that the overexpressed OPTN mutant (not sure how much it is overexpressed as they didn't show a western of the transfected cells) may also act as a dominant negative – binding TBK1 but not Ub chains. What isn't clear is whether the authors have missed an opportunity to statistically determine whether the OPTN mutant encircles damaged mito. The experiments are largely limited to mito morphology.</p><p>An important weakness of the analysis is the absence of a direct demonstration of mitophagic flux.</p><p><italic>Reviewer #2:</italic></p><p>In their manuscript, Evans and Holzbaur present data arguing two main points regarding mitophagy in neurons: (1) that mitophagy occurs mainly in the soma and not in axons, contrary to some previous work by others, and (2) that neuronal mitophagy is significantly slower relative to other cell types, as result of slow acidification of mitoautophagosomes. Although the experiments are generally well-performed additional evidence is required in support of their main conclusions.</p><p>Major comments:</p><p>1) The implication throughout the paper is that the optineurin rings forming around mitochondria in response to mild oxidative stress are due to PINK1/Parkin dependent mitophagy. This should be demonstrated with knockdown or knockout of PINK1 and Parkin. This is particularly important given lack of clarity on the role of PINK1/Parkin mitophagy in neurons in response to more physiologically relevant stressors.</p><p>2) A major finding of the manuscript is that mitophagy occurs primarily in the cell soma and not the axons, in contrast to the findings of Ashrafi et al. As a rationale for this discrepancy, they suggest that they are applying a milder stress (withholding antioxidants from neuronal media) that does not lead to global bioenergetic collapse. This explanation doesn't seem satisfactory, however, as Ashrafi et al., also, used a variety of experimental setups to induce local damage mitochondria without affecting the overall bioenergetics of the neuron. An alternative explanation for the discrepancy might be that the particular exposure used by Evans and Holzbaur (withholding antioxidants) preferentially increases oxidative stress and mitochondrial damage in the cell soma as opposed to the axons. Does ROS increase equally in the axon and cell body with antioxidant withdrawal? Does the authors treatment result in TMRE negative mitochondria in axons that are not captured by Optineurin in contrast to the cell soma? When the authors treat with antimycin for 2 hours (which increases ROS locally at the mitochondria) do they see the same preferential increase in mitophagy in the soma or are mitochondria in the axons also targeted? Ashrafi saw axonal events as soon as 45 minutes, do the authors see axonal events at these early timepoints? Ashafri noted increased axonal events with the use of lysosomal inhibitors. If these are used by the authors, do they then see axonal events?</p><p>3) In Figure 5 the authors compare the speed of mitophagosome maturation in neurons and HeLa cells. They conclude that the difference in speed reflects a difference in processes downstream of mitochondrial ubiquitination, but the level mitochondrial ubiquitination is likely very different in neurons with endogenous Parkin subjected to mild oxidative stress and HeLa cells over-expressing Parkin and fully depolarized with OA. Could this account for the difference in maturation rate? Do the authors still see a difference in the speed of mitophagosome maturation when the two cell types are subjected to more equal treatment – e.g., in neurons and HeLa cells that are both overexpressing Parkin and are subjected to the same oxidative stress (e.g., antimycin)? Additionally, the authors note that acidification of mitoauthophagosomes is delayed in neurons? How long is it delayed? What do they see at time points longer than one day?</p><p><italic>Reviewer #3:</italic></p><p>In the manuscript by Evans and Holzbaur, the authors examine the dynamics of OPTN recruitment to mitochondria and subsequent delivery to lysosomes following mild oxidative stress in primary rat hippocampal neurons. The authors mainly use transfected neurons and live-cell microscopy and find that OPTN is rapidly recruited to a subset of mitochondria, primarily in the soma, following anti-oxidant removal from the cell media. This then correlated with subsequent recruitment of mitophagy and lysosomal markers. Surprisingly, and the main take home message from the manuscript, was that the OPTN puncta on mitochondria do not become efficiently acidified (as visualized by col-localisation with lysotracker), from which the authors conclude that this is a rate-limiting step during neuronal mitophagy.</p><p>This is an intriguing manuscript with many interesting observations. The identification of &quot;mild&quot; depolarising conditions that trigger a mitophagy response will be useful to the field and certainly does appear more physiological that the use of CCCP or oligomycin/antimycin. The microscopy images are impressive and convincing in what they show. However, I think more work is needed to determine whether this phenomenon is specific to mitophagosomes and neurons in general.</p><p>Major comments:</p><p>1) I think more robust analyses of lysosome acidification are needed. It is surprising and very interesting that there is a large delay in acidification of mitolysosomes. Is this a general phenomenon, i.e. are acidified lysosomes scarce in these cells? What is the percentage of LAMP1 structures (regardless of co-localising with OPTN) that are LysoTracker +ve? If it is low, could this mean that most of the LAMP1-GFP is not in lysosomes? Could the authors use another lysosomal marker to confirm?</p><p>2) Related to the above point, the authors only use LysoTracker to estimate lysosomal acidification. Is there another way the authors could estimate this – for example using ratiometric fluorophores, such as Keima or mCherry-GFP?</p><p>3) Is the delay in acidification specific to mitolysosomes? What about autophagosomes in general? The authors could monitor the formation of OPTN -ve LC3 puncta under their conditions and determine if these equally take as long to become acidified. The authors may wish to discuss Ralph Nixon's work (e.g. Boland et al., 2008) that argues autophagosome fusion with lysosomes is very efficient in neurons.</p><p>4) Are the authors sure it is mitophagosome acidification that is rate-limiting and not an earlier step in the pathway? For example, is it possible that the autophagosome is not fully sealed (despite appearing circular by fluorescence microscopy). The authors could look at early autophagosome markers such as ULK1, ATG5 or WIPI that are not present on mature autophagosomes. Or mature autophagosome markers such as STX17.</p><p>5) The authors imply that this delay is specific to neurons, yet they only look in hippocampal neurons and compare this to HeLa cells overexpressing Parkin. I think the authors need to provide some more data in relevant cell lines for a better comparison. What about cortical neurons, as well and comparing with primary fibroblasts (which should contain all the relevant Parkin pathway components)?</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Suzanne Pfeffer (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>Based on the comments of reviewer 3, a couple of changes in the manuscript are still needed. First, some data that are described in the rebuttal don't appear in the paper, so Figure 4 may need to be updated to include data that were discussed in the rebuttal. In addition, there are a couple of suggested changes to the text that will need to be addressed.</p><p><italic>Reviewer #1 and 2:</italic></p><p>Overall, the authors have done a good job of addressing the previous comments. I have no further concerns and feel that the paper should be accepted.</p><p><italic>Reviewer #3:</italic></p><p>This is a re-review of the manuscript by Evans et al., describing the slow maturation/impaired acidification of mitophagosomes in the soma of neurons. I think the authors have done a great job in strengthening their manuscript – my main concern was with the lysosomal acidification studies and the use of the dual reporters means the data are much more convincing. I just have a few small points remaining:</p><p>1) The LAMP2 data, mentioned in subsection” Acidification of OPTN-positive mitochondria is a rate-limiting step in neuronal mitophagy” and in the comments to reviewers does not seem to be in the manuscript. The authors mention Figure 4E, but these are only LC3-related. Please include the data.</p><p>2) Likewise, the authors show data in the reviewers comments that the OPTN/LC3 structures are WIPI -ve. I do not see these data in the manuscript. This shows that the structures are not early autophagosomal in nature and thus they will be of interest to readers (and not just this reviewer) and so should be included (at least in the supplemental). I'm assuming WIPI2B is expressed in these cells and does indeed form puncta with LC3 when autophagy is induced?</p><p>3) I also take on the point that the authors have made in response to my concern raised in point 5 – i.e. that HeLa cells overexpressing Parkin are a suitable system to compare to the neurons. The HeLa cell has been instrumental in the field in terms of building up the mechanism of PINK/Parkin mitophagy. But this is not a &quot;normal&quot; cell. Normally, it does not undergo this pathway as it does not express Parkin! I think to avoid doing more experiments, the authors can be more accurate in what they state and say that this delay in acidification does not occur in HeLa cells expressing Parkin. For example in subsection “Acidification of OPTN-positive mitochondria is a rate-limiting step in neuronal mitophagy”: &quot;…..much slower than the corresponding time course in non-neuronal cells.&quot; Should be replaced with &quot;…..much slower than the corresponding time course in HeLa cells.&quot;</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50260.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>This paper addresses the interesting question of how the autophagy cargo adaptor OPTN is employed in post-mitotic neurons to remove damaged mitochondria downstream of the Parkin ubiquitin ligase. Parkin is recruited to damaged mitochondria in response to PINK1 activation and catalyzes ubiquitylation of a number of proteins on the outer membrane of mitochondria. OPTN then binds to ubiquitin chains to promote recruitment of the autophagy machinery. The authors characterize this process in neurons in the presence of &quot;endogenous&quot; mitochondrial damage. Through a series of studies, they provide evidence that mitoautophagosomes acidify slowly, suggesting that acidification is a rate-limiting step in mitophagy.</p><p>While the reviewers all feel that the paper is timely and interesting, there are several concerns that need to be addressed before the paper can be considered further. These concerns generally fall into 4 areas:</p><p>1) OPTN overexpression. The paper extensively employs ectopic expression of tagged OPTN. Although this is very useful for detection of OPTN-coated mitochondria, it raises issues in the context of the model wherein mitolysosome acidification is rate-limiting in neurons. Depending upon the levels of overexpression, it is possible that autophagosome formation is accelerated in some way that makes acidification seem slow (rate-limiting). The paper also tries to make comparisons with HeLa cells in this context. Because the abundance of endogenous OPTN relative to the tagged OPTN isn't shown in either the case of neurons or HeLa cells, it is difficult to know the extent to which this may be an issue in the experiments that are shown. It is important to show the levels of overexpression either in the population, or preferably in individual cells using endogenous OPTN antibodies. This issue is also important in light of the fact that there are a substantial number of OPTN puncta that are not co-localized with mitochondria. Are these aggregates resulting from overexpression or are they something else? DO such OPTN puncta appear in neurons using endogenous antibodies? In terms of overexpression of OPTN accelerating early steps, it may be possible to visualize mitoautophagosomes using GFP-LC3, and since this is functioning at a step downstream of OPTN recruitment, it may allow an independent assessment of whether acidification is rate-limiting.</p></disp-quote><p>We thank the reviewers for their comments and agree that it is important to consider the expression level of OPTN when discussing the rates of neuronal mitophagy. As requested, we compared OPTN expression in non-transfected and Halo-OPTN transfected cells (representative images are provided in <xref ref-type="fig" rid="respfig1">Author response image 1</xref>). Using an OPTN antibody and a Halo ligand, we observed both cytosolic localization and the presence of discrete OPTN puncta in neurons and HeLa cells expressing endogenous OPTN and in cells expressing labeled OPTN.</p><fig id="respfig1"><label>Author response image 1.</label><caption><title>Representative images of hippocampal neurons (<bold>A</bold>) and HeLa cells (<bold>B</bold>) comparing OPTN expression levels in non-transfected and Halo-OPTN transfected cells.</title><p>aOPTN polyclonal antibody; Abcam ab23666. Scale bar, 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-resp-fig1-v1.tif"/></fig><p>Representative images were previously included in Figure 2—figure supplement 1 and a representative western blot is now included in Figure 8—figure supplement 1. These observations are consistent with previous work demonstrating the punctate appearance of endogenous OPTN (Park et al., 2006). We also confirmed these findings using two independent aOPTN antibodies (Abcam ab23666 and Cayman Chemical 100000). To further avoid over-expression artifacts, we select neurons within a narrow fluorescence range in our imaging experiments.</p><p>We determined that ~60-70% of OPTN puncta are not associated with mitochondria (now included in Figure 1—figure supplement 1D). OPTN has been implicated in other processes, such as aggrephagy (Korac et al., 2013). As a result, these Halo-OPTN puncta may be localized to other autophagic cargos. Consistent with this, we found that roughly 50% of nonmitochondrial associated OPTN puncta colocalized with LAMP1-EGFP, as shown in <xref ref-type="fig" rid="respfig2">Author response image 2</xref>:</p><fig id="respfig2"><label>Author response image 2.</label><caption><title>Representative images of a hippocampal neuron showing Halo-OPTN puncta are found in LAMP1-EGFP containing organelles in the soma.</title><p>These puncta are negative for mitochondria. Examples of events are indicated by the red arrows. Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-resp-fig2-v1.tif"/></fig><p>Finally, we transfected neurons with a mitochondrial marker (Mito-SNAP) and a tandem mCherry-GFP-LC3 to look at acidification in the absence of overexpressed OPTN. We continued to find consistent evidence of spherical mitochondria that colocalized with both GFP and mCherry, further corroborating our findings that while these mitochondria are engulfed within autophagosomes, they are not yet acidified (as determined by the unquenched nature of the GFP signal on the tandem fluorescent LC3 reporter). A representative image is provided in <xref ref-type="fig" rid="respfig3">Author response image 3</xref>.</p><fig id="respfig3"><label>Author response image 3.</label><caption><title>Representative images of a hippocampal neuron following antioxidant removal for 6 hours.</title><p>An example of a LC3-positive mitochondrion in the absence of overexpressed OPTN is shown. Both the GFP and mCherry of the tandem LC3 marker are present, illustrating the damaged mitochondrion is sequestered in a nonacidified organelle. Scale bar, 1 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-resp-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2) Lysosome acidification as the rate-limiting step. All three reviewers had concerns about this strong conclusion, which is also featured in the Title of the paper. This reflects, in part, the OPTN overexpression as discussed above, as well as the approaches being used to examine acidification. The reviewer' feel that a more direct method, including measurement of mitophagic flux using Keima or mito-QC would strengthen the results. Is there evidence of mitochondria inside lysosomes that have not yet either activated the Keima red-shift or converted the yellow GFP-mCherry signal to mCherry only, which would indicate non-instantaneous acidification, and if so, what is the time constant for conversion to the acidic state? There is also some concern that the LAMP1 marker used for marking lysosomes may also, when overexpressed, mark autophagosomes, making the designation of mitolysosomes complicated. It may be possible to follow local diffusion (i.e. signal expansion) of lysotracker from a lysosome into an OPTN-positive autophagosome in order to measure the length of time from full OPTN recruitment to acidification. Previous studies have used this approach to examine the kinetics by live-cell imaging.</p></disp-quote><p>We agree that additional methods were needed to further strengthen our conclusion that lysosome acidification is rate-limiting in neuronal mitophagy. To address this point, we utilized the mitochondrial matrix directed tandem fluorescent reporter Cox8-EGFP-mCherry to look at mitophagic flux (Rojansky et al., 2016); this construct is similar to the <italic>mito</italic>-QC previously described (Allen et al., 2013; McWilliams et al., 2016). We identified OPTN-positive mitochondria and looked for the presence or absence of EGFP fluorescence coincident with mCherry fluorescence to identify non-acidified and acidified organelles. Using this assay, we found OPTN-positive mitochondria that were dual labeled with the tandem reporter, suggesting they were in non-acidified compartments. This data is now included in the revised manuscript (please see Figure 6).</p><p>To use LAMP1 as a second, independent reporter for acidified degradation-competent organelles, we utilized a dual labeled SEP-LAMP1-RFP construct where superecliptic pHluorin (SEP) is fused to the lumen of LAMP1-RFP (Farias et al., 2017). The fluorescent signal of the SEP will quench in acidic environments (pH &lt; 6; (Sankaranarayanan et al., 2000)). We felt that a dual reporter system would provide more reliable measurements than the local diffusion of lysotracker from a lysosome. As a control experiment, we used this construct to determine the number of acidified lysosomes per cell (see Figure 5—figure supplement 1) and found it to be consistent with other methods used. We then identified OPTN-positive mitochondria and quantified the relative percentage that were dual or single labeled with the tandem LAMP1 probe. We determined the majority of sequestered mitochondria were dual positive for green and red fluorescence with the SEP-LAMP1-RFP tandem probe, again suggesting that this represents a substantial population of non-acidified organelles (see Figure 6 and Figure 6—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>3) A third issue brought up by the reviewers concerns the question of whether the pathway being examined is the Parkin-PINK1 pathway or not. This is the expectation given the fact that OPTN is recruited to the damaged mitochondria, but isn't formally demonstrated. Might it be possible to deplete PINK1 or Parkin by shRNA and examine the number of OPTN-positive mitochondria that appear over time in individual cells relative to cells transfected with control shRNA?</p></disp-quote><p>To formally demonstrate whether this pathway is PINK1/Parkin-dependent, we performed Parkin knock-down and rescue experiments. The percent of neurons with OPTN-positive mitochondria was determined in neurons following antioxidant removal for 1 hour, see Figure 2—figure supplement 2 of the revised manuscript. We observed an overall 30% reduction in Parkin expression by immunoblot analysis of cell lysates, but it is important to note that this measurement is an underestimate of the reduction in Parkin expression in the imaged neurons, as transfection rates are low in hippocampal neurons and the immunoblot measurement is from an entire plate of cells and so includes neurons that did not take up siRNA. When imaging neurons, we selected cells that were transfected and therefore have also taken up siRNA. Importantly, this level of knock-down was sufficient to significantly inhibit the number of cells with OPTN-positive rings, from ~35% down to less than 10%. This deficit was rescued by reexpression of WT Parkin. These data along with our recruitment data indicate that the PINK1-Parkin pathway is involved, although we cannot rule out the involvement of other possible ROS-induced E3 ligases in addition to Parkin. This point is directly addressed in the Discussion section.</p><disp-quote content-type="editor-comment"><p>4) The current work implies that the delay in acidification is specific to mitophagosomes. However, the acidification rate of autophagosomes in general, under the authors experimental conditions, was not tested. The authors could monitor the formation of OPTN -ve LC3 puncta using their mild depolarising media and determine if these equally take as long to become acidified.</p></disp-quote><p>We agree that it is important to determine whether our mitophagy induction paradigm alters autophagosome acidification in general or if it is specific to mitophagosomes. As requested, we identified OPTN-negative LC3 puncta and monitored acidification using the tandem mCherry-GFP-LC3 reporter. We determined that 75% of autophagosomes in a cell were acidified and that there was no significant difference in acidification between control or AO-free treated conditions at 1 or 6 hours. Additionally, we monitored lysosome acidification and observed similar results. See Figure 5—figure supplement 1 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>This paper describes an analysis of mitophagy in neuronal cells. Mitophagy is perhaps best understood in the context of PINK1 and PARK2-dependent mitochondrial ubiquitylation and targeting to the autophagosome via an OPTN-TBK1-dependent pathway (although NDP52 and TAX1BP1 can also function in this pathway redundantly with OPTN). The majority of studies examining PARK2-dependent mitophagy have been done in cancer cell lines overexpressing PARK2 and there has been conflicting data for PARK2-dependent mitophagy in neuronal cell lineages. This paper tries to address some of these conflicting data and also presents a new model related to lysosomal acidification as being rate-limiting for mitophagy in neurons.</p><p>In mito-QC or mito-Keima mice that lack PINK1 or PARK2, there is no discernable defect in mitophagic flux across all/most tissues, indicating that the majority of mitophagic flux is through a PARK2-independent pathway. However, this doesn't necessarily mean that there isn't a small amount of flux (not detectable by the methods used) that is still PARK2-dependent in specific classes of neurons. Additionally, previous studies have used various types of mitochondrial depolarizing agents to examine mitophagy in neurons in culture. In some experiments, mitophagy is initiated in the axon while in others, it occurs in the soma. While there are discrepancies in some of the conclusions, it's also probably fair to say that some of the conclusions are not really based on strong experiments. As such, there is still much that is unclear concerning when, where, and how mitochondria are degraded by autophagy in neurons.</p><p>This study uses removal of anti-oxidants (AOF) from the media as a way to induce endogenous mitochondrial damage, with the idea that it will be possible to examine mitophagy mechanisms in a more physiological setting. The paper is primarily based on imaging.</p><p>Major comments:</p><p>1) Throughout the paper, the authors employ overexpression of Halo-OPTN. There is the distinct possibility that overexpression of OPTN can artificially accelerate steps in mitophagy that are downstream of PARK2-action on mitochondria. This complicates the interpretation of the data in terms of the rates of mitochondrial turnover and the conclusions related to lysosomal acidification being limiting. The recent finding that autophagy receptors (NDP52 in particular) can recruit ULK1-FIP200 raises the question as to whether having additional receptor in the cell could accelerate autophagosome formation around ubiquitylated mitochondira. Additionally, in Figure 1I, there appear to be many Halo-OPTN puncta that are not co-localizing with mitochondria. It is unclear what these puncta are. Do they reflect Halo-OPTN aggregates, for example, resulting from overexpression? Or are they OPTN localized on other autophagic cargo?</p></disp-quote><p>Halo-OPTN does form puncta that do not colocalize with mitochondria. However, we observed a similar distribution of endogenous OPTN in the soma of neurons and in HeLa cells, please see Figure 2—figure supplement 1 and additional images above. These observations are consistent with previous work demonstrating the punctate appearance of endogenous OPTN (Park et al., 2006).</p><p>It is possible that some of these puncta localize with autophagic cargos. OPTN has been suggested to function in aggrephagy and some of these Halo-OPTN puncta could localize with aggregated proteins (Korac et al., 2013). Consistent with this, we observed that many of the Halo-OPTN puncta colocalize with EGFP-LC3 and LAMP1-EGFP (see above for representative images). However, it is difficult to determine whether these puncta represent OPTN-mediated clearing events or overexpressed protein that is being cleared from the cell, as both are destined for autophagosome engulfment and degradation via lysosomal fusion.</p><disp-quote content-type="editor-comment"><p>2) In Figure 2 the authors examine localization of PARK2, TBK1 and OPTN with mitochondria and correlate it with TMRE signal. In some sense, it's a bit hard to judge because they are only showing AOF treated samples and so there isn't a systematic quantification of the number of OPTN-coated mitochondria in the absence of oxidative stress. There are a lot of OPTN-positive, TBK1-positive puncta whose identity are unknown. I also am unsure what the authors mean concerning Figure 2G, where the authors say that the number of OPTN on linear mitochondria are &quot;low and similar in either conditions&quot;. The value is ~29%, which is much higher that the OPTN on fragmented mitochondria, so this doesn't seem to make sense. I am also not sure about the argument made concerning the aspect ratio with and without AOF in Figure 2H. The highest signal in the control sample is also the &lt;1.5 ratio, and this only marginally increased with AOF. So, it would seem to be hard to conclude that this small mitochondria directly represents the ones that are subsequently tagged with OPTN.</p></disp-quote><p>On average ~95% of OPTN-positive mitochondria were TMRE negative in both control and AO-free conditions. Since mitophagy can occur at a basal level, OPTN-positive mitochondria were found in both control and treated conditions, but the number of events was higher in AO-free treated conditions compared to control (see Figure 3D, F for the percent of cells with OPTN-positive mitochondria). In Figure 2D-F, we observed two types of localization that occurred using upstream mitophagy-associated proteins, the formation of rings around damaged mitochondria and puncta that colocalized with isolated mitochondrial fragments. We highlighted examples of each using arrows, but every event was not highlighted.</p><p>As shown in Figure 1—figure supplement 1D, ~30-40% of total OPTN puncta were found on mitochondria. Of this population, most were localized to linear mitochondria under both control and AO-free conditions. Although, the percent associated with rounded mitochondria was observed to increase significantly upon mild stress in the AO-free condition. We have now clarified this description in the revised manuscript.</p><p>We measured the mitochondrial aspect ratio to determine whether we could quantify minor changes in the mitochondrial network. Overall, we observed a small but significant decrease in the mitochondrial aspect ratio. The binned data illustrate that the fraction of mitochondria with an aspect ratio of ≤1.5 was greater in neurons treated with AO-free media compared to control (now Figure 1—figure supplement 1A). Additionally, we measured the diameter of OPTN-positive mitochondrial rings and found they were on average ~1.2 µm (data not shown). Together these data suggest that some of the small mitochondria represent the ones that are engulfed by OPTN.</p><disp-quote content-type="editor-comment"><p>Figure 3 looks at the frequency of OPTN encircled mitochondria in axons, dendrites and soma, indicating that virtually no OPTN-positive mitochondria are seen in the axon. The frequency of OPTN-positive mitochondria relative to the total mitochondrial volume in the soma indicates that with AOF, there is a very small amount of damaged mitochondria relative to the total mitochondrial volume. Given this very low value, it would appear to take many axons in order to achieve a similar mitochondrial volume in order to directly compare the frequency of damage and capture by OPTN. So based on a stochastic damage argument, it may be very difficult to detect damaged mito in the axon but that doesn't necessarily mean it doesn't happen there. So, the conclusion in subsection “OPTN-mediated mitophagy occurs preferentially in the somatodendritic compartment of hippocampal neurons” might be too strong.</p></disp-quote><p>We thank the reviewer for the insightful comment and agree that it may be difficult to detect damaged mitochondria in the axon based on the stochastic damage argument. We determined the somal mitochondrial content was ~0.2 µm<sup>3</sup>/µm<sup>3</sup> (Figure 1F) and the axonal mitochondrial content to be ~0.02 µm<sup>3</sup>/µm<sup>3</sup> (data not shown). Based on these values and the number of somas analyzed in Figure 3, 210-280 axons would need to be analyzed. Since this is not the ideal system for such analysis, we cannot definitively rule out the possibility that an event occurred that we did not image. As a result, we have changed the statement to say “with limited events in dendrites and axons.” Additionally, we discuss this caveat and provide more axonal analysis in the Results section.</p><disp-quote content-type="editor-comment"><p>The experiment in Figure 5 is a bit hard to interpret. Since LAMP1 is overexpressed, it is possible that it is marking organelles such as endosomes, in addition to lysosomes. In any event, the apparent number of LysoT positive puncta is far lower than the number of LAMP1 positive puncta, albeit not in the same cells. The major conclusion is that lysosomes are acidified more slowly in neurons, and results in HeLa cells overexpressing OPTN and LAMP1 are used to compare the rates of lysosome acidification. Interpretation of this experiment is difficult because there is no indication of the levels of expression of OPTN/cell. If OPTN overexpression can accelerate the assembly of a fully coated autophagosome around the damaged mitochondria, and therefore the rate of fusion with a lysosome since full closure is required, then the difference in the apparent rate of acidification could simply represent the levels of OPTN in each cell being examined. Since there are no measurements of OPTN levels/per cell and specifically in the cells that are being imaged, it makes it challenging to make the conclusion that rates of acidification are intrinsically slower in neurons. If much less overexpressed OPTN is present in neurons than HeLa, this could explain the difference seen. The authors examined cathepsin cleavage, and find only minor differences as measured in a western blot assay. Since cathepsin processing also requires low lysosomal pH, this a priori would suggest no issue with lysosomal acidification at a global level in the neurons, raising the question of precisely how acidification is regulated.</p></disp-quote><p>We quantified the number of LAMP-positive organelles that are LysoT positive in cells overexpressing LAMP1 or LAMP2, and determined that ~89% of LAMP1 and ~88% of LAMP2 organelles colocalized with LysoT, suggesting no overall defects with lysosomal acidification. Additionally, we confirmed this finding using the SEP-LAMP1-RFP construct. We have further clarified this important issue in the revised manuscript (please see Figure 5—figure supplement 1 and accompanying text). To address the question of OPTN expression levels, as discussed above in our general response, we now provide images of non-transfected and Halo-OPTN overexpressed cells to illustrate representative levels of endogenous and overexpressed OPTN in the cells we chose for analysis (see <xref ref-type="fig" rid="respfig2">Author response image 2</xref> for images).</p><p>While we appreciate the reviewer’s comment that OPTN expression levels could accelerate the assembly of fully coated autophagosomes around damaged mitochondria, we argue that this is less relevant in our experimental conditions. In neurons, we see on average ~1-5 events per cell, which is low and distinct from the number of events during wholesale disruption of the mitochondrial network that is seen in HeLa cells treated with CCCP. As described in Figure 1, we are observing a minor fraction of the neuronal mitochondrial volume turnover. Additionally, we relied on endogenous levels of PINK1 and Parkin to initiate this pathway instead of overexpressed protein. If experimental conditions caused a substantial increase in the number of OPTN-coated mitochondria, then this point would become more relevant. We did look at cathepsin levels and observed no changes in our experimental paradigm. Importantly, we now include data to confirm that lysosomal acidification is normal (see Figure 5—figure supplement 1). Thus, it would appear that only mitophagolysosome acidification is slow. We plan to follow up on this interesting observation in the future.</p><disp-quote content-type="editor-comment"><p>With regards to the conclusions in Figure 5, an ultrastructure analysis in the cited Cheng et al., 2018 paper suggests that LAMP1 can be present on immature double membrane autophagosome-like structures. Is it possible that some of the LAMP1-positive signals lacking LysoT positivity are actually autophagosomes that are LAMP1 positive but not yet fused with a lysosome? Could LAMP1 overexpression affect the interpretation of the experiments?</p></disp-quote><p>Cheng et al., (2018) showed that there is a gradient in the number of LAMP1 organelles that contain Cathepsin D, with soma being higher than the axons and dendrites. In the Results for Figure 5, we argue that the observed discrepancy between LAMP1+/total and LysoT+/total may be in part due to the possibility that some of LAMP1 signal is on ‘late’ mitophagosomes (LC3LAMP1-positive) that have yet to fuse with degradative-competent organelles.</p><p>To address this issue more directly, we utilized a tandem SEP-LAMP1-RFP reporter where we could monitor acidified degradative-competent organelles. Using this method, we determined that the vast majority of OPTN rings around damaged mitochondria were dual labeled, indicating non-acidified compartments (see the new Figure 6).</p><disp-quote content-type="editor-comment"><p>Subsection “Low-level induction of ROS leads to selective mitochondrial damage without compromising the overall mitochondrial network”. In the two color old/new mitochondrial experiment, it's hard to imagine how the age can be precisely controlled using the described protocol. The SNAP tag for mito localization contains a COXVIII MTS sequence. As such, it would seem like any mitochondria with a functional translocon could import the SNAP-tag protein, regardless of whether it is old or new, however the authors state that the two populations are &quot;distinct&quot;. The interpretation that old mitochondria can import the newly synthesized snap tag is consistent with most of the mitochondria being double labeled (Figure 6C). Because the mass of old mitochondria is much larger than the mass of new mitochondria that has been made since the new dye was added (dye added for 1 hour) and the number of those mitochondria not undergoing intermixing by fusion is small, the frequency with which such a &quot;new&quot; mitochondria would be identified as damaged and associated with OPTN would be particularly low, relative to the much more abundant old mito. So it seems possible, that this experiment doesn't really have the statistical power to rule out similar rates of old and new mitochondrial engulfment. The authors argue that the absence in green signal means that they are exclusively old, but it also may be that the signal to noise isn't equivalent. The labeling period for old was 24 hours while the labeling for new was only 1 hour. Therefore, all things being equal in terms of mitochondrial assembly/fission/fusion, there should be far less signal for new snap relative to old snap/per individual mito.</p></disp-quote><p>In Figure 7, the labeling period is the same for both ‘first’ and ‘second’ SNAP ligands (30 minutes of labeling, 2 quick washes, and a 30 minute washout). The first SNAP ligand labeled expressed Mito-SNAP from the time of transfection until the SNAP Block labeling, ~24 hours; this is termed the ‘old’ mito population. The second SNAP ligand labeled Mito-SNAP that was expressed from the time after SNAP Block until imaging, ~22 hours; this is termed the ‘young’ mito population. The dark SNAP Block was added to saturate any remaining binding sites after the first SNAP labeling (1 µM SNAP-block; 2 hours of labeling, 2 quick washes, and a 30 minute washout).</p><p>It is possible that mitochondria with a functional translocon could import the SNAP-tag protein and ligand, but we would argued that the damaged OPTN-positive mitochondria would not have the capacity to import new protein or be labeled by the new ligand because it is sequestered. Thus, these rounded structures would indicate that they were labeled and engulfed before the addition of the new SNAP-ligand. In the revised manuscript, we more clearly describe the labeling protocol in the text and figure legends and have updated the labeling schematic in the revised Figure 7.</p><disp-quote content-type="editor-comment"><p>In Figure 7, the authors examine an OPTN mutant found in ALS, and see general but small effects on mitochondrial size. This experiment is somewhat limited by the fact that OPTN deletion by siRNA is only ~60%, and it is possible that the overexpressed OPTN mutant (not sure how much it is overexpressed as they didn't show a western of the transfected cells) may also act as a dominant negative – binding TBK1 but not Ub chains. What isn't clear is whether the authors have missed an opportunity to statistically determine whether the OPTN mutant encircles damaged mito. The experiments are largely limited to mito morphology.</p></disp-quote><p>Please see the revised Figure 8—figure supplement 1C for a western blot showing relative equal levels of overexpression of Halo-OPTN WT and E478G. However, since neuronal transfection efficiency is low, it is not surprising that a 60% reduction in OPTN was observed. This reduction in OPTN expression is from an entire plate of cells, which includes cells that did not take up the siRNA. When imaging neurons, we selected cells that are transfected and therefore were more likely to also have taken up the siRNA.</p><p>Since it was previously shown that OPTN<sup>E478G</sup> fails to engulf damaged mitochondria (Moore and Holzbaur, 2016), we sought to understand the functional significance of expression of this mutant on mitochondrial and neuronal health. Using our mitophagy-inducing paradigm, we think these experiments provide new insights into how expression of this mutant could lead to neurodegeneration.</p><disp-quote content-type="editor-comment"><p>An important weakness of the analysis is the absence of a direct demonstration of mitophagic flux.</p></disp-quote><p>We now include mitophagic (Cox8-EGFP-mCherry) flux assays and complementary autophagic (mCherry-GFP-LC3) and lysosomal (SEP-LAMP1-RFP) flux experiments, please see the new Figure 6, Figure 6—figure supplement 1, and Figure 5—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>In their manuscript, Evans and Holzbaur present data arguing two main points regarding mitophagy in neurons: (1) that mitophagy occurs mainly in the soma and not in axons, contrary to some previous work by others, and (2) that neuronal mitophagy is significantly slower relative to other cell types, as result of slow acidification of mitoautophagosomes. Although the experiments are generally well-performed additional evidence is required in support of their main conclusions.</p><p>Major comments:</p><p>1) The implication throughout the paper is that the optineurin rings forming around mitochondria in response to mild oxidative stress are due to PINK1/Parkin dependent mitophagy. This should be demonstrated with knockdown or knockout of PINK1 and Parkin. This is particularly important given lack of clarity on the role of PINK1/Parkin mitophagy in neurons in response to more physiologically relevant stressors.</p></disp-quote><p>As previously stated, we performed Parkin knock-down and rescue experiments. We observed a 30% reduction in Parkin expression by immunoblot analysis. It is important to note that this measurement is an underestimate, as lysates were generated from an entire plate of hippocampal neurons, which transfect at a low efficiency and therefore includes many cells that did not take up the siRNA. When imaging neurons, we selected cells that were transfected and therefore did take up the Parkin siRNA. This level of knock-down was sufficient to significantly inhibit the number of cells with OPTN-positive rings, from ~35% down to less than 10%, which was rescued by re-expression of WT Parkin. This data has been included in the revised manuscript, please see Figure 2—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>2) A major finding of the manuscript is that mitophagy occurs primarily in the cell soma and not the axons, in contrast to the findings of Ashrafi et al. As a rationale for this discrepancy, they suggest that they are applying a milder stress (withholding antioxidants from neuronal media) that does not lead to global bioenergetic collapse. This explanation doesn't seem satisfactory, however, as Ashrafi et al., also, used a variety of experimental setups to induce local damage mitochondria without affecting the overall bioenergetics of the neuron. An alternative explanation for the discrepancy might be that the particular exposure used by Evans and Holzbaur (withholding antioxidants) preferentially increases oxidative stress and mitochondrial damage in the cell soma as opposed to the axons. Does ROS increase equally in the axon and cell body with antioxidant withdrawal? Does the authors treatment result in TMRE negative mitochondria in axons that are not captured by Optineurin in contrast to the cell soma? When the authors treat with antimycin for 2 hours (which increases ROS locally at the mitochondria) do they see the same preferential increase in mitophagy in the soma or are mitochondria in the axons also targeted? Ashrafi saw axonal events as soon as 45 minutes, do the authors see axonal events at these early timepoints? Ashafri noted increased axonal events with the use of lysosomal inhibitors. If these are used by the authors, do they then see axonal events?</p></disp-quote><p>Ashrafi et al., (2014) induced mitochondrial damage using much higher doses of AA (20 or 40 µM) or locally via mito-KillerRed. In the mito-KillerRed experiments, imaging was initially performed in HBSS buffer instead of Hibernate E to enhance the effects of ROS produced by mito-KillerRed. We argue that this approach may affect the overall bioenergetics of the neuron.</p><p>We performed experiments to observe the ROS production of axonal mitochondria in neurons treated with antioxidant removal or by a much lower concentration of AA. We measured CellROX fluorescence intensity in the soma and processes of hippocampal neurons using fluorescence microscopy (note CellROX measurements in Figure 1B were performed on a plate reader). In these experiments, we observed significant increases in ROS production, measured by increases in CellROX intensity, in both the soma and processes of hippocampal neurons following 6 hours AO-free or 2 hours of 3 nM AA treatment (Figure 3G-H), suggesting that our global treatment targets all mitochondria. Further, since we observed shorter axonal mitochondria after 2 hours AA treatment, this timepoint should be sufficient to identify axonal events.</p><p>To follow up on this point, we measured axonal mitochondrial health using TMRE and saw no differences in TMRE intensity across these conditions (Figure 3—figure supplement 1J). However, this is not surprising as we did not observe differences in the somal mitochondrial population, where we routinely saw mitophagic events (Figure 1D). These observations are fully consistent with our approach of inducing low level damage without grossly perturbing the overall mitochondrial network.</p><p>We treated cells for 2 hours with AA and looked for colocalization of OPTN with fragmented mitochondria in the axon. Of the 21 neurons analyzed, we did not observe OPTN-positive mitochondria in the axon. Yet, similar treatments resulted in 35% of neurons having OPTN-positive mitochondria rings in the soma (Figure 3F), suggesting preferential increases in the somal compartment. Additional experiments were performed where AA treatments were reduced to 1 hour. Again, we observed mitophagic events were rare in the axon (3 events in 1 axon of the 28 neurons analyzed), but routinely found in soma (Figure 3D). However, we think it likely that if we did use a 10-20-fold higher dose of AA, we might see more evidence of axonal mitophagy as previously described (Ashrafi et al., 2014). It is possible that neurons are in a survival state, where axonal mitochondria undergo mitophagy locally to preserve the health of the neuron. We clarify this point in the revised manuscript. In general, however, under the paradigm described here axonal mitophagic events were rare across all conditions and did not increase with mild oxidative stress relative to control or with longer incubation times (1 vs 6 hours).</p><disp-quote content-type="editor-comment"><p>3) In Figure 5 the authors compare the speed of mitophagosome maturation in neurons and HeLa cells. They conclude that the difference in speed reflects a difference in processes downstream of mitochondrial ubiquitination, but the level mitochondrial ubiquitination is likely very different in neurons with endogenous Parkin subjected to mild oxidative stress and HeLa cells over-expressing Parkin and fully depolarized with OA. Could this account for the difference in maturation rate? Do the authors still see a difference in the speed of mitophagosome maturation when the two cell types are subjected to more equal treatment – e.g., in neurons and HeLa cells that are both overexpressing Parkin and are subjected to the same oxidative stress (e.g., antimycin)? Additionally, the authors note that acidification of mitoauthophagosomes is delayed in neurons? How long is it delayed? What do they see at time points longer than one day?</p></disp-quote><p>While we appreciate the point that we could use alternate paradigms to induce mitochondrial stress or attempt to equalize levels of Parkin expression to make HeLa cells a closer model of neuronal mitophagy, we thought that the more important question was to determine whether there is a universal deficit in autophagosome/lysosome acidification in hippocampal neurons subjected to mild oxidative stress, or whether there is a specific deficit in the acidification and eventual degradation of mitophagolysosomes. We therefore focused on this point. New data now included in the manuscript reveal that there is no overall perturbation in the extent of either autophagosomal or lysosomal acidification in neurons incubated in AO-free media as compared to control conditions (Figure 5—figure supplement 1). Thus, our data suggest that delayed acidification of mitophagosomes or ‘late’ mitophagosomes is specific in neurons. Using our experimental conditions, it would be difficult to continuously image cells for days. However, in Figure 7 we include data demonstrating the persistence of pulse-labeled OPTN-positive mitochondria that had yet to undergo autophagosome or lysosome engulfment 24 hours after mitophagy induction. Thus, the delay in acidification of mitophagolysosomes appears to be on the order of hours to days.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>In the manuscript by Evans and Holzbaur, the authors examine the dynamics of OPTN recruitment to mitochondria and subsequent delivery to lysosomes following mild oxidative stress in primary rat hippocampal neurons. The authors mainly use transfected neurons and live-cell microscopy and find that OPTN is rapidly recruited to a subset of mitochondria, primarily in the soma, following anti-oxidant removal from the cell media. This then correlated with subsequent recruitment of mitophagy and lysosomal markers. Surprisingly, and the main take home message from the manuscript, was that the OPTN puncta on mitochondria do not become efficiently acidified (as visualized by col-localisation with lysotracker), from which the authors conclude that this is a rate-limiting step during neuronal mitophagy.</p><p>This is an intriguing manuscript with many interesting observations. The identification of &quot;mild&quot; depolarising conditions that trigger a mitophagy response will be useful to the field and certainly does appear more physiological that the use of CCCP or oligomycin/antimycin. The microscopy images are impressive and convincing in what they show. However, I think more work is needed to determine whether this phenomenon is specific to mitophagosomes and neurons in general.</p><p>Major comments:</p><p>1) I think more robust analyses of lysosome acidification are needed. It is surprising and very interesting that there is a large delay in acidification of mitolysosomes. Is this a general phenomenon, i.e are acidified lysosomes scarce in these cells? What is the percentage of LAMP1 structures (regardless of co-localising with OPTN) that are LysoTracker +ve? If it is low, could this mean that most of the LAMP1-GFP is not in lysosomes? Could the authors use another lysosomal marker to confirm?</p></disp-quote><p>To investigate the acidification of lysosomes, we measured the percentage of LAMP1-EGFP structures that were positive for LysoT. We determined that ~89% of LAMP1 structures were also positive for LysoT (red arrows). In addition, we repeated these experiments with LAMP2GFP and observed ~88% of LAMP2 structures were also LysoT-positive. Thus, in our hands the majority of lysosomes in the soma are acidified in hippocampal neurons; representative images are shown in <xref ref-type="fig" rid="respfig4">Author response image 4</xref>.</p><fig id="respfig4"><label>Author response image 4.</label><caption><title>Representative images of hippocampal neurons illustrating that the majority of LAMP1-positive (<bold>A</bold>) or LAMP2-positive (<bold>B</bold>) organelles are acidified, as indicated by the presence of LysoT.</title><p>LAMP-LysoT-positive lysosomes are indicated by red arrows and inset; LAMP-positive LysoT-negative organelles are indicated by open white arrows. Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-resp-fig4-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2) Related to the above point, the authors only use LysoTracker to estimate lysosomal acidification. Is there another way the authors could estimate this – for example using ratiometric fluorophores, such as Keima or mCherry-GFP?</p></disp-quote><p>As described above, we utilized SEP-LAMP1-RFP, a superecliptic pHluorin that is fused to the lumen domain of LAMP1-RFP (Farias et al., 2017) to measure lysosome acidification. In the soma, ~96% of LAMP1 organelles in control conditions were positive for RFP but negative for SEP, indicating that the majority of lysosomes are acidified organelles. Similar results were observed in 1 hour AO-free conditions. These data are now included in the revised manuscript, please see Figure 5—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>3) Is the delay in acidification specific to mitolysosomes? What about autophagosomes in general? The authors could monitor the formation of OPTN -ve LC3 puncta under their conditions and determine if these equally take as long to become acidified. The authors may wish to discuss Ralph Nixon's work (e.g. Boland et al., 2008) that argues autophagosome fusion with lysosomes is very efficient in neurons.</p></disp-quote><p>We performed the requested experiment and determined that 71-85% of autophagosomes in the soma are acidified. Additionally, autophagosome acidification was not affected by antioxidant removal, with similar results found with either 1 or 6 h treatments (Figure 5—figure supplement 1). Furthermore, we observed a considerable amount of LC3-II via western blot across all conditions (Figure 1G-H). Collectively, these results suggest autophagosome fusion and acidification is efficient in neurons and support the findings of Boland et al., (2008).</p><disp-quote content-type="editor-comment"><p>4) Are the authors sure it is mitophagosome acidification that is rate-limiting and not an earlier step in the pathway? For example, is it possible that the autophagosome is not fully sealed (despite appearing circular by fluorescence microscopy). The authors could look at early autophagosome markers such as ULK1, ATG5 or WIPI that are not present on mature autophagosomes. Or mature autophagosome markers such as STX17.</p></disp-quote><p>To determine whether earlier steps in the pathway were rate-limiting, we observed WIPI2B, an early autophagosome marker, colocalization with mitophagosomes. In the soma, we observed WIPI2B puncta that colocalized with LC3, indicating these are immature autophagosomes. However, in both control and AO-free conditions OPTN-LC3-positive mitochondria were negative for WIPI2B, suggesting that these autophagosomes are fully formed.</p><fig id="respfig5"><label>Author response image 5.</label><caption><title>Representative images of neurons 1 h after control or AO-free treatment.</title><p>Mitophagosomes are indicated by red arrows and inset. OPTNLC3-positive mitochondria are negative for WIPI2B, indicating fully formed autophagosomes. Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50260-resp-fig5-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>5) The authors imply that this delay is specific to neurons, yet they only look in hippocampal neurons and compare this to HeLa cells overexpressing Parkin. I think the authors need to provide some more data in relevant cell lines for a better comparison. What about cortical neurons, as well and comparing with primary fibroblasts (which should contain all the relevant Parkin pathway components)?</p></disp-quote><p>We thank the reviewer for their comment. The use of HeLa cells provides an alternative cell line to investigate mitophagy. Since HeLa cells are readily used to characterize mitophagy and we observed similar temporal dynamics for OPTN and LC3 translocation, we felt that it was a suitable system to compare for rates of mitophagosome acidification. Previous work has looked at the time course of mitophagy in cortical neurons where the authors suggested that mitophagy was slower and compartmentally restricted compared to non-neuronal cells (Cai et al., 2012), consistent with our findings – we further clarify this point in the revised manuscript.</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>Based on the comments of reviewer 3, a couple of changes in the manuscript are still needed. First, some data that are described in the rebuttal don't appear in the paper, so Figure 4 may need to be updated to include data that were discussed in the rebuttal. In addition, there are a couple of suggested changes to the text that will need to be addressed.</p><p>Reviewer #3:</p><p>This is a re-review of the manuscript by Evans et al., describing the slow maturation/impaired acidification of mitophagosomes in the soma of neurons. I think the authors have done a great job in strengthening their manuscript – my main concern was with the lysosomal acidification studies and the use of the dual reporters means the data are much more convincing. I just have a few small points remaining:</p><p>1) The LAMP2 data, mentioned in subsection” Acidification of OPTN-positive mitochondria is a rate-limiting step in neuronal mitophagy” and in the comments to reviewers does not seem to be in the manuscript. The authors mention Figure 4E, but these are only LC3-related. Please include the data.</p></disp-quote><p>In addition to providing the percent of LAMP1 and LAMP2 structures that were Lyso-T positive in the text, we now include images in the revised manuscript (please see Figure 5—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>2) Likewise, the authors show data in the reviewers comments that the OPTN/LC3 structures are WIPI -ve. I do not see these data in the manuscript. This shows that the structures are not early autophagosomal in nature and thus they will be of interest to readers (and not just this reviewer) and so should be included (at least in the supplemental). I'm assuming WIPI2B is expressed in these cells and does indeed form puncta with LC3 when autophagy is induced?</p></disp-quote><p>At the reviewer’s request, we now include the WIPI2B data in Figure 5—figure supplement 1. WIPI2B, an early autophagosome marker, has been shown to be critical in the autophagy pathway, as depletion of WIPI2 in DRG neurons significantly decreased autophagosome biogenesis (Stavoe et al., 2019). In hippocampal neurons, we observed WIPI2B puncta that colocalized with LC3 in the soma, indicating immature autophagosomes (examples are highlighted by green arrows).</p><disp-quote content-type="editor-comment"><p>3) I also take on the point that the authors have made in response to my concern raised in point 5 – i.e. that HeLa cells overexpressing Parkin are a suitable system to compare to the neurons. The HeLa cell has been instrumental in the field in terms of building up the mechanism of PINK/Parkin mitophagy. But this is not a &quot;normal&quot; cell. Normally, it does not undergo this pathway as it does not express Parkin! I think to avoid doing more experiments, the authors can be more accurate in what they state and say that this delay in acidification does not occur in HeLa cells expressing Parkin. For example in subsection “Acidification of OPTN-positive mitochondria is a rate-limiting step in neuronal mitophagy”: &quot;…..much slower than the corresponding time course in non-neuronal cells.&quot; Should be replaced with &quot;…..much slower than the corresponding time course in HeLa cells.&quot;</p></disp-quote><p>The statement has been changed to “much slower than the corresponding time course in HeLa cells expressing exogenous Parkin.”</p></body></sub-article></article>